INTEL CORP, 10-K filed on 2/16/2018
Annual Report
Document and Entity Information (USD $)
In Billions, except Share data in Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Feb. 7, 2018
Jun. 30, 2017
Document and Entity Information [Abstract]
 
 
 
Entity Registrant Name
Intel Corporation 
 
 
Entity Central Index Key
0000050863 
 
 
Company Fiscal Year End Date
--12-30 
 
 
Entity Filer Category
Large Accelerated Filer 
 
 
Document Type
10-K 
 
 
Document Period End Date
Dec. 30, 2017 
 
 
Document Fiscal Year Focus
2017 
 
 
Document Fiscal Period Focus
FY 
 
 
Amendment Flag
false 
 
 
Entity Common Stock, Shares Outstanding
 
4,668 
 
Entity Well-known Seasoned Issuer
Yes 
 
 
Entity Voluntary Filers
No 
 
 
Entity Current Reporting Status
Yes 
 
 
Entity Public Float
 
 
$ 158.3 
Consolidated Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Income Statement [Abstract]
 
 
 
Net revenue
$ 62,761 
$ 59,387 
$ 55,355 
Cost of sales
23,692 
23,196 
20,676 
Gross margin
39,069 
36,191 
34,679 
Research and development
13,098 
12,740 
12,128 
Marketing, general and administrative
7,474 
8,397 
7,930 
Restructuring and other charges
384 
1,886 
354 
Depreciation, Depletion and Amortization, Nonproduction
177 
294 
265 
Operating expenses
21,133 
23,317 
20,677 
Operating income
17,936 
12,874 
14,002 
Gains (losses) on equity investments, net
2,651 
506 
315 
Nonoperating Income (Expense)
(235)
(444)
(105)
Income before taxes
20,352 
12,936 
14,212 
Provision for taxes
10,751 
2,620 
2,792 
Net income
$ 9,601 
$ 10,316 
$ 11,420 
Earnings per share - Basic
$ 2.04 
$ 2.18 
$ 2.41 
Earnings per share - Diluted
$ 1.99 
$ 2.12 
$ 2.33 
Weighted average shares of common stock outstanding:
 
 
 
Basic (shares)
4,701 
4,730 
4,742 
Diluted (shares)
4,835 
4,875 
4,894 
Consolidated Statements of Comprehensive Income (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Statement of Comprehensive Income [Abstract]
 
 
 
Net income
$ 9,601 
$ 10,316 
$ 11,420 
Other comprehensive income, net of tax:
 
 
 
Net unrealized holding gains (losses) on available-for-sale investments
(436)
415 
(710)
Net unrealized holding gains (losses) on available-for-sale investments
(8)
(18)
Net unrealized holding gains (losses) on derivatives
365 
157 
Actuarial valuation and other pension expenses
317 
(364)
135 
Net foreign currency translation adjustment
510 
(4)
(170)
Other comprehensive income (loss)
756 
46 
(606)
Total comprehensive income
$ 10,357 
$ 10,362 
$ 10,814 
Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Current assets:
 
 
Cash and cash equivalents
$ 3,433 
$ 5,560 
Short-term investments
1,814 
3,225 
Trading assets
8,755 
8,314 
Accounts receivable, net of allowance for doubtful accounts of $25 ($37 in 2016)
5,607 
4,690 
Inventories
6,983 
5,553 
Assets held for sale
5,210 
Other current assets
2,908 
2,956 
Total current assets
29,500 
35,508 
Property, plant and equipment, net
41,109 
36,171 
Marketable equity securities
4,192 
6,180 
Other long-term investments
3,712 
4,716 
Goodwill
24,389 
14,099 
Identified intangible assets, net
12,745 
9,494 
Other long-term assets
7,602 
7,159 
Total assets
123,249 
113,327 
Current liabilities:
 
 
Short-term debt
1,776 
4,634 
Accounts payable
2,928 
2,475 
Accrued compensation and benefits
3,526 
3,465 
Deferred income
1,656 
1,718 
Liabilities held for sale
1,920 
Other accrued liabilities
7,535 
6,090 
Total current liabilities
17,421 
20,302 
Long-term debt
25,037 
20,649 
Long-term deferred tax liabilities
3,046 
1,730 
Other long-term liabilities
7,860 
3,538 
Commitments and Contingencies (Note 20)
   
   
Temporary equity
866 
882 
Stockholders' equity:
 
 
Preferred stock, $0.001 par value, 50 shares authorized; none issued
Common stock, $0.001 par value, 10,000 shares authorized; 4,687 shares issued and outstanding (4,730 issued and outstanding in 2016) and capital in excess of par value
26,074 
25,373 
Accumulated other comprehensive income (loss)
862 
106 
Retained earnings
42,083 
40,747 
Total stockholders’ equity
69,019 
66,226 
Total liabilities, temporary equity, and stockholders’ equity
$ 123,249 
$ 113,327 
Consolidated Balance Sheets (Parenthetical) (USD $)
In Millions, except Per Share data, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Current assets:
 
 
Accounts receivable allowance for doubtful accounts
$ 25 
$ 37 
Stockholders' equity:
 
 
Preferred stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
Preferred stock, shares authorized
50 
50 
Preferred stock, shares issued
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
Common stock, shares authorized
10,000 
10,000 
Common stock, shares issued
4,687 
4,730 
Common stock, shares outstanding
4,687 
4,730 
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Statement of Cash Flows [Abstract]
 
 
 
Cash and cash equivalents, beginning of period
$ 5,560 
$ 15,308 
$ 2,561 
Cash flows provided by (used for) operating activities:
 
 
 
Net income
9,601 
10,316 
11,420 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
6,752 
6,266 
7,821 
Share-based compensation
1,358 
1,444 
1,305 
Restructuring and other charges
384 
1,886 
354 
Amortization of intangibles
1,377 
1,524 
890 
Gain (Loss) on Sale of Equity Investments
2,583 
432 
263 
Gain (Loss) on Extinguishment of Debt
476 
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
387 
Deferred taxes
1,548 
257 
(1,270)
Changes in assets and liabilities:1
 
 
 
Accounts receivable
(781)
65 
(355)
Inventories
(1,300)
119 
(764)
Accounts payable
191 
182 
(312)
Accrued compensation and benefits
(73)
(1,595)
(711)
Income taxes payable and receivable
5,230 
1,382 
386 
Other assets and liabilities
317 
394 
517 
Total adjustments
12,509 
11,492 
7,598 
Net cash provided by operating activities
22,110 
21,808 
19,018 
Cash flows provided by (used for) investing activities:
 
 
 
Additions to property, plant and equipment
(11,778)
(9,625)
(7,326)
Acquisitions, net of cash acquired
(14,499)
(15,470)
(913)
Purchases of available-for-sale investments
(2,764)
(9,269)
(8,259)
Sales of available-for-sale investments
6,978 
3,852 
2,090 
Maturities of available-for-sale investments
3,687 
5,654 
6,168 
Purchases of trading assets
(13,700)
(12,237)
(11,485)
Maturities and sales of trading assets
13,975 
10,907 
13,372 
Investments in non-marketable equity investments
(1,601)
(963)
(2,011)
Proceeds from Divestiture of Businesses
3,124 
Other investing
816 
1,334 
181 
Net cash used for investing activities
(15,762)
(25,817)
(8,183)
Cash flows provided by (used for) financing activities:
 
 
 
Issuance of long-term debt, net of issuance costs
7,716 
2,734 
9,476 
Repayments of Long-term Debt
(8,080)
(1,500)
Proceeds from sales of common stock through employee equity incentive plans
770 
1,108 
866 
Repurchase of common stock
(3,615)
(2,587)
(3,001)
Payment of dividends to stockholders
(5,072)
(4,925)
(4,556)
Other financing
(194)
(569)
(873)
Net cash provided by (used for) financing activities
(8,475)
(5,739)
1,912 
Net increase (decrease) in cash and cash equivalents
(2,127)
(9,748)
12,747 
Cash and cash equivalents, end of period
3,433 
5,560 
15,308 
Supplemental disclosures:
 
 
 
Acquisitions of property, plant, and equipment included in accounts payable and accrued liabilities
1,417 
979 
392 
Transfer to Investments
1,078 
Interest, net of capitalized interest and interest rate swap payments/receipts
624 
682 
186 
Income taxes, net of refunds
$ 3,824 
$ 877 
$ 3,439 
Consolidated Statements of Stockholders' Equity (USD $)
In Millions, unless otherwise specified
Total
Common Stock and Capital in Excess of Par Value [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Mobileye N.V. [Member]
Beginning Balance at Dec. 27, 2014
$ 55,865 
$ 21,781 
$ 666 
$ 33,418 
 
Beginning Balance, shares at Dec. 27, 2014
 
4,748 
 
 
 
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
Repurchase of common stock, shares
 
(96)
 
 
 
Restricted stock unit withholdings, shares
 
(14)
 
 
 
Components of comprehensive income, net of tax:
 
 
 
 
 
Net income
11,420 
 
 
11,420 
 
Other comprehensive income (loss)
(606)
 
(606)
 
 
Total comprehensive income
10,814 
 
 
 
 
Stock Issued During Period, Shares, Employee Stock Purchase Plans
 
87 
 
 
 
Adjustments to Additional Paid in Capital, Share-based Compensation, Employee Stock Purchase Program, Requisite Service Period Recognition
1,091 
1,091 
 
 
 
Share-based compensation
1,314 
1,314 
 
 
 
Repurchase of common stock
(3,001)
(453)
 
(2,548)
 
Restricted stock unit withholdings
(442)
(322)
 
(120)
 
Cash dividends declared
(4,556)
 
 
(4,556)
 
Ending Balance at Dec. 26, 2015
61,085 
23,411 
60 
37,614 
 
Ending Balance, shares at Dec. 26, 2015
 
4,725 
 
 
 
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
Repurchase of common stock, shares
 
(81)
 
 
 
Restricted stock unit withholdings, shares
 
(15)
 
 
 
Components of comprehensive income, net of tax:
 
 
 
 
 
Net income
10,316 
 
 
10,316 
 
Other comprehensive income (loss)
46 
 
46 
 
 
Total comprehensive income
10,362 
 
 
 
 
Stock Issued During Period, Shares, Employee Stock Purchase Plans
 
101 
 
 
 
Adjustments to Additional Paid in Capital, Share-based Compensation, Employee Stock Purchase Program, Requisite Service Period Recognition
1,322 
1,322 
 
 
 
Share-based compensation
1,438 
1,438 
 
 
 
Repurchase of common stock
(2,592)
(412)
 
(2,180)
 
Restricted stock unit withholdings
(464)
(386)
 
(78)
 
Cash dividends declared
(4,925)
 
 
(4,925)
 
Ending Balance at Dec. 31, 2016
66,226 
25,373 
106 
40,747 
 
Ending Balance, shares at Dec. 31, 2016
4,730 
4,730 
 
 
 
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value
 
 
 
 
375 
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
Repurchase of common stock, shares
 
(101)
 
 
 
Restricted stock unit withholdings, shares
 
(12)
 
 
 
Components of comprehensive income, net of tax:
 
 
 
 
 
Net income
9,601 
 
 
9,601 
 
Other comprehensive income (loss)
756 
 
756 
 
 
Total comprehensive income
10,357 
 
 
 
 
Stock Issued During Period, Shares, Employee Stock Purchase Plans
 
70 
 
 
 
Adjustments to Additional Paid in Capital, Share-based Compensation, Employee Stock Purchase Program, Requisite Service Period Recognition
1,171 
1,172 
 
(1)
 
Share-based compensation
1,296 
1,296 
 
 
 
Temporary Equity, Carrying Amount, Period Increase (Decrease)
(894)
 
 
 
 
Repurchase of common stock
(3,609)
(552)
 
(3,057)
 
Restricted stock unit withholdings
(456)
(321)
 
(135)
 
Cash dividends declared
(5,072)
 
 
(5,072)
 
Ending Balance at Dec. 30, 2017
$ 69,019 
$ 26,074 
$ 862 
$ 42,083 
 
Ending Balance, shares at Dec. 30, 2017
4,687 
4,687 
 
 
 
Consolidated Statements of Stockholders' Equity (Parenthetical) (Retained Earnings [Member], USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Retained Earnings [Member]
 
 
 
Cash dividends declared per common share (in dollars per share)
$ 1.0775 
$ 1.04 
$ 0.96 
Basis of Presentation
Basis of Presentation [Text Block]
Note 1: Basis of Presentation
We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal year 2017 was a 52-week fiscal year, while fiscal year 2016 was a 53-week fiscal year with the first quarter of 2016 being a 14-week quarter. Fiscal year 2015 was a 52-week year. Our consolidated financial statements include the accounts of Intel Corporation (Intel) and our subsidiaries. We have eliminated intercompany accounts and transactions. We have reclassified certain prior period amounts to conform to current period presentation.
USE OF ESTIMATES
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The actual results that we experience may differ materially from our estimates.
During our 2015 annual assessment of the useful lives of our property, plant and equipment, we determined that the estimated useful lives of machinery and equipment in our wafer fabrication facilities should be increased from 4 to 5 years because the lengthening of the process technology cadence resulted in longer node transitions on both 14 nanometer (nm) and 10nm products. We have also increased the re-use of machinery and tools across each generation of process technology. This change in estimate was applied prospectively, effective at the beginning of 2016. During 2016, this change increased our operating income by approximately $1.3 billion, our net income by approximately $950 million, and our diluted earnings per share by approximately $0.19.
Accounting Policies
Accounting Policies [Text Block]
Note 2: Accounting Policies
REVENUE RECOGNITION
We recognize net product revenue when the earnings process is complete and the risks and rewards of product ownership have transferred to our customers, as evidenced by the existence of an agreement, delivery having occurred, pricing being deemed fixed, and collection being considered probable. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. On sales made to distributors that allow for price protections or right of return until the distributor sells through the merchandise, we defer product revenue, and related costs of sales, due to sales price reductions and rapid technology obsolescence in our industry. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
We make payments to our customers through cooperative advertising programs, such as our Intel Inside® program, for marketing activities for certain of our products. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue.
During the first half of 2017, our cooperative advertising costs under the Intel Inside program met the criteria to be recorded as MG&A. During the second half of 2017, we transitioned customers from previous offerings under the Intel Inside program to cooperative advertising offerings more tailored to customers and their marketing audiences. In the second half of 2017, cooperative advertising costs were recorded as a reduction of revenue, as we no longer met the criteria for recording these expenses within MG&A.
INVENTORIES
We compute inventory cost on a first-in, first-out basis. Our process and product development life cycle corresponds with substantive engineering milestones. These engineering milestones are regularly and consistently applied in assessing the point at which our activities, and associated costs, change in nature from research and development (R&D) to cost of sales and when cost of sales can be capitalized as inventory.
For a product to be manufactured in high volumes and sold to our customers under our standard warranty, it must meet our rigorous technical quality specifications. This milestone is known as product release qualification (PRQ). We have identified PRQ as the point at which the costs incurred to manufacture our products are included in the valuation of inventory. Prior to PRQ, costs that do not meet the criteria for R&D are included in cost of sales in the period incurred. If the point at which we estimate that inventory meets PRQ criteria changes in the future, the timing and recognition of costs would shift between inventory, and R&D and costs of sales. A single PRQ has previously ranged up to $770 million and is dependent on product type.
The valuation of inventory includes determining which fixed production overhead costs can be included in inventory based on the normal capacity of our manufacturing and assembly and test facilities. We apply our historical loadings compared to our total available capacity in a statistical model to determine our normal capacity level. If the factory loadings are below the established normal capacity level, a portion of our fixed production overhead costs would not be included in the cost of inventory; instead, it would be recognized as cost of sales in that period. We refer to these costs as excess capacity charges. Excess capacity charges are insignificant in the years presented, charges in certain prior years have ranged from $46 million to $1.1 billion. The high end of the range would be $540 million when excluding the $1.1 billion charge taken in connection with the 2009 economic recession.
Inventory is valued at the lower of cost or net realizable value, based upon assumptions about future demand and market conditions. Product-specific facts and circumstances reviewed in the inventory valuation process include a review of our customer base, the stage of the product life cycle, and an assessment of selling price in relation to product cost. Inventory reserves increased by approximately $185 million in 2017 compared to 2016.
The valuation of inventory also requires us to estimate obsolete and excess inventory, as well as inventory that is not of saleable quality. We use the demand forecast to develop our short-term manufacturing plans to enable consistency between inventory valuations and build decisions. We compare the estimate of future demand to work in process and finished goods inventory levels to determine the amount, if any, of obsolete or excess inventory. If our demand forecast for specific products is greater than actual demand and we fail to reduce manufacturing output accordingly, we could be required to write off inventory.
PROPERTY, PLANT AND EQUIPMENT
We compute depreciation using the straight-line method over the estimated useful life of assets. We also capitalize interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. We record capital-related government grants earned as a reduction to property, plant and equipment.
Annually, we evaluate the period over which we expect to recover the economic value of our property, plant and equipment, considering factors such as the process technology cadence between node transitions, changes in machinery and equipment technology, and re-use of machinery and tools across each generation of process technology. As we make manufacturing process conversions and other factory planning decisions, we use assumptions involving the use of management judgments regarding the remaining useful lives of assets, primarily process-specific semiconductor manufacturing tools and building improvements. When we determine that the useful lives of assets are shorter or longer than we had originally estimated, we adjust the rate of depreciation to reflect the assets’ revised useful lives.
We assess property, plant and equipment for impairment when events or changes in circumstances indicate that the carrying value of the assets or the asset grouping may not be recoverable. Factors that we consider in deciding when to perform an impairment review include significant under-performance of a business or product line in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in our use of the assets. We measure the recoverability of assets that we will continue to use in our operations by comparing the carrying value of the asset grouping to our estimate of the related total future undiscounted net cash flows arising from the use of that asset grouping. If an asset grouping carrying value is not recoverable through the related undiscounted cash flows, the asset grouping is considered to be impaired. We measure the impairment by comparing the difference between the asset grouping carrying value and its fair value.
We may have certain facilities, included within construction in progress, being held in a safe state and not currently in use that we plan to place into service at a future date. The time at which these assets are placed into service depends on our existing manufacturing capacity, market demand for our products, and where we are in the transition of products on our roadmap. Management makes judgments about the timing of when these facilities will be readied for their intended use and placed into service for the manufacturing of our products. Depreciation is not recognized on these assets and they are not eligible for capitalized interest when construction is on hold.
FAIR VALUE
When determining fair value, we consider the principal or most advantageous market in which we would transact, as well as assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than three months.
The three levels of inputs that may be used to measure fair value are:
Level 1. Quoted prices in active markets for identical assets or liabilities. We evaluate security-specific market data when determining whether a market is active.
Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations. All significant inputs used in our valuations, such as discounted cash flows, are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. We use LIBOR-based yield curves, currency spot and forward rates, and credit ratings as significant inputs in our valuations. Level 2 inputs also include non-binding market consensus prices as well as quoted prices that were adjusted for security-specific restrictions. When we use non-binding market consensus prices, we corroborate them with quoted market prices for similar instruments or compare them to output from internally developed pricing models such as discounted cash flow models.
Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
CASH EQUIVALENTS
We consider all highly liquid debt investments with original maturities from the date of purchase of three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements.
TRADING ASSETS
Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge currency exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses on these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net.
AVAILABLE-FOR-SALE INVESTMENTS
Available-for-sale investments are classified within cash and cash equivalents, short-term investments, marketable equity securities, or long-term investments based on the remaining maturity of the investment.
Investments designated as available-for-sale are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in our other-than-temporary impairment policy. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We record the interest income and realized gains or losses on the sale of these instruments in interest and other, net.
Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity securities to promote business and strategic objectives. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
NON-MARKETABLE AND EQUITY METHOD INVESTMENTS
We regularly invest in non-marketable equity instruments of private companies. We account for marketable and non-marketable equity securities as equity method investments when we have the ability to exercise significant influence but do not have control over the investee. Our proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net. Non-marketable equity investments over which we cannot exercise significant influence are accounted for as cost method investments.
The carrying value of our non-marketable equity investment portfolio totaled $4.5 billion as of December 30, 2017 ($4.4 billion as of December 31, 2016), and is included in other long-term assets.
Our quarterly impairment analysis considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include industry and market conditions, the financial performance and near-term prospects of the investee, and other relevant events and factors affecting the investee. We prepare quarterly quantitative assessments of the fair value of our non-marketable equity investments using both the market and income approaches, which require judgment and the use of estimates, including discount rates, investee revenues and costs, and comparable market data of private and public companies, among others.
OTHER-THAN-TEMPORARY IMPAIRMENT
Our available-for-sale debt securities, marketable equity securities, and non-marketable equity investments are subject to periodic impairment reviews.
For available-for-sale debt securities, we consider whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis, or whether recovery of the entire amortized cost basis of the security is unlikely because a credit loss exists. When we do not expect to recover the entire amortized cost basis of the security, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts not related to credit losses, which are recognized in other comprehensive income (loss).
For marketable equity securities, we consider the severity and duration of the decline in fair value below cost and our ability and intent to hold the security for a sufficient period of time to allow for recovery of value in the foreseeable future based on the financial health of, and business outlook for, the investee.
For non-marketable equity investments, we consider the severity and duration of the impairment, the investee's financial condition and business outlook, industry and sector performance, market for technology, operational and financing cash flow factors, and changes in the investee's credit rating, among other qualitative and quantitative criteria. Impairments of non-marketable equity investments were $555 million in 2017 ($184 million in 2016 and $166 million in 2015).
We record other-than-temporary impairments for marketable equity securities, non-marketable cost method investments, and equity method investments in gains (losses) on equity investments, net.
DERIVATIVE FINANCIAL INSTRUMENTS
Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. We enter into master netting arrangements to mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty. A master netting arrangement allows counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. We also enter into collateral security arrangements with certain of our counterparties to exchange cash collateral when the net fair value of certain derivative instruments fluctuates from contractually established thresholds. We record the collateral within current other assets and long-term other assets with a corresponding liability. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are presented at fair value on a gross basis and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
Cash Flow Hedges
We use foreign currency contracts, such as currency forwards and currency interest rate swaps, to hedge exposures for the following items:
Variability in the U.S.-dollar equivalent of non-U.S.-dollar-denominated cash flows associated with our forecasted operating and capital purchases spending; and
Coupon and principal payments for our non-U.S.-dollar-denominated indebtedness.
The after-tax gains or losses from the effective portion of a cash flow hedge is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedge transaction. For foreign currency contracts hedging our capital purchases, forward points are excluded from the hedge effectiveness assessment. Ineffective portions of cash flow hedges, as well as amounts excluded from the hedge effectiveness assessment, are recognized in earnings in interest and other, net. If the cash flow hedge transactions become probable not to occur, the corresponding amounts deferred in accumulated other comprehensive income (loss) would be immediately reclassified to interest and other, net. These derivatives are classified in the consolidated statements of cash flows in the same section as the underlying item.
Fair Value Hedges
We use interest rate contracts, such as interest rate swaps, to hedge against changes in the fair value on certain of our fixed-rate indebtedness attributable to changes in the benchmark interest rate. The gains or losses on these hedges, as well as the offsetting losses or gains related to the changes in the fair value of the underlying hedged item attributable to the hedged risk, are recognized in earnings in the current period, primarily in interest and other, net. These derivatives are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from financing activities.


Non-Designated Hedges
We use foreign currency contracts to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and non-U.S.-dollar-denominated loans receivables recognized at fair value. We also use interest rate contracts to hedge interest rate risk related to our U.S.-dollar-denominated fixed-rate debt instruments classified as trading assets.
The change in fair value of these derivatives is recorded through earnings in the line item on the consolidated statements of income to which the derivatives most closely relate, primarily in interest and other, net. Changes in the fair value of the underlying assets and liabilities associated with the hedged risk are generally offset by the changes in the fair value of the related derivatives.
LOANS RECEIVABLE
We elect the fair value option when the interest rate or foreign currency exchange rate risk is economically hedged at the inception of the loan with a related derivative instrument. When the fair value option is not elected, the loans are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. We classify our loans within other current and long-term assets.
CREDIT RISK
Financial instruments that potentially subject us to concentrations of credit risk consist principally of investments in debt instruments, derivative financial instruments, loans receivable, reverse repurchase agreements, and trade receivables. We enter into master netting arrangements to mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty.
We generally place investments with high-credit-quality counterparties and, by policy, we limit the amount of credit exposure to any one counterparty based on our analysis of that counterparty’s relative credit standing. As required per our investment policy, substantially all of our investments in debt instruments and financing receivables are in investment-grade instruments. Credit-rating criteria for derivative instruments are similar to those for other investments. Due to master netting arrangements, the amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which the counterparty’s obligations exceed our obligations with that counterparty. As of December 30, 2017, our total credit exposure to any single counterparty, excluding money market funds invested in U.S. treasury and U.S. agency securities and reverse repurchase agreements collateralized by treasury and agency securities, did not exceed $800 million. To further reduce credit risk, we obtain and secure available collateral from counterparties against obligations, including securities lending transactions, when we deem it appropriate.
A substantial majority of our trade receivables are derived from sales to original equipment manufacturers and original design manufacturers. We also have accounts receivable derived from sales to industrial and communications equipment manufacturers in the computing and communications industries. We believe that the net accounts receivable balances from our three largest customers (36% in 2017) do not represent a significant credit risk, based on cash flow forecasts, balance sheet analysis, and past collection experience. For more information about the customers that represent our accounts receivable balance, see "Note 4: Operating Segments."
We have adopted credit policies and standards intended to accommodate industry growth and inherent risk. We believe that credit risks are moderated by the financial stability of our major customers. We assess credit risk through quantitative and qualitative analysis. From this analysis, we establish shipping and credit limits, and determine whether we will seek to use one or more credit support protection devices, such as obtaining a parent guarantee, standby letter of credit, or credit insurance.
BUSINESS COMBINATIONS
We allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions based on their estimated fair values at the time of acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. The most subjective areas include determining the fair value of the following:
intangible assets, including the valuation methodology, estimations of future cash flows, discount rates, market segment growth rates, our assumed market segment share, as well as the estimated useful life of intangible assets;
deferred tax assets and liabilities, uncertain tax positions, and tax-related valuation allowances, which are initially estimated as of the acquisition date;
inventory; property, plant and equipment; pre-existing liabilities or legal claims; deferred revenue; and contingent consideration, each as may be applicable; and
goodwill as measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed.
Our assumptions and estimates are based upon comparable market data and information obtained from our management and the management of the acquired companies. We allocate goodwill to the reporting units of the business that are expected to benefit from the business combination.
GOODWILL
We perform an annual impairment assessment of goodwill at the reporting unit level in the fourth quarter of each year, or more frequently if indicators of potential impairment exist. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt.
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting unit. Additionally, as part of this assessment, we may perform a quantitative analysis to support the qualitative factors above by applying sensitivities to assumptions and inputs used in measuring a reporting unit’s fair value.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. Significant estimates include market segment growth rates, our assumed market segment share, estimated costs, and discount rates based on a reporting unit's weighted average cost of capital.
We test the reasonableness of the inputs and outcomes of our discounted cash flow analysis against available market data. In the current year the fair value for all of our reporting units substantially exceeds their carrying value, and our annual qualitative assessment did not indicate that a more detailed quantitative analysis was necessary.
IDENTIFIED INTANGIBLE ASSETS
We amortize acquisition-related intangible assets that are subject to amortization over their estimated useful life. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as in-process R&D and are not subject to amortization. Once these R&D projects are completed, the asset balances are transferred from in-process R&D to acquisition-related developed technology and are subject to amortization from this point forward. The asset balances relating to projects that are abandoned after acquisition are impaired and expensed to R&D.
We perform a quarterly review of significant finite-lived identified intangible assets to determine whether facts and circumstances indicate that the carrying amount may not be recoverable. These reviews can be affected by various factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our forecasts for specific product lines.
EMPLOYEE EQUITY INCENTIVE PLANS
We use the straight-line amortization method to recognize share-based compensation over the service period of the award net of estimated forfeitures. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and RSUs with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
INCOME TAXES
We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled.
We assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that we will ultimately recover the deferred tax assets recorded on our consolidated balance sheets. Recovery of a portion of our deferred tax assets is affected by management’s plans with respect to holding or disposing of certain investments; therefore, such changes could also affect our future provision for taxes.
We recognize tax benefits from uncertain tax positions only if (based on the technical merits of the position) it is more likely than not that the tax positions will be sustained on examination by the tax authority. The tax benefits recognized in the financial statements from such positions are measured based on the largest amount that is more than 50% likely to be realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income.
We have recorded provisional estimates associated with the December 22, 2017 enactment of the U.S. Tax Cuts and Jobs Act (Tax Reform). The SEC has provided accounting and reporting guidance that allows us to report provisional amounts within a measurement period up to one year due to the complexities inherent in adopting the changes. We consider both the recognition of the transition tax and the remeasurement of deferred income taxes incomplete. New guidance from regulators, interpretation of the law, and refinement of our estimates from ongoing analysis of data and tax positions may change the provisional amounts.
The transition tax is based on our total post-1986 foreign earnings and profits that were previously deferred from U.S. taxation. We have not yet completed our substantiation of the underlying data and therefore our taxable base estimates may change. Our estimates of foreign tax credits may also change as we substantiate tax credits claimed. Further, the transition tax is based in part on the amount of foreign earnings held in cash and other liquid assets. The transition tax may change as we more precisely calculate amounts held in liquid and illiquid assets at the various measurement dates. If the final tax outcome of these matters is different than provisional amounts, its will impact the provision for income taxes and the effective tax rate in the period recorded. For more information about Tax Reform impacts, see "Note 8: Income Taxes."
We recognize the tax impact of including certain foreign earnings in U.S. taxable income as a period cost. We have not recognized deferred income taxes for local country income and withholding taxes that could be incurred on distributions of certain non-U.S. earnings or for outside basis differences in our subsidiaries, because we plan to indefinitely reinvest such earnings and basis differences. Remittances of non-U.S. earnings are based on estimates and judgments of projected cash flow needs, as well as the working capital and investment requirements of our non-U.S. and U.S. operations. Material changes in our estimates of cash, working capital, and investment needs in various jurisdictions could require repatriation of indefinitely reinvested non-U.S. earnings, which could be subject to applicable non-U.S. income and withholding taxes.
LOSS CONTINGENCIES
We are subject to loss contingencies, including various legal and regulatory proceedings, asserted and potential claims, liabilities related to repair or replacement of parts in connection with product defects, as well as product warranties and potential asset impairments that arise in the ordinary course of business. An estimated loss from such contingencies is recognized as a charge to income if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
Recent Accounting Standards
Recent Accounting Standards [Text Block]
Note 3: Recent Accounting Standards
ACCOUNTING STANDARDS ADOPTED
Standard/Description
Effective Date and Adoption Considerations
Effect on Financial Statements or Other Significant Matters
Intangibles - Goodwill and Other - Simplifying the Test for Goodwill Impairment. This accounting standard update eliminates Step 2 from the existing guidance to simplify how goodwill impairment tests are performed. With the elimination of this step, a goodwill impairment test is performed by comparing the fair value of a reporting unit to its carrying value. An impairment charge is recognized for the amount by which the reporting unit's carrying value exceeds its fair value.

We elected to early adopt this accounting standard update in the second quarter of 2017 on a prospective basis.

We expect the adoption of this update to simplify our annual goodwill impairment testing process, by eliminating the need to estimate the implied fair value of a reporting unit’s goodwill, if its respective carrying value exceeds fair value.


ACCOUNTING STANDARDS NOT YET ADOPTED
Standard/Description
Effective Date and Adoption Considerations
Effect on Financial Statements or Other Significant Matters
Revenue Recognition - Contracts with Customers. This standard was issued to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by all companies. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.
Effective in the first quarter of 2018.
We plan to adopt the standard retrospectively with the cumulative effect of initially applying it recognized at the date of initial application ("modified retrospective" approach).
Our assessment has identified a change in revenue recognition timing on our component sales made to distributors. We expect to recognize revenue when we deliver to the distributor rather than deferring recognition until the distributor sells the components.
On the date of initial application, we will remove the deferred income and related receivables on component sales made to distributors through a cumulative adjustment to retained earnings. We expect the revenue deferral, historically recognized in the following period, to be offset by the acceleration of revenue recognition as control of the product transfers to our customer.
Our assessment has also identified a change in expense recognition timing related to payments we make to our customers for distinct services they perform as part of cooperative advertising programs, which were previously recorded as operating expenses. We expect to recognize the expense for cooperative advertising in the period the marketing activities occur. We currently recognize the expense in the period the customer is entitled to participate in the program, which coincides with the period of sale. On the date of initial adoption, we will capitalize the expense of cooperative advertising not performed through a cumulative adjustment to retained earnings.
We have completed our assessment and implemented policies, processes, and controls to support the standards measurement and disclosure requirements. Refer to the table below, which summarizes the anticipated impacts of the changes discussed above to Intel's financial statements. This will be an adjustment to opening balances for the fiscal year beginning December 31, 2017.
Financial Instruments - Recognition and Measurement. Requires changes to the accounting for financial instruments that primarily affect equity investments, financial liabilities measured using the fair value option, and the presentation and disclosure requirements for such instruments.
Effective in the first quarter of 2018.
Changes to our marketable equity securities are required to be adopted using a modified retrospective approach through a cumulative effect adjustment to retained earnings for the fiscal year beginning December 31, 2017.
Since management has elected to apply the measurement alternative to non-marketable equity securities, changes to these securities are being adopted prospectively.

Marketable equity securities previously classified as available-for-sale equity investments will be measured and recorded at fair value with changes in fair value recorded through the income statement.
All non-marketable equity securities formerly classified as cost method investments will be measured and recorded using the measurement alternative upon adoption. Equity securities measured and recorded using the measurement alternative are recorded at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes. Adjustments resulting from impairments and observable price changes will be recorded in the income statement.
Beginning in the first quarter of 2018, in accordance with the standard, fair value disclosures will no longer be provided for equity securities measured using the measurement alternative. In addition, the existing impairment model will be replaced with a new one-step qualitative impairment model. No initial adoption adjustment will be recorded for these instruments since the standard is required to be applied prospectively for securities measured using the measurement alternative.
We have completed our assessment and implemented policies, processes, and controls to support the standard's measurement and disclosure requirements. Refer to the table below, which summarizes the anticipated impacts, net of tax, of the changes discussed above to Intel's financial statements. This will be an adjustment to opening balances for the fiscal year beginning December 31, 2017.
ACCOUNTING STANDARDS NOT YET ADOPTED
Standard/Description
Effective Date and Adoption Considerations
Effect on Financial Statements or Other Significant Matters
Compensation - Retirement Benefits - Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. This amended standard was issued to provide additional guidance on the presentation of net benefit cost in the income statement and on the components eligible for capitalization in assets. The service cost component of the net periodic benefit cost will continue to be reported within operating income on the consolidated income statement. All other non-service components are required to be presented separately outside operating income, and only service costs will be eligible for inventory capitalization.
Effective in the first quarter of 2018.
Changes to the presentation of benefit costs are required to be adopted retrospectively, while changes to the capitalization of service costs into inventories are required to be adopted prospectively. The standard permits, as a practical expedient, use of the amounts disclosed in the Retirement Benefit Plans footnote for the prior comparative periods as the estimation basis for applying the retrospective presentation requirement.

We expect the adoption of the amended standard to result in the reclassification of approximately $115 million from non-service components above the subtotal of operating income to interest and other, net, for the year ended December 30, 2017 ($260 million for the year ended December 31, 2016).

Leases. This new lease accounting standard requires that we recognize leased assets and corresponding liabilities on the balance sheet and provide enhanced disclosure of lease activity.
Effective in the first quarter of 2019.
We plan to adopt the new standard using a modified retrospective transition approach.
We expect the valuation of our right-of-use assets and lease liabilities, previously described as operating leases, to approximate the present value of our forecasted future lease commitments. We are currently implementing process and system changes in order to comply with the measurement and disclosure requirements.
The following table summarizes the effects of adopting Revenue Recognition - Contracts with Customers and Financial Instruments - Recognition and Measurement on our financial statements for the fiscal year beginning December 31, 2017 as an adjustment to the opening balance:
 
 
 
 
Adjustments from
 
 
Fiscal Year Beginning
(In Millions)
 
Dec 30, 2017
 
Revenue Standard
 
Financial Instruments Update
 
Dec 31, 2017
As Adjusted
Assets:
 
 
 
 
 
 
 
 
Accounts receivable, net
 
$
5,607

 
$
(530
)
 
$

 
$
5,077

Inventories
 
$
6,983

 
$
47

 
$

 
$
7,030

Other current assets
 
$
2,908

 
$
64

 
$

 
$
2,972

Equity investments
 
$

 
$

 
$
8,579

 
$
8,579

Marketable equity securities
 
$
4,192

 
$

 
$
(4,192
)
 
$

Other long-term assets
 
$
7,602

 
$

 
$
(4,387
)
 
$
3,215

 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
Accounts payable
 
$
2,928

 
$
55

 
$

 
$
2,983

Deferred income
 
$
1,656

 
$
(1,356
)
 
$

 
$
300

Other accrued liabilities
 
$
7,535

 
$
26

 
$

 
$
7,561

Long-term deferred tax liabilities
 
$
3,046

 
$
191

 
$

 
$
3,237

 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss)
 
$
862

 
$

 
$
(1,745
)
 
$
(883
)
Retained earnings
 
$
42,083

 
$
665

 
$
1,745

 
$
44,493

Operating Segments
Operating Segments
Note 4: Operating Segments
We manage our business through the following operating segments:
•    Client Computing Group (CCG)
•    Data Center Group (DCG)
•    Internet of Things Group (IOTG)
•    Non-Volatile Memory Solutions Group (NSG)
•    Programmable Solutions Group (PSG)
•    All other
In the third quarter of 2017, we completed our tender offer for the outstanding ordinary shares of Mobileye B.V. (Mobileye), formerly known as Mobileye N.V. In the second quarter of 2017, we completed the planned divestiture of the Intel Security Group (ISecG). The results for both are reported within the "all other" category. For further information, see "Note 10: Acquisitions and Divestitures."
The Chief Operating Decision Maker (CODM) is our Chief Executive Officer (CEO). The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss).
We offer platform products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone System-on-Chip (SoC), or a multichip package. A platform product may be enhanced by additional hardware, software, and services offered by Intel. Platform products are used in various form factors across our CCG, DCG, and IOTG operating segments. We derive a substantial majority of our revenue from platform products, which are our principal products and considered as one class of product.
CCG and DCG are our reportable operating segments. IOTG, NSG, and PSG do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. 
We have sales and marketing, manufacturing, engineering, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments.
The "all other" category includes revenue and expenses such as:
results of operations from non-reportable segments not otherwise presented;
historical results of operations from divested businesses;
results of operations of start-up businesses that support our initiatives, including our foundry business;
amounts included within restructuring and other charges;
a portion of employee benefits, compensation, and other expenses not allocated to the operating segments; and
acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.
The CODM does not evaluate operating segments using discrete asset information and we do not identify or allocate assets by operating segments. Based on the interchangeable nature of our manufacturing and assembly and test assets, most of the related depreciation expense is not directly identifiable within our operating segments, as it is included in overhead cost pools and subsequently absorbed into inventory as each product passes through our manufacturing process. As our products are then sold across multiple operating segments, it is impracticable to determine the total depreciation expense included as a component of each operating segment’s operating income (loss) results. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole.
Net revenue and operating income (loss) for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Net revenue:
 
 
 
 
 
 
Client Computing Group
 
 
 
 
 
 
Platform

$
31,226


$
30,751


$
30,680

Adjacent

2,777


2,157


1,539

 
 
34,003

 
32,908

 
32,219

Data Center Group
 
 
 
 
 
 
Platform
 
17,439

 
15,895

 
14,856

Adjacent
 
1,625

 
1,341

 
1,125

 
 
19,064

 
17,236

 
15,981

Internet of Things Group
 
 
 
 
 
 
Platform
 
2,645

 
2,290

 
1,976

Adjacent
 
524

 
348

 
322

 
 
3,169

 
2,638

 
2,298

Non-Volatile Memory Solutions Group
 
3,520

 
2,576

 
2,597

Programmable Solutions Group
 
1,902

 
1,669

 

All other
 
1,103

 
2,360

 
2,260

Total net revenue
 
$
62,761

 
$
59,387

 
$
55,355

 
 
 
 
 
 
 
Operating income (loss):
 
 
 
 
 
 
Client Computing Group
 
$
12,919

 
$
10,646

 
$
8,166

Data Center Group
 
8,395

 
7,520

 
7,847

Internet of Things Group
 
650

 
585

 
515

Non-Volatile Memory Solutions Group
 
(260
)
 
(544
)
 
239

Programmable Solutions Group
 
458

 
(104
)
 

All other
 
(4,226
)
 
(5,229
)
 
(2,765
)
Total operating income
 
$
17,936

 
$
12,874

 
$
14,002

Disaggregated net revenue for each period was as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Platform revenue
 
 
 
 
 
 
Desktop platform
 
$
11,647

 
$
12,371

 
$
12,754

Notebook platform
 
19,414

 
18,203

 
17,945

DCG platform
 
17,439

 
15,895

 
14,856

Other platform1
 
2,810

 
2,467

 
1,957

 
 
51,310

 
48,936

 
47,512

 
 
 
 
 
 
 
Adjacent revenue2
 
10,917

 
8,290

 
5,858

ISecG divested business
 
534

 
2,161

 
1,985

Total revenue
 
$
62,761

 
$
59,387

 
$
55,355

1 
Includes our tablet, phone, service provider, and IOTG platform revenue.
2 
Includes all of our non-platform products for CCG, DCG, and IOTG like modem, ethernet, and silicon photonic, as well as NSG, PSG, and Mobileye products.
Net revenue by country as presented below is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
China (including Hong Kong)
 
$
14,796

 
$
13,977

 
$
11,679

Singapore
 
14,285

 
12,780

 
11,544

United States
 
12,543

 
12,957

 
11,121

Taiwan
 
10,518

 
9,953

 
10,661

Other countries
 
10,619

 
9,720

 
10,350

Total net revenue
 
$
62,761

 
$
59,387

 
$
55,355

Earnings Per Share
Earnings Per Share [Text Block]
Note 5: Earnings Per Share
We computed basic earnings per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period.
Years Ended
(In Millions, Except Per Share Amounts)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Net income available to common stockholders
 
$
9,601

 
$
10,316

 
$
11,420

Weighted average shares of common stock outstanding—basic
 
4,701

 
4,730

 
4,742

Dilutive effect of employee incentive plans
 
47

 
53

 
64

Dilutive effect of convertible debt
 
87

 
92

 
88

Weighted average shares of common stock outstanding—diluted
 
4,835

 
4,875

 
4,894

Earnings per share - Basic
 
$
2.04

 
$
2.18

 
$
2.41

Earnings per share - Diluted
 
$
1.99

 
$
2.12

 
$
2.33


Potentially dilutive shares of common stock from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive shares of common stock for our junior subordinated convertible debentures due 2035 (2005 convertible) debentures are determined by applying the if-converted method. In December 2017, we paid cash to convert our 2035 debentures which we excluded from our diluted earnings per share computation in the fourth quarter and are no longer dilutive. For information on the conversion of the 2035 debentures, see "Note 14: Borrowings." Our junior subordinated convertible debentures due 2039 (2009 debentures) require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive shares of common stock are determined by applying the treasury stock method.
In all years presented, potentially dilutive securities that would have been antidilutive are insignificant and are excluded from the computation of diluted earnings per share. In all years presented, we included our 2009 debentures in the calculation of diluted earnings per share of common stock because the average market price was above the conversion price. We could potentially exclude the 2009 debentures in the future if the average market price is below the conversion price.
Other Financial Statement Details
Other Financial Statement Details [Text Block]
Note 6: Other Financial Statement Details
INVENTORIES
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Raw materials
 
$
1,098

 
$
695

Work in process
 
3,893

 
3,190

Finished goods
 
1,992

 
1,668

Total inventories
 
$
6,983

 
$
5,553

PROPERTY, PLANT AND EQUIPMENT
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Land and buildings
 
$
27,391

 
$
26,627

Machinery and equipment
 
57,192

 
52,608

Construction in progress
 
15,812

 
10,870

Total property, plant and equipment, gross
 
100,395

 
90,105

Less: accumulated depreciation
 
59,286

 
53,934

Total property, plant and equipment, net
 
$
41,109

 
$
36,171


Substantially all of our depreciable property, plant and equipment assets were depreciated over the following estimated useful lives: machinery and equipment, 2 to 5 years, and buildings, 10 to 25 years. There are no construction in progress assets held in safe state as of December 30, 2017 (approximately $2.2 billion as of December 31, 2016).
Net property, plant and equipment by country at the end of each period was as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
United States
 
$
24,459

 
$
23,598

 
$
22,611

Israel
 
6,501

 
3,923

 
1,661

China
 
4,275

 
2,306

 
537

Ireland
 
3,938

 
4,865

 
5,789

Other countries
 
1,936

 
1,479

 
1,260

Total property, plant and equipment, net
 
$
41,109

 
$
36,171

 
$
31,858

DEFERRED INCOME

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Deferred income on shipments of components to distributors
 
$
1,320

 
$
1,475

Deferred income from software, services, and other
 
336

 
243

Current deferred income
 
$
1,656

 
$
1,718

OTHER ACCRUED LIABILITIES
Other accrued liabilities include deferred compensation liabilities of $1.7 billion as of December 30, 2017 ($1.5 billion as of December 31, 2016).
ADVERTISING
Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.4 billion in 2017 ($1.8 billion in 2016 and $1.8 billion in 2015).
GAINS (LOSSES) ON EQUITY INVESTMENTS, NET
The components of gains (losses) on equity investments, net for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Share of equity method investee losses, net
 
$
(232
)
 
$
(38
)
 
$
(95
)
Impairments
 
(833
)
 
(187
)
 
(185
)
Gains on sales, net
 
3,499

 
562

 
145

Dividends
 
68

 
74

 
52

Other, net
 
149

 
95

 
398

Total gains (losses) on equity investments, net
 
$
2,651


$
506


$
315

INTEREST AND OTHER, NET
The components of interest and other, net for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Interest income
 
$
441

 
$
222

 
$
124

Interest expense
 
(646
)
 
(733
)
 
(337
)
Other, net
 
(30
)
 
67

 
108

Total interest and other, net
 
$
(235
)

$
(444
)

$
(105
)

Interest expense in the preceding table is net of $313 million of interest capitalized in 2017 ($135 million in 2016 and $258 million in 2015).
Restructuring and Other Charges
Restructuring and Other Charges [Text Block]
Note 7: Restructuring and Other Charges
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
2016 Restructuring Program
 
$
135

 
$
1,823

 
$

2015 and 2013 Restructuring Programs
 

 

 
354

ISecG separation costs and other charges
 
249

 
63

 

Total restructuring and other charges
 
$
384

 
$
1,886

 
$
354


2016 RESTRUCTURING PROGRAM
In the second quarter of 2016, management approved and commenced the 2016 Restructuring Program to accelerate our transformation from a PC company to one that powers the cloud and billions of smart, connected computing devices. Under this program, we closed certain facilities and reduced headcount globally to align our operations with evolving business needs by investing in our growth businesses and improving efficiencies. This program was completed in 2017.
Restructuring and other charges by type for the 2016 Restructuring Program were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Employee severance and benefit arrangements
 
$
70

 
$
1,737

Pension settlement charges
 
25

 
57

Asset impairment and other charges
 
40

 
29

Total restructuring and other charges
 
$
135

 
$
1,823


Restructuring and other activity for the 2016 Restructuring Program were as follows:
(In Millions)
 
Employee Severance and Benefits
 
Asset Impairments and Other
 
Total
Accrued restructuring balance as of December 26, 2015
 
$

 
$

 
$

Additional accruals
 
1,556

 
29

 
1,585

Adjustments
 
92

 

 
92

Cash payments
 
(1,063
)
 

 
(1,063
)
Non-cash settlements
 

 
(19
)
 
(19
)
Accrued restructuring balance as of December 31, 2016
 
585

 
10

 
595

Additional accruals
 

 
40

 
40

Adjustments
 
70

 

 
70

Cash payments
 
(352
)
 
(25
)
 
(377
)
Non-cash settlements
 

 
(3
)
 
(3
)
Accrued restructuring balance as of December 30, 2017
 
$
303

 
$
22

 
$
325


We recorded the additional accruals as restructuring and other charges in the consolidated statements of income and within the "all other" operating segments category. A substantial majority of the accrued restructuring balance as of December 30, 2017 is expected to be paid within the next 12 months, and was recorded within accrued compensation and benefits on the consolidated balance sheets. Restructuring actions related to this program, which were approved in 2016, impacted approximately 16,000 employees.
2015 AND 2013 RESTRUCTURING PROGRAMS
During 2015 and 2013, management approved and commenced implementation of restructuring actions, including targeted workforce reductions and the exit of certain businesses and facilities, as we adjusted resources from areas of disinvestment to areas of investment. The 2013 restructuring program included the wind down of our 200mm wafer fabrication facility in Massachusetts and the closure of our assembly and test facility in Costa Rica. Both programs were completed in 2015.
Income Taxes
Income Taxes [Text Block]
Note 8: Income Taxes
Tax Reform was enacted in December 2017 and reduced the U.S. federal corporate tax rate from 35.0% to 21.0% starting in 2018, assessed a one-time transition tax on earnings of non-U.S. subsidiaries that have not been taxed previously in the U.S., and created new taxes on certain future foreign sourced earnings. We recorded a provisional income tax expense of $5.4 billion, net within our 2017 results related to Tax Reform. Our provisional estimates will be refined throughout 2018 from our ongoing analysis of data and tax positions along with new guidance from regulators and interpretation of the law. The components of the provisional income tax expense are as follows:
Recognition of the transition tax imposed on undistributed earnings from non-U.S. subsidiaries. We have previously asserted an intent to indefinitely reinvest our earnings and other basis differences in operations outside the U.S., and have not recognized U.S. deferred income taxes. Tax Reform imposes a one-time transition tax on all of our previously untaxed historical non-U.S. earnings and profits at various tax rates. We recognized a provisional tax expense of $6.1 billion in the fourth quarter of 2017. The move to a participation exemption system allows us to make distributions of non-U.S. earnings to the U.S. without incurring additional U.S. tax, however these distributions may be subject to applicable non-U.S. taxation.
Remeasurement of deferred income taxes using the newly enacted statutory tax rate of 21.0%. The new statutory U.S. federal income tax rate is effective for the 2018 tax year. We remeasured our deferred tax assets and liabilities, including associated valuation allowances, with the new tax rate. We have recognized a provisional tax benefit of $676 million in the fourth quarter of 2017.
INCOME TAX PROVISION
Income before taxes and the provision for taxes consisted of the following:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Income before taxes:
 
 
 
 
 
 
U.S.
 
$
11,141

 
$
6,957

 
$
8,800

Non-U.S.
 
9,211

 
5,979

 
5,412

Total income before taxes
 
20,352

 
12,936

 
14,212

Provision for taxes:
 
 
 
 
 
 
Current:
 
 
 
 
 
 
Federal
 
10,207

 
1,319

 
2,828

State
 
27

 
13

 
40

Non-U.S.
 
899

 
756

 
842

Total current provision for taxes
 
11,133

 
2,088

 
3,710

Deferred:
 
 
 
 
 
 
Federal
 
(220
)
 
658

 
(862
)
Other
 
(162
)
 
(126
)
 
(56
)
Total deferred provision for taxes
 
(382
)
 
532

 
(918
)
Total provision for taxes
 
$
10,751

 
$
2,620

 
$
2,792

Effective tax rate
 
52.8
%
 
20.3
%
 
19.6
%

The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
Years Ended
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Statutory federal income tax rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
Increase (reduction) in rate resulting from:
 
 
 
 
 
 
Non-U.S. income taxed at different rates
 
(7.6
)
 
(11.7
)
 
(7.9
)
Research and development tax credits
 
(2.3
)
 
(2.3
)
 
(1.7
)
Domestic manufacturing deduction benefit
 
(1.3
)
 
(1.4
)
 
(2.0
)
Settlements, effective settlements, and related remeasurements
 

 
(0.1
)
 
(2.9
)
Tax Reform
 
26.8

 

 

ISecG divestiture
 
3.3

 

 

Other
 
(1.1
)
 
0.8

 
(0.9
)
Effective tax rate
 
52.8
 %
 
20.3
 %
 
19.6
 %

Substantially all of the increase in our effective tax rate in 2017 compared to 2016 was driven by the one-time provisional impacts from the Tax Reform enacted on December 22, 2017, the 2017 ISecG divestiture, and a higher proportion of our income in higher tax rate jurisdictions.
The majority of the increase in our effective tax rate in 2016 compared to 2015 was driven by one-time items and our 2015 decision to indefinitely reinvest some of our prior years' non-U.S. earnings, partially offset by a higher proportion of our income in lower tax jurisdictions.
We derive the effective tax rate benefit attributed to non-U.S. income taxed at different rates primarily from our operations in China, Hong Kong, Ireland, and Israel. The statutory tax rates in these jurisdictions range from 12.5% to 25.0%. In addition, we are subject to reduced tax rates in China and Israel as long as we conduct certain eligible activities and make certain capital investments. These conditional reduced tax rates expire at various dates through 2026 and we expect to apply for renewals upon expiration.
DEFERRED AND CURRENT INCOME TAXES
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Deferred tax assets:
 
 
 
 
Accrued compensation and other benefits
 
$
711

 
$
1,182

Share-based compensation
 
241

 
373

Deferred income
 
211

 
596

Inventory
 
675

 
1,044

State credits and net operating losses
 
1,081

 
846

Other, net
 
887

 
1,187

Gross deferred tax assets
 
3,806

 
5,228

Valuation allowance
 
(1,171
)
 
(953
)
Total deferred tax assets
 
2,635

 
4,275

Deferred tax liabilities:
 
 
 
 
Property, plant and equipment
 
(943
)
 
(1,574
)
Licenses and intangibles
 
(881
)
 
(1,036
)
Convertible debt
 
(374
)
 
(1,098
)
Unrealized gains on investments and derivatives
 
(421
)
 
(940
)
Transition tax
 
(1,850
)
 

Other, net
 
(373
)
 
(450
)
Total deferred tax liabilities
 
(4,842
)
 
(5,098
)
Net deferred tax assets (liabilities)
 
(2,207
)
 
(823
)
 
 
 
 
 
Reported as:
 
 
 
 
Deferred tax assets
 
840

 
907

Deferred tax liabilities
 
(3,046
)
 
(1,730
)
Net deferred tax assets (liabilities)
 
$
(2,207
)
 
$
(823
)

Deferred tax assets are included within other long-term assets on the consolidated balance sheets.
The valuation allowance as of December 30, 2017 included allowances related to unrealized state credit carryforwards of $1.1 billion and matters related to our non-U.S. subsidiaries of $99 million.
As of December 30, 2017, our federal, state, and non-U.S. net operating loss carryforwards for income tax purposes were $264 million, $149 million, and $431 million, respectively. The majority of the non-U.S. net operating loss carryforwards have no expiration date. The remaining non-U.S. and U.S. federal and state net operating loss carryforwards expire at various dates through 2036. A significant amount of the net operating loss carryforwards in the U.S. relates to acquisitions and, as a result, is limited in the amount that can be recognized in any one year. The non-U.S. net operating loss carryforwards include $249 million that is not likely to be recovered and has been reduced by a valuation allowance.
As of December 30, 2017, we have not recognized deferred income tax on certain outside basis differences in our subsidiaries, because we have the intent and ability to indefinitely reinvest these basis differences. Determining the unrecognized deferred tax liability for these outside basis differences is not practicable.
Current income taxes receivable of $71 million as of December 30, 2017 ($86 million as of December 31, 2016) are included in other current assets. Current income taxes payable of $1.4 billion as of December 30, 2017 ($329 million as of December 31, 2016) are included in other accrued liabilities.
Long-term income taxes payable of $4.1 billion as of December 30, 2017 ($125 million as of December 31, 2016) are included in other long-term liabilities, and include uncertain tax positions, reduced by the associated federal deduction for state taxes and non-U.S. tax credits, and may also include other long-term tax liabilities that are not uncertain but have not yet been paid, including the substantial majority of the transition tax from the Tax Reform, which is payable over the next eight years. The Tax Reform transition tax drove most of the increase in long-term income taxes payable from 2016.
UNCERTAIN TAX POSITIONS
Unrecognized tax benefits were $211 million as of December 30, 2017 ($154 million as of December 31, 2016 and $101 million as of December 26, 2015). If the remaining balance of unrecognized tax benefits were recognized in a future period, it would result in a tax benefit of $139 million as of December 30, 2017 ($87 million as of December 31, 2016) and a reduction in the effective tax rate. The related tax benefit for settlements, effective settlements, and remeasurements was insignificant for 2017 (insignificant in 2016 and $419 million in 2015). Interest, penalties, and accrued interest related to unrecognized tax benefits were insignificant in the periods presented.
We comply with the laws, regulations, and filing requirements of all jurisdictions in which we conduct business. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. Although the timing of the resolutions and/or closures of audits is highly uncertain, it is reasonably possible that certain U.S. federal and non-U.S. tax audits may be concluded within the next 12 months, which could significantly increase or decrease the balance of our gross unrecognized tax benefits. However, the estimated impact on income tax expense and net income is not expected to be significant.
We file federal, state, and non-U.S. tax returns. For non-U.S. tax returns, we are generally no longer subject to tax examinations for years prior to 2004. For U.S. federal and state tax returns, we are no longer subject to tax examination for years prior to 2004. We have filed petitions before the U.S. Tax Court relating to the treatment of stock-based compensation expense in an inter-company cost-sharing transaction for certain pre-acquisition Altera Corporation (Altera) tax years. The U.S. Tax Court ruled in favor of Altera and the U.S. Internal Revenue Service appealed the ruling to the U.S. Court of Appeals for the Ninth Circuit. During 2017, the U.S. Court of Appeals heard oral arguments and the outcome of those appeals is pending.
Investments
Investments [Text Block]
Note 9: Investments
AVAILABLE-FOR-SALE INVESTMENTS
 
 
December 30, 2017
 
December 31, 2016

(In Millions)
 
Adjusted
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
 
Adjusted
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Corporate debt
 
$
2,294

 
$
4

 
$
(13
)
 
$
2,285

 
$
3,847

 
$
4

 
$
(14
)
 
$
3,837

Financial institution instruments
 
3,387

 
3

 
(9
)
 
3,381

 
6,098

 
5

 
(11
)
 
6,092

Government debt
 
961

 

 
(6
)
 
955

 
1,581

 

 
(8
)
 
1,573

Marketable equity securities
 
1,507

 
2,686

 
(1
)
 
4,192

 
2,818

 
3,363

 
(1
)
 
6,180

Total available-for-sale investments
 
$
8,149

 
$
2,693

 
$
(29
)
 
$
10,813

 
$
14,344

 
$
3,372

 
$
(34
)
 
$
17,682


Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed- and floating-rate bonds, money market fund deposits, and time deposits. Substantially all time deposits were issued by institutions outside the U.S. as of December 30, 2017. Most time deposits were issued by institutions outside of the U.S. as of December 31, 2016.
During 2017, we sold available-for-sale investments for proceeds of $7.1 billion, ($4.1 billion in 2016 and $2.2 billion in 2015). The gross realized gains on sales of available-for-sale investments were $3.5 billion in 2017 ($538 million in 2016 and $133 million in 2015).
On April 28, 2017, Cloudera, Inc. (Cloudera) completed its initial public offering and we designated our previous equity and cost method investments in Cloudera as available-for-sale. During 2017, we determined we had an other-than-temporary decline in the fair value of our investment and recognized an impairment charge of $278 million. We recognized the impairment due to the duration and severity of the decline in the investment's fair value, which we determined was below cost based upon observable market prices after the initial public offering.
The fair values of available-for-sale debt investments, by contractual maturity, as of December 30, 2017 were as follows:
(In Millions)
 
Fair Value
Due in 1 year or less
 
$
2,573

Due in 1–2 years
 
1,776

Due in 2–5 years
 
1,866

Due after 5 years
 
71

Instruments not due at a single maturity date
 
335

Total
 
$
6,621


EQUITY METHOD INVESTMENTS
Equity method investments, classified within other long-term assets, at the end of each period were as follows:
 
 
December 30, 2017
 
December 31, 2016
(Dollars In Millions)
 
Carrying
Value
 
Ownership
Percentage
 
Carrying
Value
 
Ownership
Percentage
IM Flash Technologies, LLC
 
$
1,505

 
49
%
 
$
849

 
49
%
McAfee
 
153

 
49
%
 
n/a

 
n/a

Cloudera, Inc.
 
n/a

 
n/a

 
225

 
16
%
Other equity method investments
 
229

 
 
 
254

 
 
Total
 
$
1,887

 
 
 
$
1,328

 
 

IM Flash Technologies, LLC
Since the inception of IM Flash Technologies, LLC (IMFT) in 2006, Micron Technology, Inc. (Micron) and Intel have jointly developed NAND flash memory and 3D XPoint technology products. Intel also purchases jointly developed products directly from Micron under certain supply agreements.
The IMFT operating agreement continues through 2024 unless terminated earlier, and provides for certain buy-sell rights of the joint venture. Intel has the right to cause Micron to buy our interest in IMFT and, if exercised, Micron could elect to receive financing from us for one to two years. Commencing in January 2019, Micron has the right to call our interest in IMFT with the closing date to be effective within one year.
IMFT is a variable interest entity, and all costs of IMFT are passed on to Micron and Intel through sale of products or services in proportional share of ownership. Our portion of IMFT costs was approximately $415 million in 2017 (approximately $400 million in 2016 and $400 million in 2015). In the event that IMFT has excess cash, IMFT will make payments to Micron and Intel in the form of dividends.
IMFT depends on Micron and Intel for any additional cash. In addition to making capital contributions throughout the year, during the fourth quarter of 2017, we extended $650 million in member debt financing (MDF) to IMFT to fund the ramp of 3D XPoint technology. The MDF balance may be converted to a capital contribution at our request, or may be repaid upon availability of funds. Our known maximum exposure to loss approximated the carrying value of our investment balance (which included the $650 million of MDF as of December 30, 2017). Our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT and future cash calls. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value.
We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity, and therefore, we account for our interest in IMFT using the equity method of accounting.
McAfee
During the second quarter of 2017, we closed our divestiture of the ISecG business and retained a 49% interest in McAfee as partial consideration. Our investment is accounted for under the equity method of accounting and is classified within other long-term assets. During the third quarter of 2017, we received a $735 million dividend from McAfee. For further information related to the divestiture of the ISecG business, see "Note 10: Acquisitions and Divestitures."
NON-MARKETABLE COST METHOD INVESTMENTS
The carrying value of our non-marketable cost method investments was $2.6 billion as of December 30, 2017 ($3.1 billion as of December 31, 2016). In 2017, we recognized impairments of $548 million on non-marketable cost method investments ($178 million in 2016 and $164 million in 2015).
Beijing UniSpreadtrum Technology Ltd. (UniSpreadtrum)
During 2014, we entered into a series of agreements with Tsinghua Unigroup Ltd. (Tsinghua Unigroup), an operating subsidiary of Tsinghua Holdings Co. Ltd., to, among other things, jointly develop Intel architecture- and communications-based solutions for phones. During 2017, we reduced our expectation of the future operating performance for Beijing UniSpreadtrum Technology Ltd. (UniSpreadtrum) due to competitive pressures, which resulted in other-than-temporary impairment charges of $308 million. The carrying value of our investment was $658 million as of December 30, 2017 ($966 million as of December 31, 2016).
TRADING ASSETS
Net gains related to trading assets still held at the reporting date were $414 million in 2017 (net losses of $295 million in 2016 and $152 million in 2015). Net losses on the related derivatives were $422 million in 2017 (net gains of $300 million in 2016 and $137 million in 2015).
Acquisitions & Divestitures
Acquisitions and Divestitures [Text Block]
Note 10: Acquisitions and Divestitures
2017 ACQUISITIONS
Mobileye
On August 21, 2017, we completed our tender offer for all of the outstanding ordinary shares of Mobileye, a global leader in the development of computer vision and machine learning, data analysis, localization, and mapping for advanced driver assistance systems and autonomous driving. This acquisition combines Mobileye's leading computer vision expertise with Intel’s high-performance computing and connectivity expertise to create automated driving solutions from car to cloud. The combination is expected to accelerate innovation for the automotive industry and position Intel as a leading technology provider in the fast-growing market for highly and fully autonomous vehicles. The transaction also extends Intel’s strategy to invest in data-intensive market opportunities that build on our strengths in computing and connectivity from the cloud, through the network, to the device.
As of the completion of the tender offer, we acquired substantially all of the outstanding ordinary shares of Mobileye. We acquired 84.4% of the outstanding shares on August 8, 2017 and 97.3% as of August 21, 2017, and we intend to acquire all remaining outstanding shares. We have reflected the acquisition of the additional outstanding shares and reduction to the noncontrolling interest by $1.8 billion in the tables below.
Total consideration to acquire Mobileye was $14.5 billion (net of $366 million of cash and cash equivalents acquired).
The preliminary fair values of the assets acquired and liabilities assumed in the acquisition of Mobileye, by major class, were recognized as follows:
(In Millions)
 
 
Short-term investments and marketable securities
 
$
370

Tangible assets
 
227

Goodwill
 
10,278

Identified intangible assets
 
4,482

Current liabilities
 
(69
)
Deferred tax liabilities and other
 
(418
)
Noncontrolling interest
 
(375
)
Total
 
$
14,495


We assumed outstanding unvested Mobileye stock options and RSUs granted under two Mobileye equity plans. We will not grant additional equity awards under these two Mobileye equity plans. In connection with the acquisition, we recognized share-based compensation expense of $71 million for cash-settled awards.
The preliminary allocation of the purchase price was based upon estimates and assumptions that are subject to change within the one-year measurement period. The primary areas of the purchase price allocation that are not yet finalized are certain tax matters, identification of contingencies, and goodwill.
The fair value of the non-controlling interest was determined based on the quoted share price of Mobileye as of August 8, 2017, and the remaining outstanding shares that constitute the non-controlling interest. We recorded the non-controlling interest as a component of equity.
Goodwill of $10.3 billion arising from the acquisition is attributed to the expected synergies and other benefits that will be generated from the combination of Intel and Mobileye. Substantially all of the goodwill recognized is not expected to be deductible for tax purposes. The goodwill recognized from the acquisition is included within "all other."
The identified intangible assets assumed in the acquisition of Mobileye were recognized as follows:
 
 
Fair Value
(In Millions)
 
Weighted Average
Estimated Useful Life
(In Years)
Developed technology
 
$
2,346

 
9
Customer relationships
 
713

 
12
Brands
 
64

 
10
Identified intangible assets subject to amortization
 
3,123

 
 
In-process research and development
 
1,359

 
 
Identified intangible assets not subject to amortization
 
1,359

 
 
Total identified intangible assets
 
$
4,482

 
 

2016 ACQUISITIONS
Altera Corporation
On December 28, 2015, we completed the acquisition of Altera, a global semiconductor company that designs and sells programmable semiconductors and related products. We acquired all outstanding shares of Altera common stock and, subject to certain exceptions, each share of Altera common stock underlying vested stock option awards, RSUs, and performance-based RSU awards in exchange for cash. The acquired company operates as PSG and continues to design and sell programmable logic devices (PLDs), which incorporate field-programmable gate arrays (FPGAs) and complex programmable logic devices, and highly integrated SoC devices. This acquisition is expected to expand our reach within the compute continuum, as the combination of our leading-edge products and manufacturing process with Altera's leading FPGA technology enables new classes of platforms that meet customer needs in the data center and Internet of Things market segments. As we develop future platforms, the integration of PLDs into our platform solutions is expected to improve the overall performance and lower the cost of ownership for our customers. For further information, see "Note 4: Operating Segments."
Total consideration to acquire Altera was $14.5 billion (net of $2.0 billion of cash and cash equivalents acquired).
The fair values of the assets acquired and liabilities assumed in the acquisition of Altera, by major class, were recognized as follows:
(In Millions)
 
 
Short-term investments
 
$
182

Receivables
 
368

Inventory
 
555

Other current assets
 
123

Property, plant and equipment
 
312

Goodwill
 
5,448

Identified intangible assets
 
7,566

Other long-term investments and assets
 
2,515

Deferred income
 
(351
)
Other liabilities
 
(283
)
Long-term debt
 
(1,535
)
Deferred tax liabilities
 
(449
)
Total
 
$
14,451


The goodwill of $5.4 billion arising from the acquisition is attributed to the expected benefit and other benefits that will be generated by combining Intel and Altera. Substantially all of the goodwill recognized is not expected to be deductible for tax purposes. For further information on the assignment of goodwill for the acquisition, see “Note 11: Goodwill.”
The identified intangible assets assumed in the acquisition of Altera were recognized as follows based upon their fair values as of December 28, 2015:
 
 
Fair Value
(In Millions)
 
Weighted Average Estimated Useful Life
(In Years)
Developed technology
 
$
5,757

 
9
Customer relationships
 
1,121

 
12
Brands
 
87

 
6
Identified intangible assets subject to amortization
 
6,965

 
 
In-process research and development
 
601

 
 
Identified intangible assets not subject to amortization
 
601

 
 
Total identified intangible assets
 
$
7,566

 
 

OTHER ACQUISITIONS
During 2017, in addition to the Mobileye acquisition, we completed two acquisitions qualifying as business combinations that were not material to Intel’s operations.
In addition to the Altera acquisition, we completed 11 acquisitions qualifying as business combinations in 2016 and eight in 2015 for aggregate consideration of $1.1 billion and $1.0 billion, respectively. Consideration paid primarily consisted of cash and was net of cash acquired. For both periods, substantially all of the consideration was allocated to goodwill and identifiable intangible assets.
Other acquisitions completed in 2017, 2016, and 2015, both individually and in the aggregate, were not significant to our results of operations. For information on the assignment of goodwill to our operating segments, see "Note 11: Goodwill," and for information on the classification of intangible assets, see "Note 12: Identified Intangible Assets."
DIVESTITURE OF INTEL SECURITY GROUP
On April 3, 2017, we closed the transaction with TPG VII Manta Holdings, L.P., now known as Manta Holdings, L.P. (TPG), transferring certain assets and liabilities relating to ISecG to a newly formed, jointly owned, separate cybersecurity company called McAfee.
Total consideration received was $4.2 billion, consisting of $924 million in cash proceeds, $1.1 billion in the form of equity representing a 49% ownership interest in McAfee, and $2.2 billion in the form of promissory notes issued by McAfee and TPG. During the third quarter of 2017, McAfee and TPG repaid the $2.2 billion of promissory notes, which are included within proceeds from divestiture.
The carrying amounts of the major classes of ISecG assets and liabilities as of the transaction close date included the following:
(In Millions)
 
Apr 1,
2017
Accounts receivable
 
$
317

Goodwill
 
3,601

Identified intangible assets
 
965

Other assets
 
276

Total assets
 
$
5,159

 
 
 

 

Deferred income
 
$
1,553

Other liabilities
 
276

Total liabilities
 
$
1,829


As of the transaction close date, we recognized a pre-tax gain of $387 million within "Interest and other, net," which is net of $507 million of currency translation adjustment losses reclassified from accumulated other comprehensive income (loss) associated with currency charges on the carrying values of ISecG goodwill and identified intangible assets. In addition, we recognized a tax expense of $822 million.
Goodwill
Goodwill [Text Block]
Note 11: Goodwill
Goodwill activity for each period was as follows:

(In Millions)
 
Dec 31,
2016
 
Acquisitions
 
Transfers
 
Other
 
Dec 30,
2017
Client Computing Group
 
$
4,356

 
$

 
$

 
$

 
$
4,356

Data Center Group
 
5,412

 
9

 

 

 
5,421

Internet of Things Group
 
1,123

 
3

 

 

 
1,126

Programmable Solutions Group
 
2,490

 

 

 

 
2,490

All other
 
718

 
10,278

 

 

 
10,996

Total
 
$
14,099

 
$
10,290

 
$

 
$

 
$
24,389


(In Millions)
 
Dec 26,
2015
 
Acquisitions
 
Transfers
 
Other
 
Dec 31,
2016
Client Computing Group
 
$
4,078

 
$
65

 
$
213

 
$

 
$
4,356

Data Center Group
 
2,404

 
2,831

 
177

 

 
5,412

Internet of Things Group
 
428

 
659

 
36

 

 
1,123

Intel Security Group
 
3,599

 

 

 
(3,599
)
 

Software and Services Group
 
441

 

 
(441
)
 

 

Programmable Solutions Group
 

 
2,490

 

 

 
2,490

All other
 
382

 
321

 
15

 

 
718

Total
 
$
11,332

 
$
6,366

 
$

 
$
(3,599
)
 
$
14,099

During the third quarter of 2016, ISecG goodwill was reclassified to assets held for sale. This reclassification of goodwill is presented within the "Other" column in the preceding table. For further information, see "Note 10: Acquisitions and Divestitures."
During the fourth quarters of 2017, 2016, and 2015, we completed our annual impairment assessments and we concluded that goodwill was not impaired in any of these years. The accumulated impairment losses as of December 30, 2017 were $719 million: $365 million associated with CCG, $275 million associated with DCG, and $79 million associated with IOTG.
Identified Intangible Assets
Identified Intangible Assets [Text Block]
Note 12: Identified Intangible Assets
We recorded $4.5 billion of identified intangible assets from our acquisition of Mobileye during the third quarter of 2017. For further information about these acquired identified intangible assets, see "Note 10: Acquisitions and Divestitures."
 
 
December 30, 2017
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
8,912

 
$
(1,922
)
 
$
6,990

Acquisition-related customer relationships
 
2,052

 
(313
)
 
1,739

Acquisition-related brands
 
143

 
(29
)
 
114

Licensed technology and patents
 
3,104

 
(1,370
)
 
1,734

Identified intangible assets subject to amortization
 
14,211

 
(3,634
)
 
10,577

In-process research and development
 
2,168

 

 
2,168

Identified intangible assets not subject to amortization
 
2,168

 

 
2,168

Total identified intangible assets
 
$
16,379

 
$
(3,634
)
 
$
12,745

 
 
December 31, 2016
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
7,405

 
$
(1,836
)
 
$
5,569

Acquisition-related customer relationships
 
1,449

 
(260
)
 
1,189

Acquisition-related brands
 
87

 
(21
)
 
66

Licensed technology and patents
 
3,285

 
(1,423
)
 
1,862

Identified intangible assets subject to amortization
 
12,226

 
(3,540
)
 
8,686

In-process research and development
 
808

 

 
808

Identified intangible assets not subject to amortization
 
808

 

 
808

Total identified intangible assets
 
$
13,034

 
$
(3,540
)
 
$
9,494


Identified intangible assets recorded for each period and their respective estimated weighted average useful lives were as follows:
 
 
December 30, 2017
 
December 31, 2016
 
 
Gross
Assets
(In Millions)
 
Estimated Useful Life
(In Years)
 
Gross
Assets
(In Millions)
 
Estimated Useful Life
(In Years)
Acquisition-related developed technology
 
$
2,346

 
9
 
$
5,842

 
9
Acquisition-related customer relationships
 
$
713

 
12
 
$
1,148

 
12
Acquisition-related brands
 
$
64

 
10
 
$
87

 
6
Licensed technology and patents
 
$
162

 
7
 
$
342

 
12

During 2017, we acquired in-process R&D assets of $1.4 billion that were not subject to amortization.
The estimated useful life ranges for identified intangible assets that are subject to amortization were as follows:
(In Years)
 
Estimated
Useful Life Range
Acquisition-related developed technology
 
5
9
Acquisition-related customer relationships
 
7
12
Acquisition-related brands
 
6
10
Licensed technology and patents
 
2
17

Amortization expenses recorded in the consolidated statements of income for each period were as follows:
Years Ended
(In Millions)
 
Location
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Acquisition-related developed technology
 
Cost of sales
 
$
912

 
$
937

 
$
343

Acquisition-related customer relationships
 
Amortization of acquisition-related intangibles
 
161

 
270

 
258

Acquisition-related brands
 
Amortization of acquisition-related intangibles
 
16

 
24

 
7

Licensed technology and patents
 
Cost of sales
 
288

 
293

 
282

Total amortization expenses
 
 
 
$
1,377

 
$
1,524

 
$
890


We expect future amortization expense for the next five years to be as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
Acquisition-related developed technology
 
$
1,045

 
$
1,043

 
$
1,011

 
$
976

 
$
937

Acquisition-related customer relationships
 
181

 
180

 
179

 
179

 
171

Acquisition-related brands
 
20

 
20

 
20

 
20

 
6

Licensed technology and patents
 
256

 
243

 
211

 
195

 
190

Total future amortization expenses
 
$
1,502

 
$
1,486

 
$
1,421

 
$
1,370

 
$
1,304

Other Long-Term Assets
Other Long-Term Assets [Text Block]
Note 13: Other Long-Term Assets

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Equity method investments
 
$
1,887

 
$
1,328

Non-marketable cost method investments
 
2,613

 
3,098

Non-current deferred tax assets
 
840

 
907

Pre-payments for property, plant and equipment
 
714

 
347

Loans receivable
 
860

 
236

Other
 
688

 
1,243

Total other long-term assets
 
$
7,602

 
$
7,159

Borrowings
Borrowings [Text Block]
Note 14: Borrowings
SHORT-TERM DEBT

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Drafts payable
 
$
37

 
$
25

Current portion of long-term debt
 
1,739

 
4,609

Total short-term debt
 
$
1,776

 
$
4,634


Our current portion of long-term debt includes our 2009 junior subordinated convertible debentures due 2039, as well as debt classified as short-term based on contractual maturity.
We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. This amount includes an increase of $5.0 billion in the authorization limit approved by our Board of Directors in April 2017.


LONG-TERM DEBT
 
 
December 30, 2017
 
December 31, 2016
(In Millions)
 
Effective Interest Rate
 
Amount
 
Amount
Floating-rate senior notes:
 
 
 
 
 
 
   Three-month LIBOR plus 0.08%, due May 2020
 
1.40%
 
$
700

 
$

   Three-month LIBOR plus 0.35%, due May 2022
 
1.66%
 
800

 

Fixed-rate senior notes:
 
 
 
 
 
 
   1.75%, due May 2017
 
n/a
 

 
500

   1.35%, due December 2017
 
n/a
 

 
3,000

   2.50%, due November 2018
 
2.14%
 
600

 
600

   3.25%, due December 20191
 
2.19%
 
194

 
180

   1.85%, due May 2020
 
1.90%
 
1,000

 

   2.45%, due July 2020
 
2.50%
 
1,750

 
1,750

   1.70%, due May 2021
 
1.78%
 
500

 
500

   3.30%, due October 2021
 
2.69%
 
2,000

 
2,000

   2.35%, due May 2022
 
1.86%
 
750

 

   3.10%, due July 2022
 
2.50%
 
1,000

 
1,000

   4.00%, due December 20221
 
2.98%
 
428

 
396

   2.70%, due December 2022
 
2.08%
 
1,500

 
1,500

   4.10%, due November 2023
 
3.23%
 
400

 
400

   2.88%, due May 2024
 
2.36%
 
1,250

 

   2.70%, due June 2024
 
2.12%
 
600

 

   3.70%, due July 2025
 
3.20%
 
2,250

 
2,250

   2.60%, due May 2026
 
1.66%
 
1,000

 
1,000

   3.15%, due May 2027
 
2.82%
 
1,000

 

   4.00%, due December 2032
 
4.10%
 
750

 
750

   4.80%, due October 2041
 
4.86%
 
802

 
1,500

   4.25%, due December 2042
 
4.39%
 
567

 
925

   4.90%, due July 2045
 
4.92%
 
772

 
2,000

   4.90%, due August 2045
 
n/a
 

 
1,007

   4.70%, due December 2045
 
2.49%
 
915

 
915

   4.10%, due May 2046
 
4.12%
 
1,250

 
1,250

   4.10%, due May 2047
 
4.13%
 
1,000

 

   4.10%, due August 2047
 
2.15%
 
640

 

   3.73%, due December 2047
 
3.74%
 
1,967

 

Junior subordinated convertible debentures:
 
 
 
 
 
 
   2.95%, due December 2035
 
n/a
 

 
1,600

   3.25%, due August 20392
 
4.03%
 
2,000

 
2,000

Total senior notes and other borrowings
 
 
 
28,385

 
27,023

   Unamortized premium/discount and issuance costs
 
 
 
(1,357
)
 
(1,581
)
   Hedge accounting fair value adjustments
 
 
 
(252
)
 
(184
)
Long-term debt
 
 
 
26,776

 
25,258

   Current portion of long-term debt
 
 
 
(1,739
)
 
(4,609
)
Total long-term debt
 
 
 
$
25,037

 
$
20,649


1 
To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $577 million, which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see "Note 17: Derivative Financial Instruments." Principal and unamortized discount/issuance costs for the Australian-dollar-denominated notes in the table above were calculated using foreign currency exchange rates as of December 30, 2017 and December 31, 2016.
2 
Effective interest rate for the year ended December 31, 2016 was 4.01%.
In 2017, we began assessing fair value hierarchy levels for our short-term and long-term debt based on the underlying instrument type. The fair value of our convertible debentures is determined using discounted cash flow models with observable market inputs, and takes into consideration variables such as interest rate changes, comparable instruments, subordination discount, and credit-rating changes. As of December 30, 2017 and December 31, 2016, the fair value of short-term debt (excluding drafts payable) was $2.4 billion and $5.1 billion, respectively, and the fair value of long-term debt, excluding the current portion of long-term debt, was $27.0 billion and $22.0 billion, respectively. These liabilities are classified as Level 2 within the fair value hierarchy based on the nature of the fair value inputs.
Senior Notes
During 2017, we issued a total of $7.7 billion aggregate principal amount of senior notes, which excludes the private placement of $2.0 billion of senior notes issued in December 2017 as discussed in the following paragraph. We used the net proceeds from the offerings of the notes for general corporate purposes, which included refinancing of outstanding debt and repurchase of shares of our common stock. Additionally, we redeemed our $1.0 billion4.90% senior notes due August 2045.
In December 2017, we completed exchange and cash offers for our outstanding 4.80% senior notes due 2041, 4.25% senior notes due 2042, and 4.90% senior notes due 2045 (Old Notes). As a result of the exchange offer, we issued in a private placement $2.0 billion principal amount of 3.73% senior notes due 2047 and paid $293 million cash in exchange for $1.9 billion aggregate principal amount of the Old Notes. As a result of the cash offer, we paid $518 million to repurchase $425 million aggregate principal amount and recognized a $93 million loss on the extinguishment of the Old Notes.
During 2016, we issued a total of $2.8 billion aggregate principal amount of senior unsecured notes to refinance existing indebtedness, including our 1.95% senior notes due 2016 and a portion of our 1.35% senior notes due 2017. In connection with our completed acquisition of Altera, in the first quarter of 2016, we acquired a total of $1.5 billion aggregate principal amount of senior unsecured notes.
Our senior floating-rate notes pay interest quarterly and our senior fixed-rate notes pay interest semiannually. We may redeem the fixed-rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under the notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries.
Convertible Debentures
In December 2017, we paid $2.8 billion to convert our $1.6 billion 2.95% junior subordinated convertible debentures due 2035. We recognized a loss of $385 million in interest and other, net and $1.4 billion as a reduction to stockholders' equity related to the conversion feature.
In 2009, we issued junior subordinated convertible debentures due 2039 (2009 debentures), which pay a fixed rate of interest semiannually. The 2009 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events, commencing on August 1, 2019. After such date, if the 10-day average trading price of $1,000 principal amount of the bond immediately preceding any six-month interest period is less than or equal to $650 or greater than or equal to $1,500, we are required to pay contingent 0.25% or 0.50% annual interest, respectively.
The 2009 debentures are convertible, subject to certain conditions. Holders can surrender the 2009 debentures for conversion if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during the 30 consecutive trading-day period ending on the last trading day of the preceding fiscal quarter. We will settle any conversion of the 2009 debentures in cash up to the face value, and any amount in excess of face value will be settled in cash or stock at our option. On or after August 5, 2019, we can redeem, for cash, all or part of the 2009 debentures for the principal amount, plus any accrued and unpaid interest, if the closing price of Intel common stock has been at least 150% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period. In addition, if certain events occur in the future, the indenture governing the 2009 debentures provides that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. The 2009 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that the 2009 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments and are not accounted for separately as derivative liabilities.
During the fourth quarter of 2017, the closing stock price conversion right condition of the 2009 debentures continued to be met and the debentures will be convertible at the option of the holders during the first quarter of 2018. As a result, the $1.1 billion carrying amount of the 2009 debentures was classified as short-term debt on our consolidated balance sheet as of December 30, 2017 ($1.1 billion as of December 31, 2016). The excess of the amount of cash payable if converted over the carrying amount of the 2009 debentures of $866 million has been classified as temporary equity on our consolidated balance sheet as of December 30, 2017 ($882 million as of December 31, 2016). In future periods, if the closing stock price conversion right condition is no longer met, all outstanding 2009 debentures would be reclassified to long-term debt and the temporary equity would be reclassified to stockholders’ equity on our consolidated balance sheet.
 
 
2009 Debentures
(In Millions, Except Per Share Amounts)
 
Dec 30,
2017
 
Dec 31,
2016
Outstanding principal
 
$
2,000

 
$
2,000

Equity component (including temporary equity) carrying amount
 
$
613

 
$
613

Unamortized discount1
 
$
866

 
$
882

Net debt carrying amount
 
$
1,134

 
$
1,118

Conversion rate (shares of common stock per $1,000 principal amount of debentures)
 
48.37

 
47.72

Effective conversion price (per share of common stock)
 
$
20.68

 
$
20.95


1 
The unamortized discounts for the 2009 debentures are amortized over the remaining life of the debt.
The conversion rate adjusts for certain events outlined in the indentures governing the 2009 debentures, such as quarterly dividend distributions in excess of $0.14 per share, but it does not adjust for accrued interest. In addition, the conversion rate will increase for a holder of the 2009 debentures who elects to convert the debentures in connection with certain share exchanges, mergers, or consolidations involving Intel.
Debt Maturities
Our aggregate debt maturities based on outstanding principal as of December 30, 2017, by year payable, were as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023 and thereafter
 
Total
 
 
$
600

 
$
194

 
$
3,450

 
$
2,500

 
$
4,478

 
$
17,163

 
$
28,385


In the preceding table, the 2009 debentures are classified based on their stated maturity date, regardless of their classification on the consolidated balance sheet.
Floating-rate senior notes:
 
   Three-month LIBOR plus 0.08%, due May 2020
0.08
%
   Three-month LIBOR plus 0.35%, due May 2022
0.35
%
Fixed-rate senior notes:
 
   1.75%, due May 2017
N/A

   1.35%, due December 2017
N/A

   2.50%, due November 2018
2.50
%
   3.25%, due December 20191
3.25
%
   1.85%, due May 2020
1.85
%
   2.45%, due July 2020
2.45
%
   1.70%, due May 2021
1.70
%
   3.30%, due October 2021
3.30
%
   2.35%, due May 2022
2.35
%
   3.10%, due July 2022
3.10
%
   4.00%, due December 20221
4.00
%
   2.70%, due December 2022
2.70
%
   4.10%, due November 2023
4.10
%
   2.88%, due May 2024
2.88
%
   2.70%, due June 2024
2.70
%
   3.70%, due July 2025
3.70
%
   2.60%, due May 2026
2.60
%
   3.15%, due May 2027
3.15
%
   4.00%, due December 2032
4.00
%
   4.80%, due October 2041
4.80
%
   4.25%, due December 2042
4.25
%
   4.90%, due July 2045
4.90
%
   4.90%, due August 2045
N/A

   4.70%, due December 2045
4.70
%
   4.10%, due May 2046
4.10
%
   4.10%, due May 2047
4.10
%
   4.10%, due August 2047
4.10
%
   3.73%, due December 2047
3.73
%
Junior subordinated convertible debentures:
 
   2.95%, due December 2035
N/A

   3.25%, due August 20392
3.25
%
Fair Value
Fair Value [Text Block]
Note 15: Fair Value
ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS
 
 
December 30, 2017
 
December 31, 2016
 
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
(In Millions)
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 
$

 
$
30

 
$

 
$
30

 
$

 
$
498

 
$

 
$
498

Financial institution instruments 1
 
335

 
640

 

 
975

 
1,920

 
811

 

 
2,731

Government debt 2
 

 
90

 

 
90

 

 
332

 

 
332

Reverse repurchase agreements
 

 
1,399

 

 
1,399

 

 
768

 

 
768

Short-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
672

 
3

 
675

 

 
1,332

 
6

 
1,338

Financial institution instruments 1
 

 
1,009

 

 
1,009

 

 
1,603

 

 
1,603

Government debt 2
 

 
130

 

 
130

 

 
284

 

 
284

Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
 

 
2

 

 
2

 

 
87

 

 
87

Corporate debt
 

 
2,842

 

 
2,842

 

 
2,847

 

 
2,847

Financial institution instruments 1
 
59

 
1,064

 

 
1,123

 
36

 
1,608

 

 
1,644

Government debt 2
 
30

 
4,758

 

 
4,788

 
32

 
3,704

 

 
3,736

Other current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
2

 
277

 

 
279

 

 
382

 

 
382

Loans receivable
 

 
30

 

 
30

 

 
326

 

 
326

Marketable equity securities
 
4,148

 
44

 

 
4,192

 
6,180

 

 

 
6,180

Other long-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
1,576

 
4

 
1,580

 

 
1,995

 
6

 
2,001

Financial institution instruments 1
 

 
1,397

 

 
1,397

 

 
1,758

 

 
1,758

Government debt 2
 

 
735

 

 
735

 

 
957

 

 
957

Other long-term assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 

 
77

 
7

 
84

 

 
31

 
9

 
40

Loans receivable
 

 
610

 

 
610

 

 
236

 

 
236

Total assets measured and recorded at fair value
 
4,574

 
17,382

 
14

 
21,970

 
8,168

 
19,559

 
21

 
27,748

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other accrued liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 

 
454

 

 
454

 

 
371

 

 
371

Other long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 

 
297

 
6

 
303

 

 
179

 
33

 
212

Total liabilities measured and recorded at fair value
 
$

 
$
751

 
$
6

 
$
757

 
$

 
$
550

 
$
33

 
$
583


1 
Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions.
2 
Level 1 investments consist primarily of U.S. Treasury securities. Level 2 investments consist primarily of U.S. Agency notes and non-U.S. government debt.
In the second quarter of 2017, we began assigning fair value hierarchy levels based on the underlying instrument type for our fixed-income portfolio. We have reclassified prior period amounts to conform to the current period presentation.
FAIR VALUE OPTION FOR LOANS RECEIVABLE
The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance as of December 30, 2017 and December 31, 2016.
ASSETS MEASURED AND RECORDED AT FAIR VALUE ON A NON-RECURRING BASIS
Our non-marketable equity investments, marketable equity method investments, and non-financial assets—such as intangible assets and property, plant and equipment—are recorded at fair value only if an impairment is recognized.
We classified non-marketable equity investments as Level 3. Impairments recognized on non-marketable equity investments held as of December 30, 2017 were $537 million ($153 million held as of December 31, 2016 and $160 million held as of December 26, 2015).
FINANCIAL INSTRUMENTS NOT RECORDED AT FAIR VALUE ON A RECURRING BASIS
Financial instruments not recorded at fair value on a recurring basis include non-marketable cost method investments, grants receivable, loans receivable, reverse repurchase agreements, and our short-term and long-term debt.
As of December 30, 2017, the carrying amount and fair value of our non-marketable cost method investments was $2.6 billion and $3.6 billion, respectively ($3.1 billion and $3.9 billion as of December 31, 2016, respectively). These measures are classified as Level 3 within the fair value hierarchy based on the nature of the fair value inputs.
As of December 30, 2017, the aggregate carrying value of grants receivable, loans receivable, and reverse repurchase agreements was $935 million (the aggregate carrying amount as of December 31, 2016 was $876 million). The estimated fair value of these financial instruments approximates their carrying value and is categorized as Level 2 within the fair value hierarchy based on the nature of the fair value inputs.
For information related to the fair value of our short-term and long-term debt, see "Note 14: Borrowings."
Other Comprehensive Income (Loss)
Other Comprehensive Income (Loss) [Text Block]
Note 16: Other Comprehensive Income (Loss)
The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
(In Millions)
 
Unrealized Holding Gains (Losses) on Available-for-Sale Investments
 
Deferred Tax Asset Valuation Allowance
 
Unrealized Holding Gains (Losses) on Derivatives
 
Actuarial Valuation and Other Pension Expenses
 
Foreign Currency Translation Adjustment
 
Total
December 26, 2015
 
$
1,749

 
$
8

 
$
(266
)
 
$
(916
)
 
$
(515
)
 
$
60

Other comprehensive income (loss) before reclassifications
 
1,170

 

 
(26
)
 
(680
)
 
(4
)
 
460

Amounts reclassified out of accumulated other comprehensive income (loss)
 
(530
)
 

 
38

 
170

 

 
(322
)
Tax effects
 
(225
)
 
(8
)
 
(5
)
 
146

 

 
(92
)
Other comprehensive income (loss)
 
415

 
(8
)
 
7

 
(364
)
 
(4
)
 
46

December 31, 2016
 
2,164

 

 
(259
)
 
(1,280
)
 
(519
)
 
106

Other comprehensive income (loss) before reclassifications
 
2,760

 

 
605

 
275

 
3

 
3,643

Amounts reclassified out of accumulated other comprehensive income (loss)
 
(3,431
)
 

 
(69
)
 
103

 
507

 
(2,890
)
Tax effects
 
235

 

 
(171
)
 
(61
)
 

 
3

Other comprehensive income (loss)
 
(436
)
 

 
365

 
317

 
510

 
756

December 30, 2017
 
$
1,728

 
$

 
$
106

 
$
(963
)
 
$
(9
)
 
$
862



The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income for each period were as follows:
 
 
 
 
Income Before Taxes Impact for Years Ended
(In Millions)
Comprehensive Income Components
 
Location
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Unrealized holding gains (losses)1 on available-for-sale investments:
 
 
 
 
 
 
 
 
 
 
Gains (losses) on equity investments, net
 
$
3,431

 
$
530

 
$
93

 
 
 
 
3,431

 
530

 
93

Unrealized holding gains (losses) on derivatives:
 
 
 
 
 
 
 
 
Foreign currency contracts
 
Cost of sales
 
(65
)
 
(65
)
 
(290
)
 
 
Research and development
 
45

 
7

 
(177
)
 
 
Marketing, general and administrative
 
7

 
5

 
(46
)
 
 
Gains (losses) on equity investments, net
 
57

 
11

 

 
 
Interest and other, net
 
25

 
4

 
(9
)
 
 
 
 
69

 
(38
)
 
(522
)
Amortization of pension and postretirement benefit components:
 
 
 
 
 
 
 
 
Actuarial valuation and other pension expenses
 
 
 
(103
)
 
(170
)
 
(77
)
 
 
 
 
(103
)
 
(170
)
 
(77
)
Currency translation adjustment
 
Interest and other, net
 
(507
)
 

 

Total amounts reclassified out of accumulated other comprehensive income (loss)
 
 
 
$
2,890

 
$
322

 
$
(506
)

1 
We determine the cost of the investment sold based on an average cost basis at the individual security level.
The amortization of pension and postretirement benefit components is included in the computation of net periodic benefit cost. For more information, see "Note 18: Retirement Benefit Plans."
We estimate that we will reclassify approximately $108 million (before taxes) of net derivative gains included in accumulated other comprehensive income (loss) into earnings within the next 12 months.
During the second quarter of 2017, we reclassified $507 million (before taxes) of currency translation adjustment losses included in accumulated other comprehensive income (loss) into earnings as a result of our divestiture of ISecG. For more information, see "Note 10: Acquisitions and Divestitures."
Derivative Financial Instruments
Derivative Financial Instruments [Text Block]
Note 17: Derivative Financial Instruments
VOLUME OF DERIVATIVE ACTIVITY
Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Foreign currency contracts
 
$
19,958

 
$
17,960

 
$
16,721

Interest rate contracts
 
16,823

 
14,228

 
8,812

Other
 
1,636

 
1,340

 
1,122

Total
 
$
38,417


$
33,528


$
26,655

During the periods presented, we entered into $4.8 billion, $4.7 billion, and $4.4 billion, respectively, of interest rate swaps to hedge against changes in the fair value attributable to the benchmark interest rates related to our outstanding senior notes. These hedges were designated as fair value hedges. During 2015, we entered into $577 million of currency interest rate swaps to hedge against the variability in the U.S.-dollar equivalent of coupon and principal payments associated with our non-U.S.-dollar-denominated indebtedness. These hedges were designated as cash flow hedges.
During 2015, we discontinued cash flow hedge accounting treatment for $478 million of forward contracts related to our anticipated equity funding of the UniSpreadtrum investment since we could no longer assert that funding is probable to occur within the initially specified time frame. Hedge losses accumulated in other comprehensive income and subsequently released to interest and other, net, related to these de-designated forward contracts were insignificant.
FAIR VALUE OF DERIVATIVE INSTRUMENTS IN THE CONSOLIDATED BALANCE SHEETS
 
 
December 30, 2017
 
December 31, 2016
(In Millions)
 
Assets1
 
Liabilities2
 
Assets1
 
Liabilities2
Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Foreign currency contracts3
 
$
283

 
$
32

 
$
21

 
$
252

Interest rate contracts
 
1

 
254

 
3

 
187

Total derivatives designated as hedging instruments
 
284


286


24


439

Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
Foreign currency contracts3
 
52

 
447

 
374

 
114

Interest rate contracts
 
18

 
24

 
15

 
30

Other
 
9

 

 
9

 

Total derivatives not designated as hedging instruments
 
79


471


398


144

Total derivatives
 
$
363


$
757


$
422


$
583


1 
Derivative assets are recorded as other assets, current and non-current.
2 
Derivative liabilities are recorded as other liabilities, current and non-current.
3 
The majority of these instruments mature within 12 months.


AMOUNTS OFFSET IN THE CONSOLIDATED BALANCE SHEETS
The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:
 
 
December 30, 2017
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
350

 
$

 
$
350

 
$
(206
)
 
$
(130
)
 
$
14

Reverse repurchase agreements
 
1,649

 

 
1,649

 

 
(1,649
)
 

Total assets
 
1,999




1,999


(206
)

(1,779
)

14

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
745

 

 
745

 
(206
)
 
(504
)
 
35

Total liabilities
 
$
745


$


$
745


$
(206
)

$
(504
)

$
35

 
 
December 31, 2016
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
433

 
$

 
$
433

 
$
(368
)
 
$
(42
)
 
$
23

Reverse repurchase agreements
 
1,018

 

 
1,018

 

 
(1,018
)
 

Total assets
 
1,451




1,451


(368
)

(1,060
)

23

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
588

 

 
588

 
(368
)
 
(201
)
 
19

Total liabilities
 
$
588


$


$
588


$
(368
)

$
(201
)

$
19


We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate.

DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS
The before-tax net gains or losses attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss), were $605 million net gains in 2017 ($26 million net losses in 2016 and $298 million net losses in 2015). Substantially all of our cash flow hedges are foreign currency contracts for all periods presented.
Hedge ineffectiveness and amounts excluded from effectiveness testing were insignificant during all periods presented.
For information on the unrealized holding gains (losses) on derivatives reclassified out of accumulated other comprehensive income into the consolidated statements of income, see "Note 16: Other Comprehensive Income (Loss)."
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:
 
 
Gains (Losses)
Recognized in Statement of Income on
Derivatives
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Interest rate contracts
 
$
(68
)
 
$
(171
)
 
$
(13
)
Hedged items
 
68

 
171

 
13

Total
 
$

 
$

 
$


There was no ineffectiveness during all periods presented in the preceding table.
The amounts recorded on the consolidated balance sheet related to cumulative basis adjustments for fair value hedges for each period were as follows:
Line Item in the Consolidated Balance Sheet in Which the Hedged Item Is Included
 
Carrying Amount of the Hedged Item Asset/(Liabilities)
 
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 30,
2017
 
Dec 31,
2016
Long-Term Debt
 
$
(12,653
)
 
$
(8,879
)
 
$
252

 
$
184


As of December 30, 2017 and December 31, 2016, the total notional amount of pay variable/receive fixed-interest rate swaps was $12.9 billion and $9.1 billion, respectively.
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
Years Ended
(In Millions)
 
Location of Gains (Losses)
Recognized in Income on Derivatives
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Foreign currency contracts
 
Interest and other, net
 
$
(547
)
 
$
388

 
$
296

Interest rate contracts
 
Interest and other, net
 
9

 
8

 
(8
)
Other
 
Various
 
203

 
113

 
(38
)
Total
 
$
(335
)

$
509


$
250

Retirement Benefit Plans
Retirement Benefit Plans [Text Block]
Note 18: Retirement Benefit Plans
DEFINED CONTRIBUTION PLANS
We provide tax-qualified defined contribution plans for the benefit of eligible employees, former employees, and retirees in the U.S. and certain other countries. The plans are designed to provide employees with an accumulation of funds for retirement on a tax-deferred basis. For the benefit of eligible U.S. employees, we also provide an unfunded non-tax-qualified supplemental deferred compensation plan for certain highly compensated employees.
We expensed $346 million for discretionary contributions to the U.S. qualified defined contribution and non-qualified deferred compensation plans in 2017 ($326 million in 2016 and $337 million in 2015).
U.S. POSTRETIREMENT MEDICAL BENEFITS PLAN
Upon retirement, we provide benefits to eligible U.S. employees who were hired prior to 2014 under the U.S. Postretirement Medical Benefits Plan. The benefits can be used to pay all or a portion of the cost to purchase eligible coverage in a medical plan.
As of December 30, 2017 and December 31, 2016, the projected benefit obligation was $567 million and $588 million, respectively, which used the discount rate of 3.8% and 4.2%, respectively. The December 30, 2017 and December 31, 2016 corresponding fair value of plan assets was $563 million and $409 million, respectively.
The investment strategy for U.S. Postretirement Medical Benefits Plan assets is to invest primarily in liquid assets, due to the level of expected future benefit payments. The assets are invested solely in a tax-aware global equity portfolio, which is actively managed by an external investment manager. The tax-aware global equity portfolio is composed of a diversified mix of equities in developed countries. For 2018, the expected long-term rate of return for the U.S. Postretirement Medical Benefits Plan assets is 5.9%. As of December 30, 2017, substantially all of the U.S. Postretirement Medical Benefits Plan assets were invested in exchange-traded equity securities and were measured at fair value using Level 1 inputs.
The estimated benefit payments for this plan over the next 10 fiscal years are as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023-2027
Postretirement Medical Benefits
 
$
28

 
$
29

 
$
30

 
$
31

 
$
32

 
$
179


PENSION BENEFIT PLANS
We provide defined-benefit pension plans in certain countries, most significantly the U.S., Ireland, Germany, and Israel. The majority of the plans' benefits have been frozen.


BENEFIT OBLIGATION AND PLAN ASSETS FOR PENSION BENEFITS PLANS
The vested benefit obligation for a defined-benefit pension plan is the actuarial present value of the vested benefits to which the employee is currently entitled based on the employee's expected date of separation or retirement.
 
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Changes in projected benefit obligation:
 
 
 
 
Beginning projected benefit obligation
 
$
3,640

 
$
3,130

Service cost
 
84

 
130

Interest cost
 
117

 
106

Actuarial (gain) loss
 
24

 
575

Currency exchange rate changes
 
281

 
(80
)
Plan curtailments
 
(162
)
 
17

Plan settlements
 
(101
)
 
(202
)
Other
 
(41
)
 
(36
)
Ending projected benefit obligation1
 
3,842

 
3,640

 
 
 
 
 
Changes in fair value of plan assets:
 
 
 
 
Beginning fair value of plan assets
 
1,696

 
1,638

Actual return on plan assets
 
136

 
81

Employer contributions
 
471

 
416

Currency exchange rate changes
 
124

 
(26
)
Plan settlements
 
(101
)
 
(202
)
Benefits paid to plan participants
 
(42
)
 
(84
)
Other
 
3

 
(127
)
Ending fair value of plan assets2
 
2,287

 
1,696

 
 
 
 
 
Amounts recognized in the consolidated balance sheet3
 
$
1,555

 
$
1,944

 
 
 
 
 
Accumulated other comprehensive loss (income), before tax4
 
$
1,257

 
$
1,603

 
 
 
 
 
Accumulated benefit obligation5
 
$
3,423

 
$
2,976


1 
The split between U.S. and non-U.S. in the projected benefit obligation was 38% and 62%, respectively, as of December 30, 2017 and December 31, 2016.
2 
The split between the U.S. and non-U.S. in the fair value of plan assets was 49% and 51%, respectively, as of December 30, 2017 and 46% and 54%, respectively, as of December 31, 2016.
3 
Substantially all amounts recognized in the consolidated balance sheet are recorded in other long-term liabilities for all periods presented.
4 
The split between U.S. and non-U.S. in the accumulated other comprehensive loss (income), before tax, was 38% and 62%, respectively, as of December 30, 2017 and 34% and 66%, respectively, as of December 31, 2016. Substantially all amounts recognized in accumulated other comprehensive loss (income) are attributable to net actuarial gain or loss.
5 
All plans had accumulated benefit obligations and projected benefit obligations in excess of plan assets for all periods presented.
We use the corridor approach to amortize actuarial gains and losses. Under this approach, net actuarial gains or losses in excess of 10% of the larger of the projected benefit obligation or the fair value of plan assets are amortized on a straight-line basis.
ASSUMPTIONS FOR PENSION BENEFIT PLANS
 
 
Dec 30,
2017
 
Dec 31,
2016
Weighted average actuarial assumptions used to determine benefit obligations
 
 
 
 
Discount rate
 
3.0
%
 
3.2
%
Rate of compensation increase
 
3.3
%
 
3.6
%
 
 
2017
 
2016
 
2015
Weighted average actuarial assumptions used to determine costs
 
 
 
 
 
 
Discount rate
 
3.2
%
 
3.3
%
 
3.1
%
Expected long-term rate of return on plan assets
 
4.6
%
 
5.5
%
 
5.9
%
Rate of compensation increase
 
3.6
%
 
3.8
%
 
3.9
%

We establish the discount rate for each pension plan by analyzing current market long-term bond rates and matching the bond maturity with the average duration of the pension liabilities.
We establish the long-term expected rate of return by developing a forward-looking, long-term return assumption for each pension fund asset class, taking into account factors such as the expected real return for the specific asset class and inflation. A single, long-term rate of return is then calculated as the weighted average of the target asset allocation percentages and the long-term return assumption for each asset class.
FUNDING
Policy. Our practice is to fund the various pension plans in amounts sufficient to meet the minimum requirements of applicable local laws and regulations. Additional funding may be provided as deemed appropriate. Funding for the U.S. Postretirement Medical Benefits Plan is discretionary under applicable laws and regulations; additional funding may be provided as deemed appropriate.
Funding Status. On a worldwide basis, our pension and postretirement benefit plans were 65% funded as of December 30, 2017. The U.S. Intel Minimum Pension Plan, which accounts for 33% of the worldwide pension and postretirement benefit obligations, was 77% funded. Funded status is not indicative of our ability to pay ongoing pension benefits or of our obligation to fund retirement trusts. Required pension funding for U.S. retirement plans is determined in accordance with the Employee Retirement Income Security Act (ERISA), which sets required minimum contributions. Cumulative company funding to the U.S. Intel Minimum Pension Plan currently exceeds the minimum ERISA funding requirements.

NET PERIODIC BENEFIT COST
The net periodic benefit cost for pension benefits and U.S. postretirement medical benefits was $243 million in 2017, ($415 million in 2016 and $250 million in 2015). The service cost component of the corresponding net periodic benefit cost was $104 million in 2017 ($156 million in 2016 and $176 million in 2015).

The increase in the net periodic pension benefit cost in 2016 compared to 2015 was primarily attributed to plan settlements and remeasurement in conjunction with our 2016 Restructuring Program. For more information on the 2016 Restructuring Program, see "Note 7: Restructuring and Other Charges."

PENSION PLAN ASSETS
 
 
December 30, 2017
 
Dec 31,
2016
 
 
Fair Value Measured at Reporting Date Using
 
 
 
 
(In Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total
Equity securities
 
$
451

 
$

 
$
22

 
$
473

 
$
328

Fixed income
 
45

 
326

 
94

 
465

 
304

Other investments
 
19

 

 

 
19

 

Assets measured by fair value hierarchy
 
$
515

 
$
326

 
$
116

 
$
957

 
$
632

Assets measured at net asset value
 
 
 
 
 
 
 
1,208

 
1,044

Cash and cash equivalents
 
 
 
 
 
 
 
122

 
20

Total pension plan assets at fair value
 
 
 
 
 
 
 
$
2,287

 
$
1,696



U.S. Plan Assets
The investment strategy for U.S. Intel Minimum Pension Plan assets is to maximize risk-adjusted returns, taking into consideration the investment horizon and expected volatility to help ensure that sufficient assets are available to pay pension benefits as they come due. The allocation to each asset class will fluctuate with market conditions, such as volatility and liquidity concerns, and will typically be rebalanced when outside the target ranges, which were 45% fixed income, 30% hedge funds, and 25% equity investments in 2017. For 2018, the expected long-term rate of return for the U.S. Intel Minimum Pension Plan assets is 5.1%.
Substantially all of the fixed-income investments in the U.S. plan assets are asset-backed securities, corporate debt, and government debt. Government debt includes instruments such as non-U.S. government securities, U.S. agency securities, and U.S. treasury securities.
The assets measured at net asset value are invested in common collective trust funds, limited partnerships, and limited liability companies.
Non-U.S. Plan Assets
The investments of the non-U.S. plans are managed by insurance companies, pension funds, or third-party trustees, consistent with regulations or market practice of the country where the assets are invested. The investment manager makes investment decisions within the guidelines set by Intel or local regulations. Investments managed by qualified insurance companies or pension funds under standard contracts follow local regulations, and we are not actively involved in their investment strategies. For the assets that we have discretion to set investment guidelines, the assets are invested in developed country equity investments and fixed-income investments, either through index funds or direct investment. In general, the investment strategy is designed to accumulate a diversified portfolio among markets, asset classes, or individual securities to reduce market risk and to help ensure that the pension assets are available to pay benefits as they come due. The target allocation of the non-U.S. plan assets that we have control over is approximately 45% equity, 35% fixed-income, and 20% hedge fund investments. For 2018, the average expected long-term rate of return for the non-U.S. plan assets is 4.2%.
Most of the equity investments in the non-U.S. plan assets are invested in a diversified mix of equities of developed countries, including the U.S., and emerging markets throughout the world.
We have control over the investment strategy related to the majority of the assets measured at net asset value, which are invested in hedge funds, bond index, and equity index funds.
ESTIMATED FUTURE BENEFIT PAYMENTS FOR PENSION BENEFIT PLANS
Estimated benefit payments over the next 10 fiscal years are as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023-2027
Pension benefits
 
$
125

 
$
117

 
$
115

 
$
121

 
$
124

 
$
673

Employee Equity Incentive Plans
Employee Equity Incentive Plans [Text Block]
Note 19: Employee Equity Incentive Plans
Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. Our plans include our 2006 Equity Incentive Plan (the 2006 Plan) and our 2006 Stock Purchase Plan.
In May 2017, our stockholders approved an extension of the expiration date of the 2006 Plan to June 2020 and authorized an additional 33 million shares for issuance under the plan. Under the 2006 Plan, 786 million shares of common stock have been authorized for issuance as equity awards to employees and non-employee directors through June 2020. As of December 30, 2017, 215 million shares of common stock remained available for future grants.
Under the 2006 Plan, we grant RSUs and previously granted stock options. We grant RSUs with a service condition, as well as RSUs with both a market condition and a service condition (market-based RSUs), which we call outperformance stock units (OSUs), and which are granted to a group of senior officers, employees, and non-employee directors. For OSUs granted in 2017, the number of shares of our common stock to be received at vesting will range from 0% to 200% of the target grant amount, based on total stockholder return (TSR) of our common stock measured against the benchmark TSR of the S&P 500 IT Sector Index over a three-year period. TSR is a measure of stock price appreciation plus any dividends paid in this performance period. As of December 30, 2017, 9.2 million OSUs were outstanding. These OSUs generally vest three years and one month from the grant date, and OSUs granted prior to 2017 accrue dividend equivalents. Other RSU awards and option awards generally vest over four years from the grant date. Stock options generally expire seven years from the date of grant.
SHARE-BASED COMPENSATION
Share-based compensation recognized in 2017 was $1.4 billion ($1.4 billion in 2016 and $1.3 billion in 2015), which includes $71 million of cash-settled awards in connection with the Mobileye acquisition.
The total share-based compensation cost capitalized as part of inventory as of December 30, 2017 was $49 million ($44 million as of December 31, 2016 and $49 million as of December 26, 2015). During 2017, the tax benefit that we realized for the tax deduction from share-based awards totaled $520 million ($616 million in 2016 and $533 million in 2015).
We estimate the fair value of RSUs with a service condition using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our shares of common stock prior to vesting. We estimate the fair value of OSUs using a Monte Carlo simulation model on the date of grant.
We use the Black-Scholes option pricing model to estimate the fair value of rights to acquire shares of common stock granted under the 2006 Stock Purchase Plan on the date of grant. We based the weighted average estimated value of RSU and OSU grants, and rights granted under the 2006 Stock Purchase Plan, on the weighted average assumptions for each period as follows:
 
 
RSUs and OSUs
 
Stock Purchase Plan
 
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Estimated values
 
$
35.30

 
$
29.76

 
$
31.63

 
$
7.20

 
$
6.70

 
$
6.56

Risk-free interest rate
 
1.4
%
 
0.9
%
 
0.6
%
 
1.0
%
 
0.5
%
 
0.1
%
Dividend yield
 
2.9
%
 
3.3
%
 
2.9
%
 
2.9
%
 
3.2
%
 
3.1
%
Volatility
 
23
%
 
23
%
 
27
%
 
19
%
 
22
%
 
25
%
Expected life (in years)
 
n/a

 
n/a

 
n/a

 
0.5

 
0.5

 
0.5


We base the expected volatility for rights granted under the 2006 Stock Purchase Plan on implied volatility. We base expected volatility for OSUs on historical volatility. 
RESTRICTED STOCK UNIT AWARDS
RSU activity in 2017 was as follows:
 
 
Number of
RSUs
(In Millions)
 
Weighted
Average
Grant-Date
Fair Value
December 31, 2016
 
106.8

 
$
28.99

Granted
 
45.2

 
$
35.30

Assumed in acquisition
 
1.1

 
$
34.90

Vested
 
(40.5
)
 
$
27.52

Forfeited
 
(12.2
)
 
$
30.08

December 30, 2017
 
100.4

 
$
32.36

Expected to vest as of December 30, 2017
96.5

 
$
32.36


The aggregate fair value of awards that vested in 2017 was $1.6 billion ($1.6 billion in 2016 and $1.5 billion in 2015), which represents the market value of our common stock on the date that the RSUs vested. The grant-date fair value of awards that vested in 2017 was $1.1 billion ($1.3 billion in 2016 and $1.1 billion in 2015). The number of RSUs vested includes shares of common stock that we withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements. RSUs that are expected to vest are net of estimated future forfeitures.
As of December 30, 2017, unrecognized compensation costs related to RSUs granted under our equity incentive plans were $2.0 billion. We expect to recognize those costs over a weighted average period of 1.3 years.
STOCK PURCHASE PLAN
The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. Under the 2006 Stock Purchase Plan, 373 million shares of common stock are authorized for issuance through August 2021. As of December 30, 2017, 150 million shares of common stock remained available for issuance.
Employees purchased 14.5 million shares of common stock in 2017 for $432 million under the 2006 Stock Purchase Plan (16.5 million shares of common stock for $415 million in 2016 and 15.8 million shares of common stock for $421 million in 2015). As of December 30, 2017, unrecognized share-based compensation costs related to rights to acquire shares of common stock under our 2006 Stock Purchase Plan totaled $13 million. We expect to recognize those costs over a period of approximately two months.
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Note 20: Commitments and Contingencies
COMMITMENTS
Leases
Portions of our real property and equipment are under operating leases that expire at various dates through 2058. Rental expense was $264 million in 2017 ($282 million in 2016 and $253 million in 2015).
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023
and thereafter
 
Total
Minimum rental commitments under all non-cancelable leases1
 
$
215

 
$
186

 
$
162

 
$
136

 
$
105

 
$
441

 
$
1,245


1 
Includes leases with initial term in excess of one year.
Other Commitments
Commitments for construction or purchase of property, plant and equipment totaled $12.1 billion as of December 30, 2017 ($7.5 billion as of December 31, 2016), a substantial majority of which will be due within the next 12 months. Other purchase obligations and commitments totaled approximately $2.7 billion as of December 30, 2017 (approximately $3.0 billion as of December 31, 2016). Other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services, as well as payments due under non-contingent funding obligations. In addition, we have various contractual commitments with IMFT. For further information on these contractual commitments, see "Note 9: Investments."
LEGAL PROCEEDINGS
We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.
European Commission Competition Matter
In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ($1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision.
The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices.
We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice held oral argument in June 2016. In October 2016, Advocate General Wahl, an advisor to the Court of Justice, issued a non-binding advisory opinion that favored Intel on a number of grounds. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. The General Court has appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law. In November 2017, the parties filed initial “Observations” about the Court of Justice’s decision and the appeal, and have been invited by the General Court to offer supplemental comments to each other’s “Observations” by March 2018. Pending the final decision in this matter, the fine paid by Intel has been placed by the EC in commercial bank accounts where it accrues interest.
Shareholder Derivative Litigation regarding In re High Tech Employee Antitrust Litigation
In March 2014, the Police Retirement System of St. Louis (PRSSL) filed a shareholder derivative action in the Superior Court of California in Santa Clara County against Intel, certain current and former members of our Board of Directors, and former officers. The complaint alleges that the defendants breached their duties to the company by participating in, or allowing, purported antitrust violations that were alleged in a now-settled antitrust class action lawsuit captioned In re High Tech Employee Antitrust Litigation claiming that Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar conspired to suppress their employees’ compensation. In March 2014, a second plaintiff, Barbara Templeton, filed a substantially similar derivative suit in the same court. In May 2014, a third shareholder, Robert Achermann, filed a substantially similar derivative action in the same court. The court consolidated the three actions into one, which is captioned In re Intel Corporation Shareholder Derivative Litigation. Plaintiffs filed a consolidated complaint in July 2014. In August 2015, the court granted our motion to dismiss the consolidated complaint. The plaintiffs thereafter filed a motion for reconsideration and a motion for new trial, both of which the court denied in October 2015. In November 2015, plaintiffs PRSSL and Templeton appealed the court's decision. The appeal is fully briefed, and we are waiting on a hearing date from the appellate court.
In June 2015, the International Brotherhood of Electrical Workers (IBEW) filed a shareholder derivative action in the Chancery Court in Delaware against Intel, certain current and former members of our Board of Directors, and former officers. The lawsuit makes allegations substantially similar to those in the California shareholder derivative litigation described above, but additionally alleges breach of the duty of disclosure with respect to In re High Tech Employee Antitrust Litigation and that Intel's 2013 and 2014 proxy statements misrepresented the effectiveness of the Board’s oversight of compliance issues at Intel and the Board’s compliance with Intel’s Code of Conduct and Board of Director Guidelines on Significant Corporate Governance Issues. In October 2015, the court stayed the IBEW lawsuit for six months pending further developments in the California case. In March 2016, Intel and IBEW entered into a stipulated dismissal pursuant to which IBEW dismissed its complaint but may re-file upon the withdrawal or final resolution of the appeal in the PRSSL California shareholder derivative litigation.
In April 2016, John Esposito filed a shareholder derivative action in the Superior Court of California in Santa Clara County against Intel, current members of our Board of Directors, and certain former officers and employees. Esposito made a demand on our Board in 2013 to investigate whether our officers or directors should be sued for their participation in the events described in In re High Tech Employee Antitrust Litigation. In November 2015, our Board decided not to take further action on Esposito’s demand based on the recommendation of the Audit Committee of the Board after its investigation of relevant facts and circumstances. Esposito seeks to set aside such decision, and alleges that the Board was not disinterested in making that decision and that the investigation was inadequate. In November 2016, the court granted Intel’s motion to dismiss the case, without leave to amend. In March 2017, plaintiff filed a motion for fees. The court denied plaintiff’s fee motion in May 2017, and entered final judgment in this matter in June 2017. In August 2017, Esposito appealed the final judgment.
McAfee, Inc. Shareholder Litigation
On August 19, 2010, we announced that we had agreed to acquire all of the common stock of McAfee, Inc. (McAfee) for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee, and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08.
In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs appealed the final judgment. The California Court of Appeal heard oral argument in October 2017, and in November 2017, affirmed the judgment as to McAfee's nine outside directors, reversed the judgment as to former McAfee director and chief executive officer David DeWalt, Intel, and McAfee, and affirmed the trial court's ruling that the plaintiffs are not entitled to a jury trial. No bench trial date has been set. Because the resolution of pretrial motions may materially impact the scope and nature of the proceeding, and because of uncertainties regarding theories that may be asserted at trial following the appellate court's remand of only certain claims in the proceeding and the extent of Intel's responsibility, if any, with respect to such claims, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously.
Litigation related to Security Vulnerabilities
In June 2017, a Google research team notified us and other companies that it had identified security vulnerabilities (now commonly referred to as “Spectre” and “Meltdown”) that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 3, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. Numerous lawsuits have been filed against Intel and, in certain cases, our executives and directors, in U.S. federal and state courts and in certain courts in other countries relating to the Spectre and Meltdown security vulnerabilities.
As of February 15, 2018, 30 customer class action lawsuits and two securities class action lawsuits have been filed. The customer class action plaintiffs, who purport to represent various classes of end users of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. The securities class action plaintiffs, who purport to represent classes of acquirers of Intel stock between July 27, 2017 and January 4, 2018, generally allege that Intel and certain officers violated securities laws by making statements about Intel's products and internal controls that were revealed to be false or misleading by the disclosure of the security vulnerabilities. Additional lawsuits and claims may be asserted on behalf of customers and shareholders seeking monetary damages or other related relief. We dispute the claims described above and intend to defend the lawsuits vigorously. Given the procedural posture and the nature of these cases, including that the proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.  

In addition to these lawsuits, in January 2018, Joseph Tola, Joanne Bicknese, and Michael Kellogg each filed a shareholder derivative action in the Superior Court of the State of California in San Mateo County against certain members of our Board of Directors and certain officers. The complaints allege that the defendants breached their duties to Intel in connection with the disclosure of the security vulnerabilities and the failure to take action in relation to alleged insider trading. The complaints seek to recover damages from the defendants on behalf of Intel.
Valuation and Qualifying Accounts
Valuation and Qualifying Accounts [Text Block]
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
Years Ended
(In Millions)
 
Balance at Beginning of Year
 
Additions Charged to Expenses/
Other Accounts
 
Net
(Deductions)
Recoveries
 
Balance at
End of Year
Valuation allowance for deferred tax assets
 
 
 
 
 
 
 
 
December 30, 2017
 
$
953

 
$
237

 
$
(19
)
 
$
1,171

December 31, 2016
 
$
701

 
$
261

 
$
(9
)
 
$
953

December 26, 2015
 
$
595

 
$
190

 
$
(84
)
 
$
701

Accounting Policies (Policies)
REVENUE RECOGNITION
We recognize net product revenue when the earnings process is complete and the risks and rewards of product ownership have transferred to our customers, as evidenced by the existence of an agreement, delivery having occurred, pricing being deemed fixed, and collection being considered probable. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. On sales made to distributors that allow for price protections or right of return until the distributor sells through the merchandise, we defer product revenue, and related costs of sales, due to sales price reductions and rapid technology obsolescence in our industry. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
We make payments to our customers through cooperative advertising programs, such as our Intel Inside® program, for marketing activities for certain of our products. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue.
During the first half of 2017, our cooperative advertising costs under the Intel Inside program met the criteria to be recorded as MG&A. During the second half of 2017, we transitioned customers from previous offerings under the Intel Inside program to cooperative advertising offerings more tailored to customers and their marketing audiences. In the second half of 2017, cooperative advertising costs were recorded as a reduction of revenue, as we no longer met the criteria for recording these expenses within MG&A.
INVENTORIES
We compute inventory cost on a first-in, first-out basis. Our process and product development life cycle corresponds with substantive engineering milestones. These engineering milestones are regularly and consistently applied in assessing the point at which our activities, and associated costs, change in nature from research and development (R&D) to cost of sales and when cost of sales can be capitalized as inventory.
For a product to be manufactured in high volumes and sold to our customers under our standard warranty, it must meet our rigorous technical quality specifications. This milestone is known as product release qualification (PRQ). We have identified PRQ as the point at which the costs incurred to manufacture our products are included in the valuation of inventory. Prior to PRQ, costs that do not meet the criteria for R&D are included in cost of sales in the period incurred. If the point at which we estimate that inventory meets PRQ criteria changes in the future, the timing and recognition of costs would shift between inventory, and R&D and costs of sales. A single PRQ has previously ranged up to $770 million and is dependent on product type.
The valuation of inventory includes determining which fixed production overhead costs can be included in inventory based on the normal capacity of our manufacturing and assembly and test facilities. We apply our historical loadings compared to our total available capacity in a statistical model to determine our normal capacity level. If the factory loadings are below the established normal capacity level, a portion of our fixed production overhead costs would not be included in the cost of inventory; instead, it would be recognized as cost of sales in that period. We refer to these costs as excess capacity charges. Excess capacity charges are insignificant in the years presented, charges in certain prior years have ranged from $46 million to $1.1 billion. The high end of the range would be $540 million when excluding the $1.1 billion charge taken in connection with the 2009 economic recession.
Inventory is valued at the lower of cost or net realizable value, based upon assumptions about future demand and market conditions. Product-specific facts and circumstances reviewed in the inventory valuation process include a review of our customer base, the stage of the product life cycle, and an assessment of selling price in relation to product cost. Inventory reserves increased by approximately $185 million in 2017 compared to 2016.
The valuation of inventory also requires us to estimate obsolete and excess inventory, as well as inventory that is not of saleable quality. We use the demand forecast to develop our short-term manufacturing plans to enable consistency between inventory valuations and build decisions. We compare the estimate of future demand to work in process and finished goods inventory levels to determine the amount, if any, of obsolete or excess inventory. If our demand forecast for specific products is greater than actual demand and we fail to reduce manufacturing output accordingly, we could be required to write off inventory.
PROPERTY, PLANT AND EQUIPMENT
We compute depreciation using the straight-line method over the estimated useful life of assets. We also capitalize interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. We record capital-related government grants earned as a reduction to property, plant and equipment.
Annually, we evaluate the period over which we expect to recover the economic value of our property, plant and equipment, considering factors such as the process technology cadence between node transitions, changes in machinery and equipment technology, and re-use of machinery and tools across each generation of process technology. As we make manufacturing process conversions and other factory planning decisions, we use assumptions involving the use of management judgments regarding the remaining useful lives of assets, primarily process-specific semiconductor manufacturing tools and building improvements. When we determine that the useful lives of assets are shorter or longer than we had originally estimated, we adjust the rate of depreciation to reflect the assets’ revised useful lives.
We assess property, plant and equipment for impairment when events or changes in circumstances indicate that the carrying value of the assets or the asset grouping may not be recoverable. Factors that we consider in deciding when to perform an impairment review include significant under-performance of a business or product line in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in our use of the assets. We measure the recoverability of assets that we will continue to use in our operations by comparing the carrying value of the asset grouping to our estimate of the related total future undiscounted net cash flows arising from the use of that asset grouping. If an asset grouping carrying value is not recoverable through the related undiscounted cash flows, the asset grouping is considered to be impaired. We measure the impairment by comparing the difference between the asset grouping carrying value and its fair value.
We may have certain facilities, included within construction in progress, being held in a safe state and not currently in use that we plan to place into service at a future date. The time at which these assets are placed into service depends on our existing manufacturing capacity, market demand for our products, and where we are in the transition of products on our roadmap. Management makes judgments about the timing of when these facilities will be readied for their intended use and placed into service for the manufacturing of our products. Depreciation is not recognized on these assets and they are not eligible for capitalized interest when construction is on hold.
FAIR VALUE
When determining fair value, we consider the principal or most advantageous market in which we would transact, as well as assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than three months.
The three levels of inputs that may be used to measure fair value are:
Level 1. Quoted prices in active markets for identical assets or liabilities. We evaluate security-specific market data when determining whether a market is active.
Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations. All significant inputs used in our valuations, such as discounted cash flows, are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. We use LIBOR-based yield curves, currency spot and forward rates, and credit ratings as significant inputs in our valuations. Level 2 inputs also include non-binding market consensus prices as well as quoted prices that were adjusted for security-specific restrictions. When we use non-binding market consensus prices, we corroborate them with quoted market prices for similar instruments or compare them to output from internally developed pricing models such as discounted cash flow models.
Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
CASH EQUIVALENTS
We consider all highly liquid debt investments with original maturities from the date of purchase of three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements.
TRADING ASSETS
Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge currency exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses on these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net.
AVAILABLE-FOR-SALE INVESTMENTS
Available-for-sale investments are classified within cash and cash equivalents, short-term investments, marketable equity securities, or long-term investments based on the remaining maturity of the investment.
Investments designated as available-for-sale are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in our other-than-temporary impairment policy. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We record the interest income and realized gains or losses on the sale of these instruments in interest and other, net.
Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity securities to promote business and strategic objectives. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
NON-MARKETABLE AND EQUITY METHOD INVESTMENTS
We regularly invest in non-marketable equity instruments of private companies. We account for marketable and non-marketable equity securities as equity method investments when we have the ability to exercise significant influence but do not have control over the investee. Our proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net. Non-marketable equity investments over which we cannot exercise significant influence are accounted for as cost method investments.
The carrying value of our non-marketable equity investment portfolio totaled $4.5 billion as of December 30, 2017 ($4.4 billion as of December 31, 2016), and is included in other long-term assets.
Our quarterly impairment analysis considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include industry and market conditions, the financial performance and near-term prospects of the investee, and other relevant events and factors affecting the investee. We prepare quarterly quantitative assessments of the fair value of our non-marketable equity investments using both the market and income approaches, which require judgment and the use of estimates, including discount rates, investee revenues and costs, and comparable market data of private and public companies, among others.
OTHER-THAN-TEMPORARY IMPAIRMENT
Our available-for-sale debt securities, marketable equity securities, and non-marketable equity investments are subject to periodic impairment reviews.
For available-for-sale debt securities, we consider whether it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis, or whether recovery of the entire amortized cost basis of the security is unlikely because a credit loss exists. When we do not expect to recover the entire amortized cost basis of the security, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts not related to credit losses, which are recognized in other comprehensive income (loss).
For marketable equity securities, we consider the severity and duration of the decline in fair value below cost and our ability and intent to hold the security for a sufficient period of time to allow for recovery of value in the foreseeable future based on the financial health of, and business outlook for, the investee.
For non-marketable equity investments, we consider the severity and duration of the impairment, the investee's financial condition and business outlook, industry and sector performance, market for technology, operational and financing cash flow factors, and changes in the investee's credit rating, among other qualitative and quantitative criteria. Impairments of non-marketable equity investments were $555 million in 2017 ($184 million in 2016 and $166 million in 2015).
We record other-than-temporary impairments for marketable equity securities, non-marketable cost method investments, and equity method investments in gains (losses) on equity investments, net.
DERIVATIVE FINANCIAL INSTRUMENTS
Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. We enter into master netting arrangements to mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty. A master netting arrangement allows counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. We also enter into collateral security arrangements with certain of our counterparties to exchange cash collateral when the net fair value of certain derivative instruments fluctuates from contractually established thresholds. We record the collateral within current other assets and long-term other assets with a corresponding liability. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are presented at fair value on a gross basis and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
Cash Flow Hedges
We use foreign currency contracts, such as currency forwards and currency interest rate swaps, to hedge exposures for the following items:
Variability in the U.S.-dollar equivalent of non-U.S.-dollar-denominated cash flows associated with our forecasted operating and capital purchases spending; and
Coupon and principal payments for our non-U.S.-dollar-denominated indebtedness.
The after-tax gains or losses from the effective portion of a cash flow hedge is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedge transaction. For foreign currency contracts hedging our capital purchases, forward points are excluded from the hedge effectiveness assessment. Ineffective portions of cash flow hedges, as well as amounts excluded from the hedge effectiveness assessment, are recognized in earnings in interest and other, net. If the cash flow hedge transactions become probable not to occur, the corresponding amounts deferred in accumulated other comprehensive income (loss) would be immediately reclassified to interest and other, net. These derivatives are classified in the consolidated statements of cash flows in the same section as the underlying item.
Fair Value Hedges
We use interest rate contracts, such as interest rate swaps, to hedge against changes in the fair value on certain of our fixed-rate indebtedness attributable to changes in the benchmark interest rate. The gains or losses on these hedges, as well as the offsetting losses or gains related to the changes in the fair value of the underlying hedged item attributable to the hedged risk, are recognized in earnings in the current period, primarily in interest and other, net. These derivatives are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from financing activities.


Non-Designated Hedges
We use foreign currency contracts to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and non-U.S.-dollar-denominated loans receivables recognized at fair value. We also use interest rate contracts to hedge interest rate risk related to our U.S.-dollar-denominated fixed-rate debt instruments classified as trading assets.
The change in fair value of these derivatives is recorded through earnings in the line item on the consolidated statements of income to which the derivatives most closely relate, primarily in interest and other, net. Changes in the fair value of the underlying assets and liabilities associated with the hedged risk are generally offset by the changes in the fair value of the related derivatives.
LOANS RECEIVABLE
We elect the fair value option when the interest rate or foreign currency exchange rate risk is economically hedged at the inception of the loan with a related derivative instrument. When the fair value option is not elected, the loans are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. We classify our loans within other current and long-term assets.
CREDIT RISK
Financial instruments that potentially subject us to concentrations of credit risk consist principally of investments in debt instruments, derivative financial instruments, loans receivable, reverse repurchase agreements, and trade receivables. We enter into master netting arrangements to mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty.
We generally place investments with high-credit-quality counterparties and, by policy, we limit the amount of credit exposure to any one counterparty based on our analysis of that counterparty’s relative credit standing. As required per our investment policy, substantially all of our investments in debt instruments and financing receivables are in investment-grade instruments. Credit-rating criteria for derivative instruments are similar to those for other investments. Due to master netting arrangements, the amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which the counterparty’s obligations exceed our obligations with that counterparty. As of December 30, 2017, our total credit exposure to any single counterparty, excluding money market funds invested in U.S. treasury and U.S. agency securities and reverse repurchase agreements collateralized by treasury and agency securities, did not exceed $800 million. To further reduce credit risk, we obtain and secure available collateral from counterparties against obligations, including securities lending transactions, when we deem it appropriate.
A substantial majority of our trade receivables are derived from sales to original equipment manufacturers and original design manufacturers. We also have accounts receivable derived from sales to industrial and communications equipment manufacturers in the computing and communications industries. We believe that the net accounts receivable balances from our three largest customers (36% in 2017) do not represent a significant credit risk, based on cash flow forecasts, balance sheet analysis, and past collection experience. For more information about the customers that represent our accounts receivable balance, see "Note 4: Operating Segments."
We have adopted credit policies and standards intended to accommodate industry growth and inherent risk. We believe that credit risks are moderated by the financial stability of our major customers. We assess credit risk through quantitative and qualitative analysis. From this analysis, we establish shipping and credit limits, and determine whether we will seek to use one or more credit support protection devices, such as obtaining a parent guarantee, standby letter of credit, or credit insurance.
BUSINESS COMBINATIONS
We allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions based on their estimated fair values at the time of acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. The most subjective areas include determining the fair value of the following:
intangible assets, including the valuation methodology, estimations of future cash flows, discount rates, market segment growth rates, our assumed market segment share, as well as the estimated useful life of intangible assets;
deferred tax assets and liabilities, uncertain tax positions, and tax-related valuation allowances, which are initially estimated as of the acquisition date;
inventory; property, plant and equipment; pre-existing liabilities or legal claims; deferred revenue; and contingent consideration, each as may be applicable; and
goodwill as measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed.
Our assumptions and estimates are based upon comparable market data and information obtained from our management and the management of the acquired companies. We allocate goodwill to the reporting units of the business that are expected to benefit from the business combination.
GOODWILL
We perform an annual impairment assessment of goodwill at the reporting unit level in the fourth quarter of each year, or more frequently if indicators of potential impairment exist. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt.
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting unit. Additionally, as part of this assessment, we may perform a quantitative analysis to support the qualitative factors above by applying sensitivities to assumptions and inputs used in measuring a reporting unit’s fair value.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. Significant estimates include market segment growth rates, our assumed market segment share, estimated costs, and discount rates based on a reporting unit's weighted average cost of capital.
We test the reasonableness of the inputs and outcomes of our discounted cash flow analysis against available market data. In the current year the fair value for all of our reporting units substantially exceeds their carrying value, and our annual qualitative assessment did not indicate that a more detailed quantitative analysis was necessary.
IDENTIFIED INTANGIBLE ASSETS
We amortize acquisition-related intangible assets that are subject to amortization over their estimated useful life. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as in-process R&D and are not subject to amortization. Once these R&D projects are completed, the asset balances are transferred from in-process R&D to acquisition-related developed technology and are subject to amortization from this point forward. The asset balances relating to projects that are abandoned after acquisition are impaired and expensed to R&D.
We perform a quarterly review of significant finite-lived identified intangible assets to determine whether facts and circumstances indicate that the carrying amount may not be recoverable. These reviews can be affected by various factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our forecasts for specific product lines.
EMPLOYEE EQUITY INCENTIVE PLANS
We use the straight-line amortization method to recognize share-based compensation over the service period of the award net of estimated forfeitures. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and RSUs with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
INCOME TAXES
We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled.
We assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that we will ultimately recover the deferred tax assets recorded on our consolidated balance sheets. Recovery of a portion of our deferred tax assets is affected by management’s plans with respect to holding or disposing of certain investments; therefore, such changes could also affect our future provision for taxes.
We recognize tax benefits from uncertain tax positions only if (based on the technical merits of the position) it is more likely than not that the tax positions will be sustained on examination by the tax authority. The tax benefits recognized in the financial statements from such positions are measured based on the largest amount that is more than 50% likely to be realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income.
We have recorded provisional estimates associated with the December 22, 2017 enactment of the U.S. Tax Cuts and Jobs Act (Tax Reform). The SEC has provided accounting and reporting guidance that allows us to report provisional amounts within a measurement period up to one year due to the complexities inherent in adopting the changes. We consider both the recognition of the transition tax and the remeasurement of deferred income taxes incomplete. New guidance from regulators, interpretation of the law, and refinement of our estimates from ongoing analysis of data and tax positions may change the provisional amounts.
The transition tax is based on our total post-1986 foreign earnings and profits that were previously deferred from U.S. taxation. We have not yet completed our substantiation of the underlying data and therefore our taxable base estimates may change. Our estimates of foreign tax credits may also change as we substantiate tax credits claimed. Further, the transition tax is based in part on the amount of foreign earnings held in cash and other liquid assets. The transition tax may change as we more precisely calculate amounts held in liquid and illiquid assets at the various measurement dates. If the final tax outcome of these matters is different than provisional amounts, its will impact the provision for income taxes and the effective tax rate in the period recorded. For more information about Tax Reform impacts, see "Note 8: Income Taxes."
We recognize the tax impact of including certain foreign earnings in U.S. taxable income as a period cost. We have not recognized deferred income taxes for local country income and withholding taxes that could be incurred on distributions of certain non-U.S. earnings or for outside basis differences in our subsidiaries, because we plan to indefinitely reinvest such earnings and basis differences. Remittances of non-U.S. earnings are based on estimates and judgments of projected cash flow needs, as well as the working capital and investment requirements of our non-U.S. and U.S. operations. Material changes in our estimates of cash, working capital, and investment needs in various jurisdictions could require repatriation of indefinitely reinvested non-U.S. earnings, which could be subject to applicable non-U.S. income and withholding taxes.
LOSS CONTINGENCIES
We are subject to loss contingencies, including various legal and regulatory proceedings, asserted and potential claims, liabilities related to repair or replacement of parts in connection with product defects, as well as product warranties and potential asset impairments that arise in the ordinary course of business. An estimated loss from such contingencies is recognized as a charge to income if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
Recent Accounting Standards (Tables)
Recent Accounting Standards [Table Text Block]
The following table summarizes the effects of adopting Revenue Recognition - Contracts with Customers and Financial Instruments - Recognition and Measurement on our financial statements for the fiscal year beginning December 31, 2017 as an adjustment to the opening balance:
 
 
 
 
Adjustments from
 
 
Fiscal Year Beginning
(In Millions)
 
Dec 30, 2017
 
Revenue Standard
 
Financial Instruments Update
 
Dec 31, 2017
As Adjusted
Assets:
 
 
 
 
 
 
 
 
Accounts receivable, net
 
$
5,607

 
$
(530
)
 
$

 
$
5,077

Inventories
 
$
6,983

 
$
47

 
$

 
$
7,030

Other current assets
 
$
2,908

 
$
64

 
$

 
$
2,972

Equity investments
 
$

 
$

 
$
8,579

 
$
8,579

Marketable equity securities
 
$
4,192

 
$

 
$
(4,192
)
 
$

Other long-term assets
 
$
7,602

 
$

 
$
(4,387
)
 
$
3,215

 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
Accounts payable
 
$
2,928

 
$
55

 
$

 
$
2,983

Deferred income
 
$
1,656

 
$
(1,356
)
 
$

 
$
300

Other accrued liabilities
 
$
7,535

 
$
26

 
$

 
$
7,561

Long-term deferred tax liabilities
 
$
3,046

 
$
191

 
$

 
$
3,237

 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss)
 
$
862

 
$

 
$
(1,745
)
 
$
(883
)
Retained earnings
 
$
42,083

 
$
665

 
$
1,745

 
$
44,493

Operating Segments (Tables)
Net revenue and operating income (loss) for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Net revenue:
 
 
 
 
 
 
Client Computing Group
 
 
 
 
 
 
Platform

$
31,226


$
30,751


$
30,680

Adjacent

2,777


2,157


1,539

 
 
34,003

 
32,908

 
32,219

Data Center Group
 
 
 
 
 
 
Platform
 
17,439

 
15,895

 
14,856

Adjacent
 
1,625

 
1,341

 
1,125

 
 
19,064

 
17,236

 
15,981

Internet of Things Group
 
 
 
 
 
 
Platform
 
2,645

 
2,290

 
1,976

Adjacent
 
524

 
348

 
322

 
 
3,169

 
2,638

 
2,298

Non-Volatile Memory Solutions Group
 
3,520

 
2,576

 
2,597

Programmable Solutions Group
 
1,902

 
1,669

 

All other
 
1,103

 
2,360

 
2,260

Total net revenue
 
$
62,761

 
$
59,387

 
$
55,355

 
 
 
 
 
 
 
Operating income (loss):
 
 
 
 
 
 
Client Computing Group
 
$
12,919

 
$
10,646

 
$
8,166

Data Center Group
 
8,395

 
7,520

 
7,847

Internet of Things Group
 
650

 
585

 
515

Non-Volatile Memory Solutions Group
 
(260
)
 
(544
)
 
239

Programmable Solutions Group
 
458

 
(104
)
 

All other
 
(4,226
)
 
(5,229
)
 
(2,765
)
Total operating income
 
$
17,936

 
$
12,874

 
$
14,002

Disaggregated net revenue for each period was as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Platform revenue
 
 
 
 
 
 
Desktop platform
 
$
11,647

 
$
12,371

 
$
12,754

Notebook platform
 
19,414

 
18,203

 
17,945

DCG platform
 
17,439

 
15,895

 
14,856

Other platform1
 
2,810

 
2,467

 
1,957

 
 
51,310

 
48,936

 
47,512

 
 
 
 
 
 
 
Adjacent revenue2
 
10,917

 
8,290

 
5,858

ISecG divested business
 
534

 
2,161

 
1,985

Total revenue
 
$
62,761

 
$
59,387

 
$
55,355

1 
Includes our tablet, phone, service provider, and IOTG platform revenue.
2 
Includes all of our non-platform products for CCG, DCG, and IOTG like modem, ethernet, and silicon photonic, as well as NSG, PSG, and Mobileye products.
Net revenue by country as presented below is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
China (including Hong Kong)
 
$
14,796

 
$
13,977

 
$
11,679

Singapore
 
14,285

 
12,780

 
11,544

United States
 
12,543

 
12,957

 
11,121

Taiwan
 
10,518

 
9,953

 
10,661

Other countries
 
10,619

 
9,720

 
10,350

Total net revenue
 
$
62,761

 
$
59,387

 
$
55,355

Earnings Per Share (Tables)
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Years Ended
(In Millions, Except Per Share Amounts)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Net income available to common stockholders
 
$
9,601

 
$
10,316

 
$
11,420

Weighted average shares of common stock outstanding—basic
 
4,701

 
4,730

 
4,742

Dilutive effect of employee incentive plans
 
47

 
53

 
64

Dilutive effect of convertible debt
 
87

 
92

 
88

Weighted average shares of common stock outstanding—diluted
 
4,835

 
4,875

 
4,894

Earnings per share - Basic
 
$
2.04

 
$
2.18

 
$
2.41

Earnings per share - Diluted
 
$
1.99

 
$
2.12

 
$
2.33

Other Financial Statement Details (Tables)
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Raw materials
 
$
1,098

 
$
695

Work in process
 
3,893

 
3,190

Finished goods
 
1,992

 
1,668

Total inventories
 
$
6,983

 
$
5,553

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Land and buildings
 
$
27,391

 
$
26,627

Machinery and equipment
 
57,192

 
52,608

Construction in progress
 
15,812

 
10,870

Total property, plant and equipment, gross
 
100,395

 
90,105

Less: accumulated depreciation
 
59,286

 
53,934

Total property, plant and equipment, net
 
$
41,109

 
$
36,171

Net property, plant and equipment by country at the end of each period was as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
United States
 
$
24,459

 
$
23,598

 
$
22,611

Israel
 
6,501

 
3,923

 
1,661

China
 
4,275

 
2,306

 
537

Ireland
 
3,938

 
4,865

 
5,789

Other countries
 
1,936

 
1,479

 
1,260

Total property, plant and equipment, net
 
$
41,109

 
$
36,171

 
$
31,858


(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Deferred income on shipments of components to distributors
 
$
1,320

 
$
1,475

Deferred income from software, services, and other
 
336

 
243

Current deferred income
 
$
1,656

 
$
1,718

The components of gains (losses) on equity investments, net for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Share of equity method investee losses, net
 
$
(232
)
 
$
(38
)
 
$
(95
)
Impairments
 
(833
)
 
(187
)
 
(185
)
Gains on sales, net
 
3,499

 
562

 
145

Dividends
 
68

 
74

 
52

Other, net
 
149

 
95

 
398

Total gains (losses) on equity investments, net
 
$
2,651


$
506


$
315

The components of interest and other, net for each period were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Interest income
 
$
441

 
$
222

 
$
124

Interest expense
 
(646
)
 
(733
)
 
(337
)
Other, net
 
(30
)
 
67

 
108

Total interest and other, net
 
$
(235
)

$
(444
)

$
(105
)
Restructuring and Other Charges (Tables)
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
2016 Restructuring Program
 
$
135

 
$
1,823

 
$

2015 and 2013 Restructuring Programs
 

 

 
354

ISecG separation costs and other charges
 
249

 
63

 

Total restructuring and other charges
 
$
384

 
$
1,886

 
$
354

Restructuring and other charges by type for the 2016 Restructuring Program were as follows:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Employee severance and benefit arrangements
 
$
70

 
$
1,737

Pension settlement charges
 
25

 
57

Asset impairment and other charges
 
40

 
29

Total restructuring and other charges
 
$
135

 
$
1,823

Restructuring and other activity for the 2016 Restructuring Program were as follows:
(In Millions)
 
Employee Severance and Benefits
 
Asset Impairments and Other
 
Total
Accrued restructuring balance as of December 26, 2015
 
$

 
$

 
$

Additional accruals
 
1,556

 
29

 
1,585

Adjustments
 
92

 

 
92

Cash payments
 
(1,063
)
 

 
(1,063
)
Non-cash settlements
 

 
(19
)
 
(19
)
Accrued restructuring balance as of December 31, 2016
 
585

 
10

 
595

Additional accruals
 

 
40

 
40

Adjustments
 
70

 

 
70

Cash payments
 
(352
)
 
(25
)
 
(377
)
Non-cash settlements
 

 
(3
)
 
(3
)
Accrued restructuring balance as of December 30, 2017
 
$
303

 
$
22

 
$
325

Income Taxes (Tables)
Income before taxes and the provision for taxes consisted of the following:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Income before taxes:
 
 
 
 
 
 
U.S.
 
$
11,141

 
$
6,957

 
$
8,800

Non-U.S.
 
9,211

 
5,979

 
5,412

Total income before taxes
 
20,352

 
12,936

 
14,212

Provision for taxes:
 
 
 
 
 
 
Current:
 
 
 
 
 
 
Federal
 
10,207

 
1,319

 
2,828

State
 
27

 
13

 
40

Non-U.S.
 
899

 
756

 
842

Total current provision for taxes
 
11,133

 
2,088

 
3,710

Deferred:
 
 
 
 
 
 
Federal
 
(220
)
 
658

 
(862
)
Other
 
(162
)
 
(126
)
 
(56
)
Total deferred provision for taxes
 
(382
)
 
532

 
(918
)
Total provision for taxes
 
$
10,751

 
$
2,620

 
$
2,792

Effective tax rate
 
52.8
%
 
20.3
%
 
19.6
%
Income before taxes and the provision for taxes consisted of the following:
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Income before taxes:
 
 
 
 
 
 
U.S.
 
$
11,141

 
$
6,957

 
$
8,800

Non-U.S.
 
9,211

 
5,979

 
5,412

Total income before taxes
 
20,352

 
12,936

 
14,212

Provision for taxes:
 
 
 
 
 
 
Current:
 
 
 
 
 
 
Federal
 
10,207

 
1,319

 
2,828

State
 
27

 
13

 
40

Non-U.S.
 
899

 
756

 
842

Total current provision for taxes
 
11,133

 
2,088

 
3,710

Deferred:
 
 
 
 
 
 
Federal
 
(220
)
 
658

 
(862
)
Other
 
(162
)
 
(126
)
 
(56
)
Total deferred provision for taxes
 
(382
)
 
532

 
(918
)
Total provision for taxes
 
$
10,751

 
$
2,620

 
$
2,792

Effective tax rate
 
52.8
%
 
20.3
%
 
19.6
%
The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
Years Ended
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Statutory federal income tax rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
Increase (reduction) in rate resulting from:
 
 
 
 
 
 
Non-U.S. income taxed at different rates
 
(7.6
)
 
(11.7
)
 
(7.9
)
Research and development tax credits
 
(2.3
)
 
(2.3
)
 
(1.7
)
Domestic manufacturing deduction benefit
 
(1.3
)
 
(1.4
)
 
(2.0
)
Settlements, effective settlements, and related remeasurements
 

 
(0.1
)
 
(2.9
)
Tax Reform
 
26.8

 

 

ISecG divestiture
 
3.3

 

 

Other
 
(1.1
)
 
0.8

 
(0.9
)
Effective tax rate
 
52.8
 %
 
20.3
 %
 
19.6
 %
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Deferred tax assets:
 
 
 
 
Accrued compensation and other benefits
 
$
711

 
$
1,182

Share-based compensation
 
241

 
373

Deferred income
 
211

 
596

Inventory
 
675

 
1,044

State credits and net operating losses
 
1,081

 
846

Other, net
 
887

 
1,187

Gross deferred tax assets
 
3,806

 
5,228

Valuation allowance
 
(1,171
)
 
(953
)
Total deferred tax assets
 
2,635

 
4,275

Deferred tax liabilities:
 
 
 
 
Property, plant and equipment
 
(943
)
 
(1,574
)
Licenses and intangibles
 
(881
)
 
(1,036
)
Convertible debt
 
(374
)
 
(1,098
)
Unrealized gains on investments and derivatives
 
(421
)
 
(940
)
Transition tax
 
(1,850
)
 

Other, net
 
(373
)
 
(450
)
Total deferred tax liabilities
 
(4,842
)
 
(5,098
)
Net deferred tax assets (liabilities)
 
(2,207
)
 
(823
)
 
 
 
 
 
Reported as:
 
 
 
 
Deferred tax assets
 
840

 
907

Deferred tax liabilities
 
(3,046
)
 
(1,730
)
Net deferred tax assets (liabilities)
 
$
(2,207
)
 
$
(823
)
Investments (Tables)
AVAILABLE-FOR-SALE INVESTMENTS
 
 
December 30, 2017
 
December 31, 2016

(In Millions)
 
Adjusted
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
 
Adjusted
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Corporate debt
 
$
2,294

 
$
4

 
$
(13
)
 
$
2,285

 
$
3,847

 
$
4

 
$
(14
)
 
$
3,837

Financial institution instruments
 
3,387

 
3

 
(9
)
 
3,381

 
6,098

 
5

 
(11
)
 
6,092

Government debt
 
961

 

 
(6
)
 
955

 
1,581

 

 
(8
)
 
1,573

Marketable equity securities
 
1,507

 
2,686

 
(1
)
 
4,192

 
2,818

 
3,363

 
(1
)
 
6,180

Total available-for-sale investments
 
$
8,149

 
$
2,693

 
$
(29
)
 
$
10,813

 
$
14,344

 
$
3,372

 
$
(34
)
 
$
17,682

Equity method investments, classified within other long-term assets, at the end of each period were as follows:
 
 
December 30, 2017
 
December 31, 2016
(Dollars In Millions)
 
Carrying
Value
 
Ownership
Percentage
 
Carrying
Value
 
Ownership
Percentage
IM Flash Technologies, LLC
 
$
1,505

 
49
%
 
$
849

 
49
%
McAfee
 
153

 
49
%
 
n/a

 
n/a

Cloudera, Inc.
 
n/a

 
n/a

 
225

 
16
%
Other equity method investments
 
229

 
 
 
254

 
 
Total
 
$
1,887

 
 
 
$
1,328

 
 
The fair values of available-for-sale debt investments, by contractual maturity, as of December 30, 2017 were as follows:
(In Millions)
 
Fair Value
Due in 1 year or less
 
$
2,573

Due in 1–2 years
 
1,776

Due in 2–5 years
 
1,866

Due after 5 years
 
71

Instruments not due at a single maturity date
 
335

Total
 
$
6,621

Acquisitions & Divestitures (Tables)
The preliminary fair values of the assets acquired and liabilities assumed in the acquisition of Mobileye, by major class, were recognized as follows:
(In Millions)
 
 
Short-term investments and marketable securities
 
$
370

Tangible assets
 
227

Goodwill
 
10,278

Identified intangible assets
 
4,482

Current liabilities
 
(69
)
Deferred tax liabilities and other
 
(418
)
Noncontrolling interest
 
(375
)
Total
 
$
14,495

The identified intangible assets assumed in the acquisition of Mobileye were recognized as follows:
 
 
Fair Value
(In Millions)
 
Weighted Average
Estimated Useful Life
(In Years)
Developed technology
 
$
2,346

 
9
Customer relationships
 
713

 
12
Brands
 
64

 
10
Identified intangible assets subject to amortization
 
3,123

 
 
In-process research and development
 
1,359

 
 
Identified intangible assets not subject to amortization
 
1,359

 
 
Total identified intangible assets
 
$
4,482

 
 
The fair values of the assets acquired and liabilities assumed in the acquisition of Altera, by major class, were recognized as follows:
(In Millions)
 
 
Short-term investments
 
$
182

Receivables
 
368

Inventory
 
555

Other current assets
 
123

Property, plant and equipment
 
312

Goodwill
 
5,448

Identified intangible assets
 
7,566

Other long-term investments and assets
 
2,515

Deferred income
 
(351
)
Other liabilities
 
(283
)
Long-term debt
 
(1,535
)
Deferred tax liabilities
 
(449
)
Total
 
$
14,451

The identified intangible assets assumed in the acquisition of Altera were recognized as follows based upon their fair values as of December 28, 2015:
 
 
Fair Value
(In Millions)
 
Weighted Average Estimated Useful Life
(In Years)
Developed technology
 
$
5,757

 
9
Customer relationships
 
1,121

 
12
Brands
 
87

 
6
Identified intangible assets subject to amortization
 
6,965

 
 
In-process research and development
 
601

 
 
Identified intangible assets not subject to amortization
 
601

 
 
Total identified intangible assets
 
$
7,566

 
 
Goodwill (Tables)
Schedule of Goodwill [Table Text Block]
Goodwill activity for each period was as follows:

(In Millions)
 
Dec 31,
2016
 
Acquisitions
 
Transfers
 
Other
 
Dec 30,
2017
Client Computing Group
 
$
4,356

 
$

 
$

 
$

 
$
4,356

Data Center Group
 
5,412

 
9

 

 

 
5,421

Internet of Things Group
 
1,123

 
3

 

 

 
1,126

Programmable Solutions Group
 
2,490

 

 

 

 
2,490

All other
 
718

 
10,278

 

 

 
10,996

Total
 
$
14,099

 
$
10,290

 
$

 
$

 
$
24,389


(In Millions)
 
Dec 26,
2015
 
Acquisitions
 
Transfers
 
Other
 
Dec 31,
2016
Client Computing Group
 
$
4,078

 
$
65

 
$
213

 
$

 
$
4,356

Data Center Group
 
2,404

 
2,831

 
177

 

 
5,412

Internet of Things Group
 
428

 
659

 
36

 

 
1,123

Intel Security Group
 
3,599

 

 

 
(3,599
)
 

Software and Services Group
 
441

 

 
(441
)
 

 

Programmable Solutions Group
 

 
2,490

 

 

 
2,490

All other
 
382

 
321

 
15

 

 
718

Total
 
$
11,332

 
$
6,366

 
$

 
$
(3,599
)
 
$
14,099

Identified Intangible Assets (Tables)
 
 
December 30, 2017
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
8,912

 
$
(1,922
)
 
$
6,990

Acquisition-related customer relationships
 
2,052

 
(313
)
 
1,739

Acquisition-related brands
 
143

 
(29
)
 
114

Licensed technology and patents
 
3,104

 
(1,370
)
 
1,734

Identified intangible assets subject to amortization
 
14,211

 
(3,634
)
 
10,577

In-process research and development
 
2,168

 

 
2,168

Identified intangible assets not subject to amortization
 
2,168

 

 
2,168

Total identified intangible assets
 
$
16,379

 
$
(3,634
)
 
$
12,745

 
 
December 31, 2016
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
7,405

 
$
(1,836
)
 
$
5,569

Acquisition-related customer relationships
 
1,449

 
(260
)
 
1,189

Acquisition-related brands
 
87

 
(21
)
 
66

Licensed technology and patents
 
3,285

 
(1,423
)
 
1,862

Identified intangible assets subject to amortization
 
12,226

 
(3,540
)
 
8,686

In-process research and development
 
808

 

 
808

Identified intangible assets not subject to amortization
 
808

 

 
808

Total identified intangible assets
 
$
13,034

 
$
(3,540
)
 
$
9,494

 
 
December 30, 2017
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
8,912

 
$
(1,922
)
 
$
6,990

Acquisition-related customer relationships
 
2,052

 
(313
)
 
1,739

Acquisition-related brands
 
143

 
(29
)
 
114

Licensed technology and patents
 
3,104

 
(1,370
)
 
1,734

Identified intangible assets subject to amortization
 
14,211

 
(3,634
)
 
10,577

In-process research and development
 
2,168

 

 
2,168

Identified intangible assets not subject to amortization
 
2,168

 

 
2,168

Total identified intangible assets
 
$
16,379

 
$
(3,634
)
 
$
12,745

 
 
December 31, 2016
(In Millions)
 
Gross
Assets
 
Accumulated
Amortization
 
Net
Acquisition-related developed technology
 
$
7,405

 
$
(1,836
)
 
$
5,569

Acquisition-related customer relationships
 
1,449

 
(260
)
 
1,189

Acquisition-related brands
 
87

 
(21
)
 
66

Licensed technology and patents
 
3,285

 
(1,423
)
 
1,862

Identified intangible assets subject to amortization
 
12,226

 
(3,540
)
 
8,686

In-process research and development
 
808

 

 
808

Identified intangible assets not subject to amortization
 
808

 

 
808

Total identified intangible assets
 
$
13,034

 
$
(3,540
)
 
$
9,494

dentified intangible assets recorded for each period and their respective estimated weighted average useful lives were as follows:
 
 
December 30, 2017
 
December 31, 2016
 
 
Gross
Assets
(In Millions)
 
Estimated Useful Life
(In Years)
 
Gross
Assets
(In Millions)
 
Estimated Useful Life
(In Years)
Acquisition-related developed technology
 
$
2,346

 
9
 
$
5,842

 
9
Acquisition-related customer relationships
 
$
713

 
12
 
$
1,148

 
12
Acquisition-related brands
 
$
64

 
10
 
$
87

 
6
Licensed technology and patents
 
$
162

 
7
 
$
342

 
12
The estimated useful life ranges for identified intangible assets that are subject to amortization were as follows:
(In Years)
 
Estimated
Useful Life Range
Acquisition-related developed technology
 
5
9
Acquisition-related customer relationships
 
7
12
Acquisition-related brands
 
6
10
Licensed technology and patents
 
2
17
Amortization expenses recorded in the consolidated statements of income for each period were as follows:
Years Ended
(In Millions)
 
Location
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Acquisition-related developed technology
 
Cost of sales
 
$
912

 
$
937

 
$
343

Acquisition-related customer relationships
 
Amortization of acquisition-related intangibles
 
161

 
270

 
258

Acquisition-related brands
 
Amortization of acquisition-related intangibles
 
16

 
24

 
7

Licensed technology and patents
 
Cost of sales
 
288

 
293

 
282

Total amortization expenses
 
 
 
$
1,377

 
$
1,524

 
$
890

e expect future amortization expense for the next five years to be as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
Acquisition-related developed technology
 
$
1,045

 
$
1,043

 
$
1,011

 
$
976

 
$
937

Acquisition-related customer relationships
 
181

 
180

 
179

 
179

 
171

Acquisition-related brands
 
20

 
20

 
20

 
20

 
6

Licensed technology and patents
 
256

 
243

 
211

 
195

 
190

Total future amortization expenses
 
$
1,502

 
$
1,486

 
$
1,421

 
$
1,370

 
$
1,304

Other Long-Term Assets (Tables)
Schedule of Other Assets, Noncurrent [Table Text Block]

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Equity method investments
 
$
1,887

 
$
1,328

Non-marketable cost method investments
 
2,613

 
3,098

Non-current deferred tax assets
 
840

 
907

Pre-payments for property, plant and equipment
 
714

 
347

Loans receivable
 
860

 
236

Other
 
688

 
1,243

Total other long-term assets
 
$
7,602

 
$
7,159

Borrowings (Tables)
SHORT-TERM DEBT

(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Drafts payable
 
$
37

 
$
25

Current portion of long-term debt
 
1,739

 
4,609

Total short-term debt
 
$
1,776

 
$
4,634

LONG-TERM DEBT
 
 
December 30, 2017
 
December 31, 2016
(In Millions)
 
Effective Interest Rate
 
Amount
 
Amount
Floating-rate senior notes:
 
 
 
 
 
 
   Three-month LIBOR plus 0.08%, due May 2020
 
1.40%
 
$
700

 
$

   Three-month LIBOR plus 0.35%, due May 2022
 
1.66%
 
800

 

Fixed-rate senior notes:
 
 
 
 
 
 
   1.75%, due May 2017
 
n/a
 

 
500

   1.35%, due December 2017
 
n/a
 

 
3,000

   2.50%, due November 2018
 
2.14%
 
600

 
600

   3.25%, due December 20191
 
2.19%
 
194

 
180

   1.85%, due May 2020
 
1.90%
 
1,000

 

   2.45%, due July 2020
 
2.50%
 
1,750

 
1,750

   1.70%, due May 2021
 
1.78%
 
500

 
500

   3.30%, due October 2021
 
2.69%
 
2,000

 
2,000

   2.35%, due May 2022
 
1.86%
 
750

 

   3.10%, due July 2022
 
2.50%
 
1,000

 
1,000

   4.00%, due December 20221
 
2.98%
 
428

 
396

   2.70%, due December 2022
 
2.08%
 
1,500

 
1,500

   4.10%, due November 2023
 
3.23%
 
400

 
400

   2.88%, due May 2024
 
2.36%
 
1,250

 

   2.70%, due June 2024
 
2.12%
 
600

 

   3.70%, due July 2025
 
3.20%
 
2,250

 
2,250

   2.60%, due May 2026
 
1.66%
 
1,000

 
1,000

   3.15%, due May 2027
 
2.82%
 
1,000

 

   4.00%, due December 2032
 
4.10%
 
750

 
750

   4.80%, due October 2041
 
4.86%
 
802

 
1,500

   4.25%, due December 2042
 
4.39%
 
567

 
925

   4.90%, due July 2045
 
4.92%
 
772

 
2,000

   4.90%, due August 2045
 
n/a
 

 
1,007

   4.70%, due December 2045
 
2.49%
 
915

 
915

   4.10%, due May 2046
 
4.12%
 
1,250

 
1,250

   4.10%, due May 2047
 
4.13%
 
1,000

 

   4.10%, due August 2047
 
2.15%
 
640

 

   3.73%, due December 2047
 
3.74%
 
1,967

 

Junior subordinated convertible debentures:
 
 
 
 
 
 
   2.95%, due December 2035
 
n/a
 

 
1,600

   3.25%, due August 20392
 
4.03%
 
2,000

 
2,000

Total senior notes and other borrowings
 
 
 
28,385

 
27,023

   Unamortized premium/discount and issuance costs
 
 
 
(1,357
)
 
(1,581
)
   Hedge accounting fair value adjustments
 
 
 
(252
)
 
(184
)
Long-term debt
 
 
 
26,776

 
25,258

   Current portion of long-term debt
 
 
 
(1,739
)
 
(4,609
)
Total long-term debt
 
 
 
$
25,037

 
$
20,649


1 
To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $577 million, which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see "Note 17: Derivative Financial Instruments." Principal and unamortized discount/issuance costs for the Australian-dollar-denominated notes in the table above were calculated using foreign currency exchange rates as of December 30, 2017 and December 31, 2016.
2 
Effective interest rate for the year ended December 31, 2016 was 4.01%.
 
 
2009 Debentures
(In Millions, Except Per Share Amounts)
 
Dec 30,
2017
 
Dec 31,
2016
Outstanding principal
 
$
2,000

 
$
2,000

Equity component (including temporary equity) carrying amount
 
$
613

 
$
613

Unamortized discount1
 
$
866

 
$
882

Net debt carrying amount
 
$
1,134

 
$
1,118

Conversion rate (shares of common stock per $1,000 principal amount of debentures)
 
48.37

 
47.72

Effective conversion price (per share of common stock)
 
$
20.68

 
$
20.95

Our aggregate debt maturities based on outstanding principal as of December 30, 2017, by year payable, were as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023 and thereafter
 
Total
 
 
$
600

 
$
194

 
$
3,450

 
$
2,500

 
$
4,478

 
$
17,163

 
$
28,385

Fair Value (Tables)
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS
 
 
December 30, 2017
 
December 31, 2016
 
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
(In Millions)
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 
$

 
$
30

 
$

 
$
30

 
$

 
$
498

 
$

 
$
498

Financial institution instruments 1
 
335

 
640

 

 
975

 
1,920

 
811

 

 
2,731

Government debt 2
 

 
90

 

 
90

 

 
332

 

 
332

Reverse repurchase agreements
 

 
1,399

 

 
1,399

 

 
768

 

 
768

Short-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
672

 
3

 
675

 

 
1,332

 
6

 
1,338

Financial institution instruments 1
 

 
1,009

 

 
1,009

 

 
1,603

 

 
1,603

Government debt 2
 

 
130

 

 
130

 

 
284

 

 
284

Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
 

 
2

 

 
2

 

 
87

 

 
87

Corporate debt
 

 
2,842

 

 
2,842

 

 
2,847

 

 
2,847

Financial institution instruments 1
 
59

 
1,064

 

 
1,123

 
36

 
1,608

 

 
1,644

Government debt 2
 
30

 
4,758

 

 
4,788

 
32

 
3,704

 

 
3,736

Other current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
2

 
277

 

 
279

 

 
382

 

 
382

Loans receivable
 

 
30

 

 
30

 

 
326

 

 
326

Marketable equity securities
 
4,148

 
44

 

 
4,192

 
6,180

 

 

 
6,180

Other long-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
1,576

 
4

 
1,580

 

 
1,995

 
6

 
2,001

Financial institution instruments 1
 

 
1,397

 

 
1,397

 

 
1,758

 

 
1,758

Government debt 2
 

 
735

 

 
735

 

 
957

 

 
957

Other long-term assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 

 
77

 
7

 
84

 

 
31

 
9

 
40

Loans receivable
 

 
610

 

 
610

 

 
236

 

 
236

Total assets measured and recorded at fair value
 
4,574

 
17,382

 
14

 
21,970

 
8,168

 
19,559

 
21

 
27,748

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other accrued liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 

 
454

 

 
454

 

 
371

 

 
371

Other long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 

 
297

 
6

 
303

 

 
179

 
33

 
212

Total liabilities measured and recorded at fair value
 
$

 
$
751

 
$
6

 
$
757

 
$

 
$
550

 
$
33

 
$
583

Other Comprehensive Income (Loss) (Tables)
The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
(In Millions)
 
Unrealized Holding Gains (Losses) on Available-for-Sale Investments
 
Deferred Tax Asset Valuation Allowance
 
Unrealized Holding Gains (Losses) on Derivatives
 
Actuarial Valuation and Other Pension Expenses
 
Foreign Currency Translation Adjustment
 
Total
December 26, 2015
 
$
1,749

 
$
8

 
$
(266
)
 
$
(916
)
 
$
(515
)
 
$
60

Other comprehensive income (loss) before reclassifications
 
1,170

 

 
(26
)
 
(680
)
 
(4
)
 
460

Amounts reclassified out of accumulated other comprehensive income (loss)
 
(530
)
 

 
38

 
170

 

 
(322
)
Tax effects
 
(225
)
 
(8
)
 
(5
)
 
146

 

 
(92
)
Other comprehensive income (loss)
 
415

 
(8
)
 
7

 
(364
)
 
(4
)
 
46

December 31, 2016
 
2,164

 

 
(259
)
 
(1,280
)
 
(519
)
 
106

Other comprehensive income (loss) before reclassifications
 
2,760

 

 
605

 
275

 
3

 
3,643

Amounts reclassified out of accumulated other comprehensive income (loss)
 
(3,431
)
 

 
(69
)
 
103

 
507

 
(2,890
)
Tax effects
 
235

 

 
(171
)
 
(61
)
 

 
3

Other comprehensive income (loss)
 
(436
)
 

 
365

 
317

 
510

 
756

December 30, 2017
 
$
1,728

 
$

 
$
106

 
$
(963
)
 
$
(9
)
 
$
862

The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income for each period were as follows:
 
 
 
 
Income Before Taxes Impact for Years Ended
(In Millions)
Comprehensive Income Components
 
Location
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Unrealized holding gains (losses)1 on available-for-sale investments:
 
 
 
 
 
 
 
 
 
 
Gains (losses) on equity investments, net
 
$
3,431

 
$
530

 
$
93

 
 
 
 
3,431

 
530

 
93

Unrealized holding gains (losses) on derivatives:
 
 
 
 
 
 
 
 
Foreign currency contracts
 
Cost of sales
 
(65
)
 
(65
)
 
(290
)
 
 
Research and development
 
45

 
7

 
(177
)
 
 
Marketing, general and administrative
 
7

 
5

 
(46
)
 
 
Gains (losses) on equity investments, net
 
57

 
11

 

 
 
Interest and other, net
 
25

 
4

 
(9
)
 
 
 
 
69

 
(38
)
 
(522
)
Amortization of pension and postretirement benefit components:
 
 
 
 
 
 
 
 
Actuarial valuation and other pension expenses
 
 
 
(103
)
 
(170
)
 
(77
)
 
 
 
 
(103
)
 
(170
)
 
(77
)
Currency translation adjustment
 
Interest and other, net
 
(507
)
 

 

Total amounts reclassified out of accumulated other comprehensive income (loss)
 
 
 
$
2,890

 
$
322

 
$
(506
)
Derivative Financial Instruments (Tables)
Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows:
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Foreign currency contracts
 
$
19,958

 
$
17,960

 
$
16,721

Interest rate contracts
 
16,823

 
14,228

 
8,812

Other
 
1,636

 
1,340

 
1,122

Total
 
$
38,417


$
33,528


$
26,655

FAIR VALUE OF DERIVATIVE INSTRUMENTS IN THE CONSOLIDATED BALANCE SHEETS
 
 
December 30, 2017
 
December 31, 2016
(In Millions)
 
Assets1
 
Liabilities2
 
Assets1
 
Liabilities2
Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Foreign currency contracts3
 
$
283

 
$
32

 
$
21

 
$
252

Interest rate contracts
 
1

 
254

 
3

 
187

Total derivatives designated as hedging instruments
 
284


286


24


439

Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
Foreign currency contracts3
 
52

 
447

 
374

 
114

Interest rate contracts
 
18

 
24

 
15

 
30

Other
 
9

 

 
9

 

Total derivatives not designated as hedging instruments
 
79


471


398


144

Total derivatives
 
$
363


$
757


$
422


$
583

The amounts recorded on the consolidated balance sheet related to cumulative basis adjustments for fair value hedges for each period were as follows:
Line Item in the Consolidated Balance Sheet in Which the Hedged Item Is Included
 
Carrying Amount of the Hedged Item Asset/(Liabilities)
 
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 30,
2017
 
Dec 31,
2016
Long-Term Debt
 
$
(12,653
)
 
$
(8,879
)
 
$
252

 
$
184

The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:
 
 
December 30, 2017
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
350

 
$

 
$
350

 
$
(206
)
 
$
(130
)
 
$
14

Reverse repurchase agreements
 
1,649

 

 
1,649

 

 
(1,649
)
 

Total assets
 
1,999




1,999


(206
)

(1,779
)

14

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
745

 

 
745

 
(206
)
 
(504
)
 
35

Total liabilities
 
$
745


$


$
745


$
(206
)

$
(504
)

$
35

 
 
December 31, 2016
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
433

 
$

 
$
433

 
$
(368
)
 
$
(42
)
 
$
23

Reverse repurchase agreements
 
1,018

 

 
1,018

 

 
(1,018
)
 

Total assets
 
1,451




1,451


(368
)

(1,060
)

23

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
588

 

 
588

 
(368
)
 
(201
)
 
19

Total liabilities
 
$
588


$


$
588


$
(368
)

$
(201
)

$
19

The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:
 
 
December 30, 2017
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
350

 
$

 
$
350

 
$
(206
)
 
$
(130
)
 
$
14

Reverse repurchase agreements
 
1,649

 

 
1,649

 

 
(1,649
)
 

Total assets
 
1,999




1,999


(206
)

(1,779
)

14

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
745

 

 
745

 
(206
)
 
(504
)
 
35

Total liabilities
 
$
745


$


$
745


$
(206
)

$
(504
)

$
35

 
 
December 31, 2016
 
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheet
 
 
(In Millions)
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheet
 
Net Amounts Presented in the Balance Sheet
 
Financial Instruments
 
Cash and Non-Cash Collateral Received or Pledged
 
Net Amount
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets subject to master netting arrangements
 
$
433

 
$

 
$
433

 
$
(368
)
 
$
(42
)
 
$
23

Reverse repurchase agreements
 
1,018

 

 
1,018

 

 
(1,018
)
 

Total assets
 
1,451




1,451


(368
)

(1,060
)

23

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities subject to master netting arrangements
 
588

 

 
588

 
(368
)
 
(201
)
 
19

Total liabilities
 
$
588


$


$
588


$
(368
)

$
(201
)

$
19

The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:
 
 
Gains (Losses)
Recognized in Statement of Income on
Derivatives
Years Ended
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Interest rate contracts
 
$
(68
)
 
$
(171
)
 
$
(13
)
Hedged items
 
68

 
171

 
13

Total
 
$

 
$

 
$

The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
Years Ended
(In Millions)
 
Location of Gains (Losses)
Recognized in Income on Derivatives
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Foreign currency contracts
 
Interest and other, net
 
$
(547
)
 
$
388

 
$
296

Interest rate contracts
 
Interest and other, net
 
9

 
8

 
(8
)
Other
 
Various
 
203

 
113

 
(38
)
Total
 
$
(335
)

$
509


$
250

Retirement Benefit Plans (Tables)
The vested benefit obligation for a defined-benefit pension plan is the actuarial present value of the vested benefits to which the employee is currently entitled based on the employee's expected date of separation or retirement.
 
(In Millions)
 
Dec 30,
2017
 
Dec 31,
2016
Changes in projected benefit obligation:
 
 
 
 
Beginning projected benefit obligation
 
$
3,640

 
$
3,130

Service cost
 
84

 
130

Interest cost
 
117

 
106

Actuarial (gain) loss
 
24

 
575

Currency exchange rate changes
 
281

 
(80
)
Plan curtailments
 
(162
)
 
17

Plan settlements
 
(101
)
 
(202
)
Other
 
(41
)
 
(36
)
Ending projected benefit obligation1
 
3,842

 
3,640

 
 
 
 
 
Changes in fair value of plan assets:
 
 
 
 
Beginning fair value of plan assets
 
1,696

 
1,638

Actual return on plan assets
 
136

 
81

Employer contributions
 
471

 
416

Currency exchange rate changes
 
124

 
(26
)
Plan settlements
 
(101
)
 
(202
)
Benefits paid to plan participants
 
(42
)
 
(84
)
Other
 
3

 
(127
)
Ending fair value of plan assets2
 
2,287

 
1,696

 
 
 
 
 
Amounts recognized in the consolidated balance sheet3
 
$
1,555

 
$
1,944

 
 
 
 
 
Accumulated other comprehensive loss (income), before tax4
 
$
1,257

 
$
1,603

 
 
 
 
 
Accumulated benefit obligation5
 
$
3,423

 
$
2,976

ASSUMPTIONS FOR PENSION BENEFIT PLANS
 
 
Dec 30,
2017
 
Dec 31,
2016
Weighted average actuarial assumptions used to determine benefit obligations
 
 
 
 
Discount rate
 
3.0
%
 
3.2
%
Rate of compensation increase
 
3.3
%
 
3.6
%
 
 
2017
 
2016
 
2015
Weighted average actuarial assumptions used to determine costs
 
 
 
 
 
 
Discount rate
 
3.2
%
 
3.3
%
 
3.1
%
Expected long-term rate of return on plan assets
 
4.6
%
 
5.5
%
 
5.9
%
Rate of compensation increase
 
3.6
%
 
3.8
%
 
3.9
%
PENSION PLAN ASSETS
 
 
December 30, 2017
 
Dec 31,
2016
 
 
Fair Value Measured at Reporting Date Using
 
 
 
 
(In Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total
Equity securities
 
$
451

 
$

 
$
22

 
$
473

 
$
328

Fixed income
 
45

 
326

 
94

 
465

 
304

Other investments
 
19

 

 

 
19

 

Assets measured by fair value hierarchy
 
$
515

 
$
326

 
$
116

 
$
957

 
$
632

Assets measured at net asset value
 
 
 
 
 
 
 
1,208

 
1,044

Cash and cash equivalents
 
 
 
 
 
 
 
122

 
20

Total pension plan assets at fair value
 
 
 
 
 
 
 
$
2,287

 
$
1,696

The estimated benefit payments for this plan over the next 10 fiscal years are as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023-2027
Postretirement Medical Benefits
 
$
28

 
$
29

 
$
30

 
$
31

 
$
32

 
$
179

Estimated benefit payments over the next 10 fiscal years are as follows:
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023-2027
Pension benefits
 
$
125

 
$
117

 
$
115

 
$
121

 
$
124

 
$
673

Employee Equity Incentive Plans (Tables)
We use the Black-Scholes option pricing model to estimate the fair value of rights to acquire shares of common stock granted under the 2006 Stock Purchase Plan on the date of grant. We based the weighted average estimated value of RSU and OSU grants, and rights granted under the 2006 Stock Purchase Plan, on the weighted average assumptions for each period as follows:
 
 
RSUs and OSUs
 
Stock Purchase Plan
 
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Estimated values
 
$
35.30

 
$
29.76

 
$
31.63

 
$
7.20

 
$
6.70

 
$
6.56

Risk-free interest rate
 
1.4
%
 
0.9
%
 
0.6
%
 
1.0
%
 
0.5
%
 
0.1
%
Dividend yield
 
2.9
%
 
3.3
%
 
2.9
%
 
2.9
%
 
3.2
%
 
3.1
%
Volatility
 
23
%
 
23
%
 
27
%
 
19
%
 
22
%
 
25
%
Expected life (in years)
 
n/a

 
n/a

 
n/a

 
0.5

 
0.5

 
0.5

We use the Black-Scholes option pricing model to estimate the fair value of rights to acquire shares of common stock granted under the 2006 Stock Purchase Plan on the date of grant. We based the weighted average estimated value of RSU and OSU grants, and rights granted under the 2006 Stock Purchase Plan, on the weighted average assumptions for each period as follows:
 
 
RSUs and OSUs
 
Stock Purchase Plan
 
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
 
Dec 30,
2017
 
Dec 31,
2016
 
Dec 26,
2015
Estimated values
 
$
35.30

 
$
29.76

 
$
31.63

 
$
7.20

 
$
6.70

 
$
6.56

Risk-free interest rate
 
1.4
%
 
0.9
%
 
0.6
%
 
1.0
%
 
0.5
%
 
0.1
%
Dividend yield
 
2.9
%
 
3.3
%
 
2.9
%
 
2.9
%
 
3.2
%
 
3.1
%
Volatility
 
23
%
 
23
%
 
27
%
 
19
%
 
22
%
 
25
%
Expected life (in years)
 
n/a

 
n/a

 
n/a

 
0.5

 
0.5

 
0.5

RSU activity in 2017 was as follows:
 
 
Number of
RSUs
(In Millions)
 
Weighted
Average
Grant-Date
Fair Value
December 31, 2016
 
106.8

 
$
28.99

Granted
 
45.2

 
$
35.30

Assumed in acquisition
 
1.1

 
$
34.90

Vested
 
(40.5
)
 
$
27.52

Forfeited
 
(12.2
)
 
$
30.08

December 30, 2017
 
100.4

 
$
32.36

Expected to vest as of December 30, 2017
96.5

 
$
32.36

Commitments and Contingencies (Tables)
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
(In Millions)
 
2018
 
2019
 
2020
 
2021
 
2022
 
2023
and thereafter
 
Total
Minimum rental commitments under all non-cancelable leases1
 
$
215

 
$
186

 
$
162

 
$
136

 
$
105

 
$
441

 
$
1,245

Basis of Presentation Basis of Presentation (Details) (Machinery and Equipment [Member], USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2016
Dec. 26, 2015
Change in Accounting Estimate [Line Items]
 
 
Property, Plant and Equipment, Useful Life
5 years 
4 years 
Service Life [Member]
 
 
Change in Accounting Estimate [Line Items]
 
 
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Operating Results
$ 1,300 
 
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income
$ 950 
 
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Diluted Earnings Per Share
$ 0.19 
 
Accounting Policies (Detail) (USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Revenue, Major Customer [Line Items]
 
 
 
PRQ Max
$ 770,000,000 
 
 
Manufacturing Costs, less recession charge
540,000,000 
 
 
Production Related Impairments or Charges [Abstract]
 
 
 
Inventory Write-down
185,000,000 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Impairments
833,000,000 
187,000,000 
185,000,000 
Non-marketable equity investments [Member]
 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Other Long-term Investments
4,500,000,000 
4,400,000,000 
 
Impairments
555,000,000 
184,000,000 
166,000,000 
Credit Concentration Risk [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure
800,000,000 
 
 
Credit Concentration Risk [Member] |
Accounts Receivable [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
36.00% 
31.00% 
 
Maximum [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Manufacturing Costs
46,000,000 
 
 
Minimum [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Manufacturing Costs
$ 1,100,000,000 
 
 
Recent Accounting Standards (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 30, 2017
Accounting Standards Update 2016-01 [Member]
Dec. 30, 2017
Accounting Standards Update 2014-09 [Member]
Dec. 30, 2017
Nonoperating Income (Expense) [Member]
Adjustments for New Accounting Pronouncement [Member]
Dec. 31, 2016
Nonoperating Income (Expense) [Member]
Adjustments for New Accounting Pronouncement [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Accounts Receivable [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Inventories [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Other Current Assets [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Equity [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Available-for-sale Securities [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Other long-term assets [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Accounts Payable [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Deferred Revenue [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Other Accrued Liabilities [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Long-term deferred tax liabilities [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Retained Earnings [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts receivable, net of allowance for doubtful accounts of $25 ($37 in 2016)
$ 5,607 
$ 4,690 
$ 0 
$ (530)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inventory, Net
6,983 
5,553 
47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Assets, Current
2,908 
2,956 
64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New Equity Line Item
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity Method Investments
1,887 
1,328 
8,579 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale Securities, Equity Securities, Noncurrent
4,192 
6,180 
(4,192)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Assets, Noncurrent
7,602 
7,159 
(4,387)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts Payable, Current
2,928 
2,475 
55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current deferred income
1,656 
1,718 
(1,356)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Liabilities, Current
7,535 
6,090 
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Long-term deferred tax liabilities
3,046 
1,730 
191 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax
862 
106 
(1,745)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retained Earnings (Accumulated Deficit)
42,083 
40,747 
1,745 
665 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification
 
 
 
 
 
 
5,077 
7,030 
2,972 
8,579 
3,215 
2,983 
300 
7,561 
3,237 
(883)
44,493 
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Operating Results
 
 
 
 
$ 115 
$ 260 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Segments and Geographic Information (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
$ 62,761 
$ 59,387 
$ 55,355 
Operating Income (Loss)
17,936 
12,874 
14,002 
Desktop Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
11,647 
12,371 
12,754 
Other Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
2,810 
2,467 
1,957 
DCG Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
17,439 
15,895 
14,856 
Notebook Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
19,414 
18,203 
17,945 
Other Product Or Service [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
10,917 
8,290 
5,858 
Platform [Member]
 
 
 
Revenue from External Customer [Line Items]
 
 
 
Revenues
51,310 
48,936 
47,512 
Client Computing Group [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
34,003 
32,908 
32,219 
Operating Income (Loss)
12,919 
10,646 
8,166 
Client Computing Group [Member] |
Other Product Or Service [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
2,777 
2,157 
1,539 
Client Computing Group [Member] |
Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
31,226 
30,751 
30,680 
Data Center Group [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
19,064 
17,236 
15,981 
Operating Income (Loss)
8,395 
7,520 
7,847 
Data Center Group [Member] |
Other Product Or Service [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
1,625 
1,341 
1,125 
Internet of Things Group [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
3,169 
2,638 
2,298 
Operating Income (Loss)
650 
585 
515 
Internet of Things Group [Member] |
Other Product Or Service [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
524 
348 
322 
Internet of Things Group [Member] |
Platform [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
2,645 
2,290 
1,976 
Non-Volatile Memory Solutions Group [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
3,520 
2,576 
2,597 
Operating Income (Loss)
(260)
(544)
239 
Intel Security Group [Member] |
Other Product Or Service [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
534 
2,161 
1,985 
Programmable Solutions Group [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
1,902 
1,669 
Operating Income (Loss)
458 
(104)
All other [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue, Net
1,103 
2,360 
2,260 
Operating Income (Loss)
$ (4,226)
$ (5,229)
$ (2,765)
Operating Segments and Geographic Information, Revenue by Major Customers (Detail)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Customer Concentration Risk [Member] |
Sales Revenue, Net [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
40.00% 
38.00% 
 
Customer Concentration Risk [Member] |
Sales Revenue, Net [Member] |
Dell Inc. [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
16.00% 
15.00% 
15.00% 
Customer Concentration Risk [Member] |
Sales Revenue, Net [Member] |
Lenovo Group Limited [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
13.00% 
13.00% 
13.00% 
Customer Concentration Risk [Member] |
Sales Revenue, Net [Member] |
HP Inc. [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
11.00% 
 
 
Customer Concentration Risk [Member] |
Sales Revenue, Net [Member] |
Hewlett-Packard Company [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
 
10.00% 
18.00% 
Credit Concentration Risk [Member] |
Accounts Receivable [Member]
 
 
 
Revenue, Major Customer [Line Items]
 
 
 
Concentration Risk, Percentage
36.00% 
31.00% 
 
Operating Segments and Geographic Information, Revenues from External Customers by Country (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
$ 62,761 
$ 59,387 
$ 55,355 
China (Including Hong Kong) [Member]
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
14,796 
13,977 
11,679 
Singapore [Member]
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
14,285 
12,780 
11,544 
UNITED STATES
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
12,543 
12,957 
11,121 
Taiwan [Member]
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
10,518 
9,953 
10,661 
Other Countries [Member]
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
Revenue, Net
$ 10,619 
$ 9,720 
$ 10,350 
Earnings Per Share (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Earnings Per Share [Abstract]
 
 
 
Net Income
$ 9,601 
$ 10,316 
$ 11,420 
Weighted average shares of common stock outstanding-basic
4,701 
4,730 
4,742 
Dilutive effect of employee equity incentive plans (shares)
47 
53 
64 
Dilutive effect of convertible debt (shares)
87 
92 
88 
Weighted average shares of common stock outstanding-diluted
4,835 
4,875 
4,894 
Earnings per share - Basic
$ 2.04 
$ 2.18 
$ 2.41 
Earnings per share - Diluted
$ 1.99 
$ 2.12 
$ 2.33 
Other Financial Statement Details Inventories (Details) (USD $)
In Millions, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Inventory, Net [Abstract]
 
 
Raw materials
$ 1,098 
$ 695 
Work in process
3,893 
3,190 
Finished goods
1,992 
1,668 
Total inventories
$ 6,983 
$ 5,553 
Other Financial Statement Details Property, Plant and Equipment (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
UNITED STATES
Dec. 31, 2016
UNITED STATES
Dec. 26, 2015
UNITED STATES
Dec. 30, 2017
ISRAEL
Dec. 31, 2016
ISRAEL
Dec. 26, 2015
ISRAEL
Dec. 30, 2017
CHINA
Dec. 31, 2016
CHINA
Dec. 26, 2015
CHINA
Dec. 30, 2017
IRELAND
Dec. 31, 2016
IRELAND
Dec. 26, 2015
IRELAND
Dec. 30, 2017
Other Countries [Member]
Dec. 31, 2016
Other Countries [Member]
Dec. 26, 2015
Other Countries [Member]
Dec. 30, 2017
Land and Building [Member]
Dec. 31, 2016
Land and Building [Member]
Dec. 31, 2016
Machinery and Equipment [Member]
Dec. 26, 2015
Machinery and Equipment [Member]
Dec. 30, 2017
Machinery and Equipment [Member]
Dec. 30, 2017
Construction in Progress [Member]
Dec. 31, 2016
Construction in Progress [Member]
Dec. 31, 2016
ConstructionInProgressOnHold [Member]
Dec. 30, 2017
Minimum [Member]
Machinery and Equipment [Member]
Dec. 30, 2017
Minimum [Member]
Building [Member]
Dec. 30, 2017
Maximum [Member]
Machinery and Equipment [Member]
Dec. 30, 2017
Maximum [Member]
Building [Member]
Property, Plant and Equipment [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property, Plant and Equipment, Gross
$ 100,395 
$ 90,105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 27,391 
$ 26,627 
$ 52,608 
 
$ 57,192 
$ 15,812 
$ 10,870 
$ 2,200 
 
 
 
 
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
59,286 
53,934 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
$ 41,109 
$ 36,171 
$ 31,858 
$ 24,459 
$ 23,598 
$ 22,611 
$ 6,501 
$ 3,923 
$ 1,661 
$ 4,275 
$ 2,306 
$ 537 
$ 3,938 
$ 4,865 
$ 5,789 
$ 1,936 
$ 1,479 
$ 1,260 
 
 
 
 
 
 
 
 
 
 
 
 
Property, Plant and Equipment, Useful Life
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 years 
4 years 
 
 
 
 
2 years 
10 years 
5 years 
25 years 
Other Financial Statement Details Deferred Income (Details) (USD $)
In Millions, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Deferred Revenue Arrangement [Line Items]
 
 
Current deferred income
$ 1,656 
$ 1,718 
Shipments Of Components To Distributors [Member]
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Current deferred income
1,320 
1,475 
Software Services And Other [Member]
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Current deferred income
$ 336 
$ 243 
Other Financial Statement Details Other Accrued Liabilities (Details) (USD $)
In Billions, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Statement of Financial Position [Abstract]
 
 
Deferred compensation liabilities
$ 1.7 
$ 1.5 
Other Financial Statement Details Advertising (Details) (USD $)
In Billions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Income Statement [Abstract]
 
 
 
Advertising Expense
$ 1.4 
$ 1.8 
$ 1.8 
Other Financial Statement Details Gains (Losses) on Equity Investments, Net (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Gain (Loss) on Investments [Line Items]
 
 
 
Share of equity method investee losses, net
$ (232)
$ (38)
$ (95)
Impairments
(833)
(187)
(185)
Other, net
149 
95 
398 
Total gains (losses) on equity investments, net
2,651 
506 
315 
Equity Securities [Member]
 
 
 
Gain (Loss) on Investments [Line Items]
 
 
 
Gains on sales, net
3,499 
562 
145 
Dividends
$ 68 
$ 74 
$ 52 
Other Financial Statement Details Interest and Other, Net (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Other Nonoperating Income (Expense) [Abstract]
 
 
 
Interest income
$ 441 
$ 222 
$ 124 
Interest expense
(646)
(733)
(337)
Other, net
(30)
67 
108 
Total Interest and other, net
(235)
(444)
(105)
Interest Costs, Capitalized During Period
$ 313 
$ 135 
$ 258 
Restructuring and Other Charges (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Restructuring Cost and Reserve [Line Items]
 
 
 
Restructuring and other charges
$ 384 
$ 1,886 
$ 354 
ISecG separation costs and other charges
249 
63 
2016 Restructuring Program [Member]
 
 
 
Restructuring Cost and Reserve [Line Items]
 
 
 
Restructuring and other charges
135 
1,823 
Restructuring and Related Cost, Incurred Cost
135 
1,823 
 
Restructuring and Related Cost, Expected Number of Positions Eliminated
16,000 
 
 
Restructuring Reserve [Roll Forward]
 
 
 
Restructuring Reserve, Beginning Balance
595 
 
Restructuring Reserve, Additional accruals
40 
1,585 
 
Restructuring Reserve, Adjustments
70 
92 
 
Restructuring Reserve, Cash payments
(377)
(1,063)
 
Restructuring Reserve, Non-cash settlements
(3)
(19)
 
Restructuring Reserve, Ending Balance
325 
595 
2016 Restructuring Program [Member] |
Employee severance and benefits arrangements [Member]
 
 
 
Restructuring Cost and Reserve [Line Items]
 
 
 
Restructuring and Related Cost, Incurred Cost
70 
1,737 
 
Restructuring Reserve [Roll Forward]
 
 
 
Restructuring Reserve, Beginning Balance
585 
 
Restructuring Reserve, Additional accruals
1,556 
 
Restructuring Reserve, Adjustments
70 
92 
 
Restructuring Reserve, Cash payments
(352)
(1,063)
 
Restructuring Reserve, Non-cash settlements
 
Restructuring Reserve, Ending Balance
303 
585 
 
2016 Restructuring Program [Member] |
Pension settlement charges [Member]
 
 
 
Restructuring Cost and Reserve [Line Items]
 
 
 
Pension settlement charges
25 
57 
 
2016 Restructuring Program [Member] |
Other Restructuring [Member]
 
 
 
Restructuring Cost and Reserve [Line Items]
 
 
 
Restructuring and Related Cost, Incurred Cost
40 
29 
 
Restructuring Reserve [Roll Forward]
 
 
 
Restructuring Reserve, Beginning Balance
10 
 
Restructuring Reserve, Additional accruals
40 
29 
 
Restructuring Reserve, Adjustments
 
Restructuring Reserve, Cash payments
(25)
 
Restructuring Reserve, Non-cash settlements
(3)
(19)
 
Restructuring Reserve, Ending Balance
22 
10 
 
2015 & 2013 Restructuring Program [Member]
 
 
 
Restructuring Cost and Reserve [Line Items]
 
 
 
Restructuring and other charges
$ 0 
$ 0 
$ 354 
Income Taxes (Detail) (USD $)
12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
Domestic Tax Authority [Member]
Dec. 30, 2017
State and Local Jurisdiction [Member]
Dec. 30, 2017
Non-U.S. [Member]
Dec. 30, 2017
2017 U.S. Tax Reform [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Dec. 30, 2017
Minimum [Member]
Dec. 30, 2017
Maximum [Member]
Income Tax Disclosure [Abstract]
 
 
 
 
 
 
 
 
 
 
Income before taxes: U.S.
$ 11,141,000,000 
$ 6,957,000,000 
$ 8,800,000,000 
 
 
 
 
 
 
 
Income before taxes: Non-U.S.
9,211,000,000 
5,979,000,000 
5,412,000,000 
 
 
 
 
 
 
 
Income before taxes
20,352,000,000 
12,936,000,000 
14,212,000,000 
 
 
 
 
 
 
 
Provision for taxes, Current: Federal
10,207,000,000 
1,319,000,000 
2,828,000,000 
 
 
 
 
 
 
 
Provision for taxes, Current: State
27,000,000 
13,000,000 
40,000,000 
 
 
 
 
 
 
 
Provision for taxes, Current: Non-U.S.
899,000,000 
756,000,000 
842,000,000 
 
 
 
 
 
 
 
Total current provision for taxes
11,133,000,000 
2,088,000,000 
3,710,000,000 
 
 
 
 
 
 
 
Provision for taxes, Deferred: Federal
(220,000,000)
658,000,000 
(862,000,000)
 
 
 
 
 
 
 
Deferred Other Tax Expense (Benefit)
(162,000,000)
(126,000,000)
(56,000,000)
 
 
 
 
 
 
 
Total deferred provision for taxes
(382,000,000)
532,000,000 
(918,000,000)
 
 
 
 
 
 
 
Total Provision for taxes
10,751,000,000 
2,620,000,000 
2,792,000,000 
 
 
 
5,400,000,000 
 
 
 
Effective tax rate
52.80% 
20.30% 
19.60% 
 
 
 
 
 
 
 
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
 
 
 
 
 
 
 
 
 
 
Statutory federal income tax rate
35.00% 
35.00% 
35.00% 
 
 
 
 
21.00% 
 
 
Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates
(7.60%)
(11.70%)
(7.90%)
 
 
 
 
 
 
 
Increase (reduction) in rate resulting from: Research and Development tax credits
(2.30%)
(2.30%)
(1.70%)
 
 
 
 
 
 
 
Increase (reduction) in rate resulting from: Domestic manufacturing deduction benefit
(1.30%)
(1.40%)
(2.00%)
 
 
 
 
 
 
 
Increase (reduction) in rate resulting from: Settlements and related measurements
0.00% 
(0.10%)
(2.90%)
 
 
 
 
 
 
 
Effective Income Tax Rate Reconciliation, Transition Tax for Accumulated Foreign Earnings, Percent
26.80% 
0.00% 
0.00% 
 
 
 
 
 
 
 
Increase (reduction) in rate resulting from: Disposition of Business
3.30% 
0.00% 
0.00% 
 
 
 
 
 
 
 
Increase (reduction) in rate resulting from: Other
(1.10%)
0.80% 
(0.90%)
 
 
 
 
 
 
 
Income Tax Disclosure [Line Items]
 
 
 
 
 
 
 
 
 
 
Effective Income Tax Rate Reconciliation, at Foreign Statutory Income Tax Rate, Percent
 
 
 
 
 
 
 
 
12.50% 
25.00% 
Statutory federal income tax rate
35.00% 
35.00% 
35.00% 
 
 
 
 
21.00% 
 
 
Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates
(7.60%)
(11.70%)
(7.90%)
 
 
 
 
 
 
 
Income Tax Holiday, Termination Date
2026 
 
 
 
 
 
 
 
 
 
Income Tax Reconciliation, Transition Tax for Accumulated Foreign Earnings
 
 
 
 
 
 
6,100,000,000 
 
 
 
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
 
 
 
 
 
 
676,000,000 
 
 
 
Income Tax Expense (Benefit)
10,751,000,000 
2,620,000,000 
2,792,000,000 
 
 
 
5,400,000,000 
 
 
 
Accrued Income Taxes, Current
1,392,000,000 
329,000,000 
 
 
 
 
 
 
 
 
Long-term income taxes payable
4,069,000,000 
125,000,000 
 
 
 
 
 
 
 
 
Income Taxes Receivable, Current
71,000,000 
86,000,000 
 
 
 
 
 
 
 
 
Components of Deferred Tax Assets and Liabilities [Abstract]
 
 
 
 
 
 
 
 
 
 
Deferred tax assets, Accrued compensation and other benefits
711,000,000 
1,182,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, Share-based compensation
241,000,000 
373,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, Deferred income
211,000,000 
596,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, Inventory
675,000,000 
1,044,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, State credits and net operating losses
1,081,000,000 
846,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, Other, net
887,000,000 
1,187,000,000 
 
 
 
 
 
 
 
 
Gross deferred tax assets
3,806,000,000 
5,228,000,000 
 
 
 
 
 
 
 
 
Deferred tax assets, Valuation allowance
(1,171,000,000)
(953,000,000)
 
 
(1,072,000,000)
(99,000,000)
 
 
 
 
Total deferred tax assets
2,635,000,000 
4,275,000,000 
 
 
 
 
 
 
 
 
Deferred tax liabilities, Property, plant and equipment
(943,000,000)
(1,574,000,000)
 
 
 
 
 
 
 
 
Deferred tax liabilities, Licenses and intangibles
(881,000,000)
(1,036,000,000)
 
 
 
 
 
 
 
 
Deferred tax liabilities, Convertible debt
(374,000,000)
(1,098,000,000)
 
 
 
 
 
 
 
 
Deferred Tax Liabilities, Unrealized Gains On Investments And Derivatives
(421,000,000)
(940,000,000)
 
 
 
 
 
 
 
 
Deferred tax liabilities, Investments in non-U.S. subsidiaries
(1,850,000,000)
 
 
 
 
 
 
 
 
Deferred tax liabilities, Other, net
(373,000,000)
(450,000,000)
 
 
 
 
 
 
 
 
Total deferred tax liabilities
(4,842,000,000)
(5,098,000,000)
 
 
 
 
 
 
 
 
Net deferred tax assets (liabilities)
(2,207,000,000)
(823,000,000)
 
 
 
 
 
 
 
 
Non-current deferred tax assets
840,000,000 
907,000,000 
 
 
 
 
 
 
 
 
Long-term deferred tax liabilities
(3,046,000,000)
(1,730,000,000)
 
 
 
 
 
 
 
 
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
 
 
 
 
 
 
 
 
 
 
Unrecognized tax benefits, Gross, Beginning Balance
154,000,000 
101,000,000 
 
 
 
 
 
 
 
 
Unrecognized tax benefits, Gross, Ending Balance
211,000,000 
154,000,000 
101,000,000 
 
 
 
 
 
 
 
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
139,000,000 
87,000,000 
 
 
 
 
 
 
 
 
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
 
 
419,000,000 
 
 
 
 
 
 
 
Year Which Prior Years' Tax Returns Are Generally No Longer Subject To Tax Examination (date)
 
 
 
 
 
Dec. 31, 2004 
 
 
 
 
Year Which Prior Years' Tax Returns Are No Longer Subject To Tax Examination (date)
 
 
 
Dec. 31, 2004 
 
 
 
 
 
 
Operating Loss Carryforwards [Line Items]
 
 
 
 
 
 
 
 
 
 
Operating Loss Carryforwards
 
 
 
264,000,000 
149,000,000 
431,000,000 
 
 
 
 
Operating Loss Carryforwards, Expiration Dates
Dec. 31, 2036 
 
 
 
 
 
 
 
 
 
Operating Loss Carryforwards, Valuation Allowance
 
 
 
 
 
249,000,000 
 
 
 
 
Valuation Allowance, Amount
$ 1,171,000,000 
$ 953,000,000 
 
 
$ 1,072,000,000 
$ 99,000,000 
 
 
 
 
Investments, Available For Sale Investments (Detail) (USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Available-for-sale Securities [Abstract]
 
 
 
Fair Value
$ 6,621,000,000 
 
 
Adjusted Cost, Total
8,149,000,000 
14,344,000,000 
 
Gross Unrealized Gains, Total
2,693,000,000 
3,372,000,000 
 
Gross Unrealized Losses, Total
(29,000,000)
(34,000,000)
 
Fair Value, Total
10,813,000,000 
17,682,000,000 
 
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds
7,100,000,000 
4,100,000,000 
2,200,000,000 
Available-for-sale Securities, Gross Realized Gains
3,500,000,000 
538,000,000 
133,000,000 
Due in 1 year or less, Fair Value
2,573,000,000 
 
 
Due in 1-2 years, Fair Value
1,776,000,000 
 
 
Due in 2-5 years, Fair Value
1,866,000,000 
 
 
Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Fair Value
71,000,000 
 
 
Instruments not due at a single maturity date, Fair Value
335,000,000 
 
 
Corporate debt
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
Adjusted Cost
2,294,000,000 
3,847,000,000 
 
Gross Unrealized Gains
4,000,000 
4,000,000 
 
Gross Unrealized Losses
(13,000,000)
(14,000,000)
 
Fair Value
2,285,000,000 
3,837,000,000 
 
Financial institution instruments
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
Adjusted Cost
3,387,000,000 
6,098,000,000 
 
Gross Unrealized Gains
3,000,000 
5,000,000 
 
Gross Unrealized Losses
(9,000,000)
(11,000,000)
 
Fair Value
3,381,000,000 
6,092,000,000 
 
Government debt
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
Adjusted Cost
961,000,000 
1,581,000,000 
 
Gross Unrealized Gains
 
Gross Unrealized Losses
(6,000,000)
(8,000,000)
 
Fair Value
955,000,000 
1,573,000,000 
 
Marketable equity securities
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
Adjusted Cost
1,507,000,000 
2,818,000,000 
 
Gross Unrealized Gains
2,686,000,000 
3,363,000,000 
 
Gross Unrealized Losses
(1,000,000)
(1,000,000)
 
Fair Value
4,192,000,000 
6,180,000,000 
 
Cloudera, Inc. [Member]
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
Equity Method Investment, Other than Temporary Impairment
$ 278,000,000 
 
 
Investments, Equity Method and Cost Method Investments (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Schedule of Equity Method Investments [Line Items]
 
 
 
Equity Method Investments
$ 1,887 
$ 1,328 
 
IM Flash Technologies, LLC [Member]
 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Equity Method Investments
1,505 
849 
 
Equity Method Investment, Ownership Percentage
49.00% 
49.00% 
 
Related Party Transaction, Purchases from Related Party
415 
400 
400 
Due from Joint Ventures, Noncurrent
650 
 
 
Percentage Of Purchase Commitment Of Production Output And Production Related Services
49.00% 
 
 
McAfee [Member]
 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Equity Method Investments
153 
 
 
Equity Method Investment, Ownership Percentage
49.00% 
 
 
Proceeds from Equity Method Investment, Distribution, Return of Capital
735 
 
 
Cloudera, Inc. [Member]
 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Equity Method Investments
 
225 
 
Equity Method Investment, Ownership Percentage
 
16.00% 
 
Other Equity Method Investments [Member]
 
 
 
Schedule of Equity Method Investments [Line Items]
 
 
 
Equity Method Investments
$ 229 
$ 254 
 
Investments, Non-Marketable Cost Method Investments (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Schedule of Cost-method Investments [Line Items]
 
 
 
Non-marketable cost method investments
$ 2,613 
$ 3,098 
 
Impairments
833 
187 
185 
Cost-method Investments [Member]
 
 
 
Schedule of Cost-method Investments [Line Items]
 
 
 
Impairments
548 
178 
164 
Beijing UniSpreadtrum Technology Ltd [Member]
 
 
 
Schedule of Cost-method Investments [Line Items]
 
 
 
Non-marketable cost method investments
658 
966 
 
Beijing UniSpreadtrum Technology Ltd [Member] |
Cost-method Investments [Member]
 
 
 
Schedule of Cost-method Investments [Line Items]
 
 
 
Impairments
$ 308 
 
 
Investments, Trading Assets (Detail) (Debt Securities [Member], USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Debt Securities [Member]
 
 
 
Schedule Of Trading Securities And Other Trading Assets [Line Items]
 
 
 
Trading Securities, Change in Unrealized Holding Gain (Loss)
$ 414 
$ (295)
$ (152)
Unrealized Gain (Loss) on Derivatives
$ (422)
$ 300 
$ 137 
Acquisitions (Details) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
Developed technology
Dec. 31, 2016
Developed technology
Dec. 30, 2017
Customer relationships
Dec. 31, 2016
Customer relationships
Dec. 30, 2017
Mobileye N.V. [Member]
Aug. 21, 2017
Mobileye N.V. [Member]
Aug. 8, 2017
Mobileye N.V. [Member]
Aug. 8, 2017
Mobileye N.V. [Member]
In-process research and development
Dec. 30, 2017
Mobileye N.V. [Member]
Developed technology
Aug. 8, 2017
Mobileye N.V. [Member]
Developed technology
Dec. 30, 2017
Mobileye N.V. [Member]
Customer relationships
Aug. 8, 2017
Mobileye N.V. [Member]
Customer relationships
Dec. 30, 2017
Mobileye N.V. [Member]
Brands
Aug. 8, 2017
Mobileye N.V. [Member]
Brands
Dec. 30, 2017
Series of Individually Immaterial Business Acquisitions [Member]
Acquisition
Dec. 31, 2016
Series of Individually Immaterial Business Acquisitions [Member]
Acquisition
Dec. 26, 2015
Series of Individually Immaterial Business Acquisitions [Member]
Acquisition
Dec. 30, 2017
Altera Corporation [Member]
Dec. 28, 2015
Altera Corporation [Member]
Dec. 28, 2015
Altera Corporation [Member]
In-process research and development
Dec. 30, 2017
Altera Corporation [Member]
Developed technology
Dec. 28, 2015
Altera Corporation [Member]
Developed technology
Dec. 30, 2017
Altera Corporation [Member]
Customer relationships
Dec. 28, 2015
Altera Corporation [Member]
Customer relationships
Dec. 30, 2017
Altera Corporation [Member]
Brands
Dec. 28, 2015
Altera Corporation [Member]
Brands
Business Acquisition [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business Acquisition, Percentage of Voting Interests Acquired
 
 
 
 
 
 
 
 
97.30% 
84.40% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
 
 
 
 
 
 
 
$ 1,800,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business Combinations During Period, Consideration Transferred
 
 
 
 
 
 
 
14,500,000,000 
 
 
 
 
 
 
 
 
 
1,100,000,000 
1,000,000,000 
 
14,500,000,000 
 
 
 
 
 
 
 
 
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
 
 
 
 
 
 
 
 
 
366,000,000 
 
 
 
 
 
 
 
 
 
 
 
2,048,000,000 
 
 
 
 
 
 
 
Short-term investments and marketable securities
 
 
 
 
 
 
 
 
 
370,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tangible assets
 
 
 
 
 
 
 
 
 
227,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Goodwill, Acquired During Period
10,290,000,000 
6,366,000,000 
 
 
 
 
 
10,278,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identified intangible assets
 
 
 
 
 
 
 
 
 
4,500,000,000 
 
 
 
 
 
 
 
 
 
 
 
7,566,000,000 
 
 
 
 
 
 
 
Current Liabilities
 
 
 
 
 
 
 
 
 
(69,000,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred tax liabilities and other
 
 
 
 
 
 
 
 
 
(418,000,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value
 
 
 
 
 
 
 
375,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest
 
 
 
 
 
 
 
 
 
14,495,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost
 
 
 
 
 
 
 
71,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short-term investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
182,000,000 
 
 
 
 
 
 
 
Receivables
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
368,000,000 
 
 
 
 
 
 
 
Inventory
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
555,000,000 
 
 
 
 
 
 
 
Other current assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
123,000,000 
 
 
 
 
 
 
 
Property, plant and equipment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
312,000,000 
 
 
 
 
 
 
 
Goodwill
24,389,000,000 
14,099,000,000 
11,332,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5,448,000,000 
 
 
 
 
 
 
 
Other long-term investments and assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,515,000,000 
 
 
 
 
 
 
 
Deferred income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(351,000,000)
 
 
 
 
 
 
 
Other liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(283,000,000)
 
 
 
 
 
 
 
Long-term debt
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1,535,000,000)
 
 
 
 
 
 
 
Deferred tax liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(449,000,000)
 
 
 
 
 
 
 
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14,451,000,000 
 
 
 
 
 
 
 
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles
 
 
 
 
 
 
 
 
 
3,123,000,000 
 
 
2,346,000,000 
 
713,000,000 
 
64,000,000 
 
 
 
 
6,965,000,000 
 
 
5,757,000,000 
 
1,121,000,000 
 
87,000,000 
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets
 
 
 
 
 
 
 
 
 
$ 1,359,000,000 
$ 1,359,000,000 
 
 
 
 
 
 
 
 
 
 
$ 601,000,000 
$ 601,000,000 
 
 
 
 
 
 
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life
 
 
 
9 years 
9 years 
12 years 
12 years 
 
 
 
 
9 years 
 
12 years 
 
10 years 
 
 
 
 
 
 
 
9 years 
 
12 years 
 
6 years 
 
Number of Businesses Acquired
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
 
 
 
 
 
 
 
 
Divestitures (Details) (USD $)
12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
Intel Security Group [Member]
Apr. 3, 2017
Intel Security Group [Member]
Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Dec. 30, 2017
McAfee [Member]
Intel Security Group [Member]
Dec. 30, 2017
Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]
Intel Security Group [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
 
 
 
 
 
 
 
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
$ 387,000,000 
$ 0 
$ 0 
$ 387,000,000 
 
 
 
Divestiture Transaction Value
 
 
 
4,200,000,000 
 
 
 
Proceeds from Divestiture of Businesses
3,124,000,000 
924,000,000 
 
 
 
Equity Method Investments
1,887,000,000 
1,328,000,000 
 
1,100,000,000 
 
 
 
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal
 
 
 
49.00% 
 
 
 
Notes Receivable, Related Parties, Noncurrent
 
 
 
 
 
2,200,000,000 
 
Proceeds from divestiture
 
 
 
 
 
2,200,000,000 
 
Accounts receivable held for sale
 
 
 
 
317,000,000 
 
 
Goodwill held for sale
 
 
 
 
3,601,000,000 
 
 
Identified intangible assets held for sale
 
 
 
 
965,000,000 
 
 
Other assets held for sale
 
 
 
 
276,000,000 
 
 
Disposal Group, Including Discontinued Operation, Assets
 
 
 
 
5,159,000,000 
 
 
Deferred income held for sale
 
 
 
 
1,553,000,000 
 
 
Other liabilities held for sale
 
 
 
 
276,000,000 
 
 
Disposal Group, Including Discontinued Operation, Liabilities
 
 
 
 
1,829,000,000 
 
 
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)
 
 
 
 
 
 
(507,000,000)
Current Income Tax Expense (Benefit)
$ 11,133,000,000 
$ 2,088,000,000 
$ 3,710,000,000 
$ 822,000,000 
 
 
 
Goodwill (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
$ 14,099 
$ 11,332 
Goodwill, Acquisitions
10,290 
6,366 
Goodwill, Transfers
Goodwill, Other
(3,599)
Goodwill, Ending Balance
24,389 
14,099 
Goodwill, Impaired, Accumulated Impairment Loss
719 
 
Client Computing Group [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
4,356 
4,078 
Goodwill, Acquisitions
65 
Goodwill, Transfers
213 
Goodwill, Other
Goodwill, Ending Balance
4,356 
4,356 
Goodwill, Impaired, Accumulated Impairment Loss
365 
 
Data Center Group [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
5,412 
2,404 
Goodwill, Acquisitions
2,831 
Goodwill, Transfers
177 
Goodwill, Other
Goodwill, Ending Balance
5,421 
5,412 
Goodwill, Impaired, Accumulated Impairment Loss
275 
 
Internet of Things Group [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
1,123 
428 
Goodwill, Acquisitions
659 
Goodwill, Transfers
36 
Goodwill, Other
Goodwill, Ending Balance
1,126 
1,123 
Goodwill, Impaired, Accumulated Impairment Loss
79 
 
Intel Security Group [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
 
3,599 
Goodwill, Acquisitions
 
Goodwill, Transfers
 
Goodwill, Other
 
(3,599)
Goodwill, Ending Balance
 
Software and services operating segments [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
 
441 
Goodwill, Acquisitions
 
Goodwill, Transfers
 
(441)
Goodwill, Other
 
Goodwill, Ending Balance
 
Programmable Solutions Group [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
2,490 
Goodwill, Acquisitions
2,490 
Goodwill, Transfers
Goodwill, Other
Goodwill, Ending Balance
2,490 
2,490 
All other [Member]
 
 
Goodwill [Roll Forward]
 
 
Goodwill, Beginning Balance
718 
382 
Goodwill, Acquisitions
10,278 
321 
Goodwill, Transfers
15 
Goodwill, Other
Goodwill, Ending Balance
$ 10,996 
$ 718 
Identified Intangible Assets (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
Acquisition-related Developed Technology [Member]
Dec. 31, 2016
Acquisition-related Developed Technology [Member]
Dec. 30, 2017
Acquisition-related customer relationships
Dec. 31, 2016
Acquisition-related customer relationships
Dec. 26, 2015
Acquisition-related customer relationships
Dec. 30, 2017
Acquisition-related Brands [Member]
Dec. 31, 2016
Acquisition-related Brands [Member]
Dec. 26, 2015
Acquisition-related Brands [Member]
Dec. 30, 2017
Licensed Technology and Patents [Member]
Dec. 31, 2016
Licensed Technology and Patents [Member]
Dec. 30, 2017
Cost of sales [Member]
Acquisition-related Developed Technology [Member]
Dec. 31, 2016
Cost of sales [Member]
Acquisition-related Developed Technology [Member]
Dec. 26, 2015
Cost of sales [Member]
Acquisition-related Developed Technology [Member]
Dec. 30, 2017
Cost of sales [Member]
Licensed Technology and Patents [Member]
Dec. 31, 2016
Cost of sales [Member]
Licensed Technology and Patents [Member]
Dec. 26, 2015
Cost of sales [Member]
Licensed Technology and Patents [Member]
Dec. 30, 2017
Minimum [Member]
Acquisition-related Developed Technology [Member]
Dec. 30, 2017
Minimum [Member]
Acquisition-related customer relationships
Dec. 30, 2017
Minimum [Member]
Acquisition-related Brands [Member]
Dec. 30, 2017
Minimum [Member]
Licensed Technology and Patents [Member]
Dec. 30, 2017
Maximum [Member]
Acquisition-related Developed Technology [Member]
Dec. 30, 2017
Maximum [Member]
Acquisition-related customer relationships
Dec. 30, 2017
Maximum [Member]
Acquisition-related Brands [Member]
Dec. 30, 2017
Maximum [Member]
Licensed Technology and Patents [Member]
Dec. 30, 2017
In Process Research and Development [Member]
Dec. 31, 2016
In Process Research and Development [Member]
Aug. 8, 2017
Mobileye N.V. [Member]
Dec. 30, 2017
Mobileye N.V. [Member]
Acquisition-related Developed Technology [Member]
Dec. 30, 2017
Mobileye N.V. [Member]
Acquisition-related customer relationships
Indefinite-lived Intangible Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identified intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 4,500 
 
 
Gross assets, Indefinite-Lived Intangible Assets
2,168 
808 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,168 
808 
 
 
 
Indefinite-lived Intangible Assets Acquired
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,359 
 
 
 
 
Finite Lived Intangible Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross Assets, Finite-lived Intangible Assets
14,211 
12,226 
 
8,912 
7,405 
2,052 
1,449 
 
143 
87 
 
3,104 
3,285 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated Amortization
(3,634)
(3,540)
 
(1,922)
(1,836)
(313)
(260)
 
(29)
(21)
 
(1,370)
(1,423)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net
10,577 
8,686 
 
6,990 
5,569 
1,739 
1,189 
 
114 
66 
 
1,734 
1,862 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finite-Lived Intangible Asset, Useful Life
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 years 
7 years 
6 years 
2 years 
9 years 
12 years 
10 years 
17 years 
 
 
 
 
 
Identified Intangible Assets Acquired During Period
 
 
 
2,346 
5,842 
713 
1,148 
 
64 
87 
 
162 
342 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)
 
 
 
9 years 
9 years 
12 years 
12 years 
 
10 years 
6 years 
 
7 years 
12 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 years 
12 years 
Amortization of intangibles
1,377 
1,524 
890 
 
 
 
 
 
 
 
 
 
 
912 
937 
343 
288 
293 
282 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation, Depletion and Amortization, Nonproduction
177 
294 
265 
 
 
161 
270 
258 
16 
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Amortization Expense, 2017
1,502 
 
 
1,045 
 
181 
 
 
20 
 
 
256 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Amortization Expense, 2018
1,486 
 
 
1,043 
 
180 
 
 
20 
 
 
243 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Amortization Expense, 2019
1,421 
 
 
1,011 
 
179 
 
 
20 
 
 
211 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Amortization Expense, 2020
1,370 
 
 
976 
 
179 
 
 
20 
 
 
195 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Amortization Expense, 2021
1,304 
 
 
937 
 
171 
 
 
 
 
190 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total identified intangible assets, gross
16,379 
13,034 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identified intangible assets, net
$ 12,745 
$ 9,494 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Long-Term Assets (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 30, 2017
Dec. 31, 2016
Equity Method Investments
$ 1,887 
$ 1,328 
Non-marketable cost method investments
2,613 
3,098 
Non-current deferred tax assets
840 
907 
Loans receivable
860 
236 
Other
688 
1,243 
Total other long-term assets
7,602 
7,159 
Machinery and Equipment [Member]
 
 
Prepaid Expense Other, Noncurrent
$ 714 
$ 347 
Borrowings, Short-term Debt (Detail) (USD $)
Dec. 30, 2017
Dec. 31, 2016
Short-term Debt [Line Items]
 
 
Short-term Debt, Fair Value
$ 2,400,000,000 
$ 5,100,000,000 
Drafts payable
37,000,000 
25,000,000 
Current portion of long-term debt
1,739,000,000 
4,609,000,000 
Total short-term debt
1,776,000,000 
4,634,000,000 
Commercial Paper [Member]
 
 
Short-term Debt [Line Items]
 
 
Line of Credit Facility, Maximum Borrowing Capacity
10,000,000,000 
 
BoardofDirectorsAuthorizedIncreasetoMaximumBorrowingCapacity
$ 5,000,000,000 
 
Borrowings, Long-term Debt (Detail) (USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Repurchase Amount
$ 1,900,000,000 
 
 
Debt Instrument, Interest Rate, Effective Percentage
 
4.01% 
 
Long-term debt
(1,739,000,000)
(4,609,000,000)
 
Total long-term debt
25,037,000,000 
20,649,000,000 
 
Derivative, Notional Amount
38,417,000,000 
33,528,000,000 
26,655,000,000 
Long-term Debt, Fair Value
27,000,000,000 
22,000,000,000 
 
Extinguishment of Debt, Amount
425,000,000 
 
 
Gain (Loss) on Extinguishment of Debt
(476,000,000)
Outstanding principal
28,385,000,000 
27,023,000,000 
 
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
(1,357,000,000)
(1,581,000,000)
 
Total senior notes and other borrowings
26,776,000,000 
25,258,000,000 
 
Temporary equity
866,000,000 
882,000,000 
 
Year Payable, 2018
600,000,000 
 
 
Year Payable, 2019
194,000,000 
 
 
Year Payable, 2020
3,450,000,000 
 
 
Year Payable, 2021
2,500,000,000 
 
 
Year Payable, 2022
4,478,000,000 
 
 
2022 and thereafter
17,163,000,000 
 
 
2017 Senior notes due May 2020 at .08% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Basis Spread on Variable Rate
0.08% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.40% 
 
 
Outstanding principal
700,000,000 
 
2017 Senior notes due May 2022 at .35% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Basis Spread on Variable Rate
0.35% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.66% 
 
 
Outstanding principal
800,000,000 
 
2016 Altera acquired Senior notes due May 2017 at 1.75% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Outstanding principal
500,000,000 
 
Debt Instrument Nine [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
1.35% 
 
 
Outstanding principal
3,000,000,000 
 
Debt Instrument Twenty Six [Member] |
Altera Corporation [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Face Amount
1,500,000,000 
 
 
2016 Altera acquired Senior notes due November 2018 at 2.50% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.50% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.14% 
 
 
Outstanding principal
600,000,000 
600,000,000 
 
2015 AUD-denominated Senior notes due December 2019 at 3.25% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.25% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.19% 
 
 
Outstanding principal
194,000,000 
180,000,000 
 
2017 Senior notes due May 2020 at 1.85% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
1.85% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.90% 
 
 
Outstanding principal
1,000,000,000 
 
2015 Senior notes due July 2020 at 2.45% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.45% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.50% 
 
 
Outstanding principal
1,750,000,000 
1,750,000,000 
 
2016 Senior notes due May 2021 at 1.70% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
1.70% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.78% 
 
 
Outstanding principal
500,000,000 
500,000,000 
 
2011 Senior notes due October 2021 at 3.30% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.30% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.69% 
 
 
Outstanding principal
2,000,000,000 
2,000,000,000 
 
2017 Senior notes due May 2022 at 2.35% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.35% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.86% 
 
 
Outstanding principal
750,000,000 
 
2015 Senior notes due July 2022 at 3.10% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.10% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.50% 
 
 
Outstanding principal
1,000,000,000 
1,000,000,000 
 
2015 Senior notes due December 2022 at 4.00% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.00% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.98% 
 
 
Outstanding principal
428,000,000 
396,000,000 
 
2012 Senior notes due December 2022 at 2.70% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.70% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.08% 
 
 
Outstanding principal
1,500,000,000 
1,500,000,000 
 
2016 Altera acquired Senior notes due November 2023 at 4.10% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.10% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
3.23% 
 
 
Outstanding principal
400,000,000 
400,000,000 
 
2017 Senior notes due May 2024 at 2.88% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.88% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.36% 
 
 
Outstanding principal
1,250,000,000 
 
2017 Senior notes due June 2024 at 2.70% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.70% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.12% 
 
 
Outstanding principal
600,000,000 
 
2015 Senior notes due July 2025 at 3.70% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.70% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
3.20% 
 
 
Outstanding principal
2,250,000,000 
2,250,000,000 
 
2016 Senior notes due May 2026 at 2.60% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.60% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
1.66% 
 
 
Outstanding principal
1,000,000,000 
1,000,000,000 
 
2017 Senior notes due May 2027 at 3.15% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.15% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.82% 
 
 
Outstanding principal
1,000,000,000 
 
2012 Senior notes due December 2032 at 4.00% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.00% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.10% 
 
 
Outstanding principal
750,000,000 
750,000,000 
 
2011 Senior notes due October 2041 at 4.80% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.80% 
 
 
Repayments of Debt
518,000,000 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.86% 
 
 
Outstanding principal
802,000,000 
1,500,000,000 
 
2012 Senior notes due December 2042 at 4.25% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.25% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.39% 
 
 
Outstanding principal
567,000,000 
925,000,000 
 
2015 Senior notes due July 2045 at 4.90% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.90% 
 
 
Repayments of Debt
293,000,000 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.92% 
 
 
Gain (Loss) on Extinguishment of Debt
93,000,000 
 
 
Outstanding principal
772,000,000 
2,000,000,000 
 
Debt Instrument Twenty [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.90% 
 
 
Debt Instrument, Repurchased Face Amount
1,000,000,000 
 
 
Outstanding principal
1,007,000,000 
 
2015 Senior notes due December 2045 at 4.70% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.70% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.49% 
 
 
Outstanding principal
915,000,000 
915,000,000 
 
2016 Senior notes due May 2046 at 4.10% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.10% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.12% 
 
 
Outstanding principal
1,250,000,000 
1,250,000,000 
 
2017 Senior notes due May 2047 at 4.10% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.10% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.13% 
 
 
Outstanding principal
1,000,000,000 
 
$640, 4.10%, Senior Notes due August 2047 [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
4.10% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
2.15% 
 
 
Outstanding principal
640,000,000 
 
2017 Senior notes due December 2047 at 3.73% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.73% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
3.74% 
 
 
Outstanding principal
1,967,000,000 
 
Junior Subordinate due August 2039 at 3.25% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
3.25% 
 
 
Debt Instrument, Interest Rate, Effective Percentage
4.03% 
 
 
Convertible Subordinated Debt
2,000,000,000 
2,000,000,000 
 
Long-term debt
(1,100,000,000)
(1,100,000,000)
 
Outstanding principal
2,000,000,000 
2,000,000,000 
 
Trading Days Period Prior To Semi Annual Interest Period, Contingent Interest
10 days 
 
 
Principal Amount Per Debenture Used In Conversion Rate
1,000 
 
 
Debenture Interest Period Length, Contingent Interest
6 months 
 
 
Average Lowerbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest
650 
 
 
Average Upperbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest
1,500 
 
 
Minimum Percentage Of Contingent Interest That Could Accrue Per Year
0.25% 
 
 
Maximum Percentage Of Contingent Interest That Could Accrue Per Year
0.50% 
 
 
Company Stock As Percentage Of Conversion Price, Surrender For Conversion
130.00% 
 
 
Debt Instrument, Convertible, Threshold Trading Days
20 
 
 
Debt Instrument, Convertible, Threshold Consecutive Trading Days
30 
 
 
Company Stock As Percentage Of Conversion Price, Redemption Of Principal
150.00% 
 
 
Trading Days During Thirty Day Period In Which Company Stock Has Been At Least One Hundred-Fifty Percent Of Conversion Price, Redemption Of Principal
20 days 
 
 
Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal
30 days 
 
 
Equity component carrying amount
613,000,000 
613,000,000 
 
Debt Instrument, Unamortized Discount
866,000,000 
882,000,000 
 
Total senior notes and other borrowings
1,134,000,000 
1,118,000,000 
 
Conversion rate (shares of common stock per $1,000 principal amount of debentures)
48.37 
47.72 
 
Effective conversion price (per share of common stock)
$ 20.68 
$ 20.95 
 
Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share
$ 0.14 
 
 
2005 Junior Subordinated Convertible Debentures Due December 2035 At 2.95% [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
2.95% 
 
 
Repayments of Debt
2,800,000,000 
 
 
Convertible Subordinated Debt
1,600,000,000 
 
Debt Instrument, Repurchased Face Amount
1,600,000,000 
 
 
Gain (Loss) on Extinguishment of Debt
385,000,000 
 
 
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
1,400,000,000 
 
 
2017 Senior Notes [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Face Amount
7,700,000,000 
 
 
2016 Senior notes [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Debt Instrument, Face Amount
2,800,000,000 
 
 
Debt Instrument Six [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Effective Interest Rate
1.95% 
 
 
Cross Currency Interest Rate Contract [Member] |
2015 AUD-denominated Senior notes [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Derivative, Notional Amount
577,000,000 
 
 
Fair Value Hedging [Member] |
Interest Rate Swaps [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Derivative, Notional Amount
4,800,000,000 
4,700,000,000 
4,400,000,000 
Fair Value Hedging [Member] |
Long-term Debt [Member] |
Interest Rate Swaps [Member]
 
 
 
Debt Instrument [Line Items]
 
 
 
Derivative, Gain (Loss) on Derivative, Net
$ (252,000,000)
$ (184,000,000)
 
Fair Value (Detail) (USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
$ 8,755,000,000 
$ 8,314,000,000 
 
Derivative Assets, Fair Value Disclosure
350,000,000 
433,000,000 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
745,000,000 
588,000,000 
 
Other than Temporary Impairment Losses, Investments
833,000,000 
187,000,000 
185,000,000 
Non-marketable cost method investments
2,613,000,000 
3,098,000,000 
 
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Assets, Fair Value Disclosure
21,970,000,000 
27,748,000,000 
 
Liabilities, Fair Value Disclosure
757,000,000 
583,000,000 
 
Fair Value, Measurements, Nonrecurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Non-marketable cost method investments, Fair Value
3,600,000,000 
3,900,000,000 
 
Fair Value, Measurements, Nonrecurring [Member] |
Carrying Value [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Grants Receivable
935,000,000 
876,000,000 
 
Non-marketable cost method investments
2,613,000,000 
3,098,000,000 
 
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
2,842,000,000 
2,847,000,000 
 
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
1,123,000,000 
1,644,000,000 
 
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
4,788,000,000 
3,736,000,000 
 
Asset-backed securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
2,000,000 
87,000,000 
 
Marketable equity securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
4,192,000,000 
6,180,000,000 
 
Cost-method Investments [Member] |
Fair Value, Measurements, Nonrecurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Other than Temporary Impairment Losses, Investments
(537,000,000)
153,000,000 
160,000,000 
Cash Equivalents [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
30,000,000 
498,000,000 
 
Cash Equivalents [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
975,000,000 
2,731,000,000 
 
Cash Equivalents [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
90,000,000 
332,000,000 
 
Cash Equivalents [Member] |
Repurchase Agreements [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,399,000,000 
768,000,000 
 
Short-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
675,000,000 
1,338,000,000 
 
Short-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,009,000,000 
1,603,000,000 
 
Short-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
130,000,000 
284,000,000 
 
Other Current Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
279,000,000 
382,000,000 
 
Loans Receivable, Fair Value Disclosure
30,000,000 
326,000,000 
 
Other Long-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,580,000,000 
2,001,000,000 
 
Other Long-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,397,000,000 
1,758,000,000 
 
Other Long-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
735,000,000 
957,000,000 
 
Other Long-Term Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
84,000,000 
40,000,000 
 
Loans Receivable, Fair Value Disclosure
610,000,000 
236,000,000 
 
Other Accrued Liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
454,000,000 
371,000,000 
 
Other long-term liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
303,000,000 
212,000,000 
 
Level 1 [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Assets, Fair Value Disclosure
4,574,000,000 
8,168,000,000 
 
Liabilities, Fair Value Disclosure
 
Level 1 [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 1 [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
59,000,000 
36,000,000 
 
Level 1 [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
30,000,000 
32,000,000 
 
Level 1 [Member] |
Asset-backed securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 1 [Member] |
Marketable equity securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
4,148,000,000 
6,180,000,000 
 
Level 1 [Member] |
Cash Equivalents [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Cash Equivalents [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
335,000,000 
1,920,000,000 
 
Level 1 [Member] |
Cash Equivalents [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Cash Equivalents [Member] |
Repurchase Agreements [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Short-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Short-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Short-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Other Current Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
2,000,000 
 
Loans Receivable, Fair Value Disclosure
 
Level 1 [Member] |
Other Long-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Other Long-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Other Long-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 1 [Member] |
Other Long-Term Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
 
Loans Receivable, Fair Value Disclosure
 
Level 1 [Member] |
Other Accrued Liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
 
Level 1 [Member] |
Other long-term liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
 
Level 2 [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Assets, Fair Value Disclosure
17,382,000,000 
19,559,000,000 
 
Liabilities, Fair Value Disclosure
751,000,000 
550,000,000 
 
Level 2 [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
2,842,000,000 
2,847,000,000 
 
Level 2 [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
1,064,000,000 
1,608,000,000 
 
Level 2 [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
4,758,000,000 
3,704,000,000 
 
Level 2 [Member] |
Asset-backed securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
2,000,000 
87,000,000 
 
Level 2 [Member] |
Marketable equity securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
44,000,000 
 
Level 2 [Member] |
Cash Equivalents [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
30,000,000 
498,000,000 
 
Level 2 [Member] |
Cash Equivalents [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
640,000,000 
811,000,000 
 
Level 2 [Member] |
Cash Equivalents [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
90,000,000 
332,000,000 
 
Level 2 [Member] |
Cash Equivalents [Member] |
Repurchase Agreements [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,399,000,000 
768,000,000 
 
Level 2 [Member] |
Short-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
672,000,000 
1,332,000,000 
 
Level 2 [Member] |
Short-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,009,000,000 
1,603,000,000 
 
Level 2 [Member] |
Short-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
130,000,000 
284,000,000 
 
Level 2 [Member] |
Other Current Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
277,000,000 
382,000,000 
 
Loans Receivable, Fair Value Disclosure
30,000,000 
326,000,000 
 
Level 2 [Member] |
Other Long-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,576,000,000 
1,995,000,000 
 
Level 2 [Member] |
Other Long-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
1,397,000,000 
1,758,000,000 
 
Level 2 [Member] |
Other Long-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
735,000,000 
957,000,000 
 
Level 2 [Member] |
Other Long-Term Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
77,000,000 
31,000,000 
 
Loans Receivable, Fair Value Disclosure
610,000,000 
236,000,000 
 
Level 2 [Member] |
Other Accrued Liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
454,000,000 
371,000,000 
 
Level 2 [Member] |
Other long-term liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
297,000,000 
179,000,000 
 
Level 3 [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Assets, Fair Value Disclosure
14,000,000 
21,000,000 
 
Liabilities, Fair Value Disclosure
6,000,000 
33,000,000 
 
Level 3 [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 3 [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 3 [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 3 [Member] |
Asset-backed securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Trading assets
 
Level 3 [Member] |
Marketable equity securities |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Cash Equivalents [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Cash Equivalents [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Cash Equivalents [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Cash Equivalents [Member] |
Repurchase Agreements [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Short-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
3,000,000 
6,000,000 
 
Level 3 [Member] |
Short-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Short-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Other Current Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
 
Loans Receivable, Fair Value Disclosure
 
Level 3 [Member] |
Other Long-Term Investments [Member] |
Corporate debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
4,000,000 
6,000,000 
 
Level 3 [Member] |
Other Long-Term Investments [Member] |
Financial institution instruments |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Other Long-Term Investments [Member] |
Government debt |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Investments, Fair Value Disclosure
 
Level 3 [Member] |
Other Long-Term Assets [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Assets, Fair Value Disclosure
7,000,000 
9,000,000 
 
Loans Receivable, Fair Value Disclosure
 
Level 3 [Member] |
Other Accrued Liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
 
Level 3 [Member] |
Other long-term liabilities [Member] |
Fair Value, Measurements, Recurring [Member]
 
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
$ 6,000,000 
$ 33,000,000 
 
Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Other Comprehensive Income (Loss), before Reclassifications, before Tax
$ 3,643 
$ 460 
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
(2,890)
(322)
506 
Tax effects
(92)
 
Other comprehensive income (loss)
756 
46 
(606)
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months
108 
 
 
Unrealized holding gains (losses) on available-for-sale investments [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
1,728 
2,164 
1,749 
Other Comprehensive Income (Loss), before Reclassifications, before Tax
2,760 
1,170 
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
(3,431)
(530)
 
Tax effects
235 
(225)
 
Other comprehensive income (loss)
(436)
415 
 
Valuation Allowance of Deferred Tax Assets [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Other Comprehensive Income (Loss), before Reclassifications, before Tax
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
 
Tax effects
(8)
 
Other comprehensive income (loss)
(8)
 
Unrealized holding gains (losses) on derivatives [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
106 
(259)
(266)
Other Comprehensive Income (Loss), before Reclassifications, before Tax
605 
(26)
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
(69)
38 
 
Tax effects
(171)
(5)
 
Other comprehensive income (loss)
365 
 
Actuarial gains (losses) [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
(963)
(1,280)
(916)
Other Comprehensive Income (Loss), before Reclassifications, before Tax
275 
(680)
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
103 
170 
77 
Tax effects
(61)
146 
 
Other comprehensive income (loss)
317 
(364)
 
Foreign Currency translation adjustment [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
(9)
(519)
(515)
Other Comprehensive Income (Loss), before Reclassifications, before Tax
(4)
 
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax
507 
 
Tax effects
 
Other comprehensive income (loss)
510 
(4)
 
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
 
 
 
Accumulated Other Comprehensive Income (Loss) [Line Items]
 
 
 
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
$ 862 
$ 106 
$ 60 
Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Gains (losses) on equity investments, net
$ 2,651 
$ 506 
$ 315 
Other Nonoperating Income (Expense)
(30)
67 
108 
Income before taxes
20,352 
12,936 
14,212 
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
2,890 
322 
(506)
Cost of sales
(23,692)
(23,196)
(20,676)
Research and development
(13,098)
(12,740)
(12,128)
Marketing, general and administrative
(7,474)
(8,397)
(7,930)
Unrealized holding gains (losses) on available-for-sale investments [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
3,431 
530 
 
Unrealized holding gains (losses) on available-for-sale investments [Member] |
Reclassification out of Accumulated Other Comprehensive Income [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Gains (losses) on equity investments, net
3,431 
530 
93 
Income before taxes
3,431 
530 
93 
Unrealized holding gains (losses) on derivatives [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
69 
(38)
 
Unrealized holding gains (losses) on derivatives [Member] |
Reclassification out of Accumulated Other Comprehensive Income [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Income before taxes
69 
(38)
(522)
Unrealized holding gains (losses) on derivatives [Member] |
Reclassification out of Accumulated Other Comprehensive Income [Member] |
Foreign currency contracts [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Gains (losses) on equity investments, net
57 
11 
Other Nonoperating Income (Expense)
25 
(9)
Cost of sales
(65)
(65)
(290)
Research and development
45 
(177)
Marketing, general and administrative
(46)
Actuarial gains (losses) [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
(103)
(170)
(77)
Amortization of pension and postretirement benefit components [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
(103)
(170)
(77)
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] |
Reclassification out of Accumulated Other Comprehensive Income [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Other Nonoperating Income (Expense)
(507)
Intel Security Group [Member] |
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] |
Reclassification out of Accumulated Other Comprehensive Income [Member]
 
 
 
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
 
 
 
Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)
$ (507)
 
 
Derivative Financial Instruments (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Derivative [Line Items]
 
 
 
Impairments
$ 833 
$ 187 
$ 185 
Derivative Asset, Fair Value, Gross Asset
350 
433 
 
Effect of Fair Value Hedges on Results of Operations [Abstract]
 
 
 
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
68 
171 
13 
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
38,417 
33,528 
26,655 
Offsetting Derivative Assets [Abstract]
 
 
 
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet
 
Derivative Assets, Fair Value Disclosure
350 
433 
 
Derivative Asset, Not Offset, Policy Election Deduction
(206)
(368)
 
Derivative, Collateral, Obligation to Return Cash
(130)
(42)
 
Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election
14 
23 
 
Reverse Repurchase Agreements, Gross Amounts Recognized
1,649 
1,018 
 
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet
 
Securities Purchased under Agreements to Resell
1,649 
1,018 
 
Securities Purchased under Agreements to Resell, Not Offset, Policy Election Deduction
 
Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments
(1,649)
(1,018)
 
Securities Purchased under Agreements to Resell, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election
 
Total Assets, Gross Amounts Recognized
1,999 
1,451 
 
Total Assets, Gross Amounts Offset In The Balance Sheet
 
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed
1,999 
1,451 
 
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Not Offset, Policy Election Deduction
(206)
(368)
 
Total Assets, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged
(1,779)
(1,060)
 
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election
14 
23 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
745 
588 
 
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet
 
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
745 
588 
 
Derivative Liability, Not Offset, Policy Election Deduction
(206)
(368)
 
Derivative, Collateral, Right to Reclaim Cash
(504)
(201)
 
Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election
35 
19 
 
Designated as Hedging Instrument [Member] |
Interest and other, net [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
Not Designated as Hedging Instrument [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
(335)
509 
250 
Fair Value Hedging [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative, Net Hedge Ineffectiveness Gain (Loss)
Assets [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
363 
422 
 
Assets [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
284 
24 
 
Assets [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
79 
398 
 
Liabilities [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
757 
583 
 
Liabilities [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
286 
439 
 
Liabilities [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
471 
144 
 
Foreign currency contracts [Member]
 
 
 
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
19,958 
17,960 
16,721 
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net [Abstract]
 
 
 
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)
605 
(26)
(298)
Foreign currency contracts [Member] |
Not Designated as Hedging Instrument [Member] |
Interest and other, net [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
(547)
388 
296 
Foreign currency contracts [Member] |
Assets [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
283 
21 
 
Foreign currency contracts [Member] |
Assets [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
52 
374 
 
Foreign currency contracts [Member] |
Liabilities [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
32 
252 
 
Foreign currency contracts [Member] |
Liabilities [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
447 
114 
 
Interest Rate Contracts [Member]
 
 
 
Effect of Fair Value Hedges on Results of Operations [Abstract]
 
 
 
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments
(68)
(171)
(13)
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
16,823 
14,228 
8,812 
Interest Rate Contracts [Member] |
Not Designated as Hedging Instrument [Member] |
Interest and other, net [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
(8)
Interest Rate Contracts [Member] |
Assets [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
 
Interest Rate Contracts [Member] |
Assets [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
18 
15 
 
Interest Rate Contracts [Member] |
Liabilities [Member] |
Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
254 
187 
 
Interest Rate Contracts [Member] |
Liabilities [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
24 
30 
 
Other contracts [Member]
 
 
 
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
1,636 
1,340 
1,122 
Other contracts [Member] |
Not Designated as Hedging Instrument [Member] |
Various [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
203 
113 
(38)
Other contracts [Member] |
Assets [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative Asset, Fair Value, Gross Asset
 
Other contracts [Member] |
Liabilities [Member] |
Not Designated as Hedging Instrument [Member]
 
 
 
Offsetting Derivative Liabilities [Abstract]
 
 
 
Total Liabilities, Gross Amounts Recognized
 
Foreign Exchange Forward [Member]
 
 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Discontinuation of Cash Flow Hedge
 
 
478 
Interest Rate Swaps [Member] |
Fair Value Hedging [Member]
 
 
 
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
4,800 
4,700 
4,400 
Interest Rate Swaps [Member] |
Long-term Debt [Member] |
Fair Value Hedging [Member]
 
 
 
Derivative [Line Items]
 
 
 
Derivative, Fair Value, Net
(12,653)
(8,879)
 
Derivative, Amount of Hedged Item
12,900 
9,100 
 
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
 
 
 
Gains (Losses) Recognized in Income on Derivatives
252 
184 
 
Cross Currency Interest Rate Contract [Member] |
Cash Flow Hedging [Member]
 
 
 
Gross Notional Amounts [Abstract]
 
 
 
Derivative, Notional Amount
 
577 
 
Cost-method Investments [Member] |
Fair Value, Measurements, Nonrecurring [Member]
 
 
 
Derivative [Line Items]
 
 
 
Impairments
$ (537)
$ 153 
$ 160 
Retirement Benefit Plans (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Dec. 30, 2017
Pension Plan [Member]
Dec. 31, 2016
Pension Plan [Member]
Dec. 30, 2017
Domestic Plan [Member]
Dec. 31, 2016
Domestic Plan [Member]
Dec. 26, 2015
Domestic Plan [Member]
Dec. 30, 2017
Domestic Plan [Member]
Pension Plan [Member]
Dec. 31, 2016
Domestic Plan [Member]
Pension Plan [Member]
Dec. 26, 2015
Domestic Plan [Member]
Pension Plan [Member]
Dec. 29, 2018
Domestic Plan [Member]
Postretirement Health Coverage [Member]
Dec. 30, 2017
Domestic Plan [Member]
Postretirement Health Coverage [Member]
Dec. 31, 2016
Domestic Plan [Member]
Postretirement Health Coverage [Member]
Dec. 30, 2017
Foreign Plan [Member]
Dec. 31, 2016
Foreign Plan [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Domestic Plan [Member]
Dec. 29, 2018
Scenario, Forecast [Member]
Foreign Plan [Member]
Dec. 30, 2017
Marketable equity securities
Dec. 31, 2016
Marketable equity securities
Dec. 30, 2017
Marketable equity securities
Domestic Plan [Member]
Dec. 30, 2017
Financial institution instruments
Dec. 31, 2016
Financial institution instruments
Dec. 30, 2017
Financial institution instruments
Domestic Plan [Member]
Dec. 30, 2017
Other Investments [Member]
Dec. 30, 2017
Assets measured at net asset value [Member]
Dec. 31, 2016
Assets measured at net asset value [Member]
Dec. 30, 2017
Cash [Member]
Dec. 31, 2016
Cash [Member]
Dec. 30, 2017
Hedge Funds [Member]
Domestic Plan [Member]
Dec. 30, 2017
Hedge Funds [Member]
Foreign Plan [Member]
Dec. 30, 2017
Level 1 [Member]
Dec. 30, 2017
Level 1 [Member]
Marketable equity securities
Dec. 30, 2017
Level 1 [Member]
Financial institution instruments
Dec. 30, 2017
Level 1 [Member]
Other Investments [Member]
Dec. 30, 2017
Level 2 [Member]
Dec. 30, 2017
Level 2 [Member]
Marketable equity securities
Dec. 30, 2017
Level 2 [Member]
Financial institution instruments
Dec. 30, 2017
Level 2 [Member]
Other Investments [Member]
Dec. 30, 2017
Level 3 [Member]
Dec. 30, 2017
Level 3 [Member]
Marketable equity securities
Dec. 30, 2017
Level 3 [Member]
Financial institution instruments
Dec. 30, 2017
Level 3 [Member]
Other Investments [Member]
Dec. 31, 2016
Level 3 [Member]
Other Investments [Member]
Dec. 30, 2017
Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Income Tax Rate Reconciliation, at Foreign Statutory Income Tax Rate, Percent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25.00% 
Projected Benefit Obligations Percentage Split
 
 
 
 
 
38.00% 
 
 
 
 
 
 
 
 
62.00% 
62.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value of Plan Assets Percentage Split
 
 
 
 
 
49.00% 
46.00% 
 
 
 
 
 
 
 
51.00% 
54.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AOCI Percentage Split
 
 
 
 
 
38.00% 
34.00% 
 
 
 
 
 
 
 
62.00% 
66.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Contribution Plan, Employer Discretionary Contribution Amount
 
 
 
 
 
$ 346 
$ 326 
$ 337 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beginning projected benefit obligation
3,842 
3,640 
3,130 
 
 
 
 
 
 
 
 
 
567 
588 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost
84 
130 
 
 
 
 
 
 
104 
156 
176 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest cost
117 
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Actuarial (gain) loss
24 
575 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Currency exchange rate changes
281 
(80)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plan curtailments
162 
(17)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plan settlements
(101)
(202)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other changes in projected benefit obligation
(41)
(36)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value of plan assets
2,287 
1,696 
1,638 
957 
632 
 
 
 
 
 
 
 
563 
409 
 
 
 
 
473 
328 
 
465 
304 
 
19 
1,208 
1,044 
122 
20 
 
 
515 
451 
45 
19 
326 
326 
116 
22 
94 
 
Actual return on plan assets
136 
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Employer contributions
471 
416 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Currency exchange rate changes
124 
(26)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plan settlements
(101)
(202)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefits paid to plan participants
(42)
(84)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other
(127)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amounts recognized in the consolidated balance sheet3
1,555 
1,944 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated other comprehensive loss (income), before tax4
1,257 
1,603 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated benefit obligation5
3,423 
2,976 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Target Plan Asset Allocations (percent)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45.00% 
 
25.00% 
35.00% 
 
45.00% 
 
 
 
 
 
30.00% 
20.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Funded Status Percentage [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Funded Percentage
65.00% 
 
 
 
 
77.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Component Of Worldwide Pension And Postretirement Benefit Obligation (percent)
33.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
3.00% 
3.20% 
 
 
 
 
 
 
 
 
 
 
3.80% 
4.20% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate of compensation increase
3.30% 
3.60% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
3.20% 
3.30% 
3.10% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected long-term rate of return on plan assets
4.60% 
5.50% 
5.90% 
 
 
 
 
 
 
 
 
5.90% 
 
 
 
 
5.10% 
4.20% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate of compensation increase
3.60% 
3.80% 
3.90% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
 
 
 
 
 
 
 
 
243 
415 
250 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2018
125 
 
 
 
 
 
 
 
 
 
 
 
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2019
117 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2020
115 
 
 
 
 
 
 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2021
121 
 
 
 
 
 
 
 
 
 
 
 
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2022
124 
 
 
 
 
 
 
 
 
 
 
 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated Benefit Payments, 2023-2027
$ 673 
 
 
 
 
 
 
 
 
 
 
 
$ 179 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Actuarial (Gain) Loss Amortization Percent
10.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Employee Equity Incentive Plans (Detail) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Market-Based Restricted Stock Units Performance Period (In Years)
3 years 
 
 
Share-based Compensation
$ 1,358,000,000 
$ 1,444,000,000 
$ 1,305,000,000 
Tax Benefit from Compensation Expense
520,000,000 
616,000,000 
533,000,000 
Restricted Stock Units (RSUs) [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Award Requisite Service Period
4 years 
 
 
RSUs Vested in Period, Total Fair Value
1,600,000,000 
1,600,000,000 
1,500,000,000 
RSUs Aggregate Intrinsic Value, Vested
1,100,000,000 
1,300,000,000 
1,100,000,000 
Compensation Cost Not yet Recognized
2,000,000,000 
 
 
Compensation Cost Not yet Recognized, Period for Recognition
1 year 3 months 
 
 
Estimated Values And Weighted Average Assumptions [Abstract]
 
 
 
Estimated values (in dollars per share)
$ 35.30 
$ 29.76 
$ 31.63 
Risk-free interest rate
1.40% 
0.90% 
0.60% 
Dividend yield
2.90% 
3.30% 
2.90% 
Restricted Stock Units Activity [Roll Forward]
 
 
 
Number of RSUs outstanding, beginning balance
106.8 
 
 
Number of RSUs granted
45.2 
 
 
Number of RSUs assumed In acquisition
1.1 
 
 
Number of RSUs vested
(40.5)
 
 
Number of RSUs forfeited
(12.2)
 
 
Number of RSUs outstanding, ending balance
100.4 
106.8 
 
Number of RSUs expected to vest
96.5 
 
 
Weighted average grant date fair value, RSUs outstanding
$ 32.36 
$ 28.99 
 
Weighted average grant date fair value, RSUs granted
$ 35.30 
 
 
Weighted average grant date fair value, RSUs assumed in acquisition
$ 34.90 
 
 
Weighted average grant date fair value, RSUs vested
$ 27.52 
 
 
Weighted average grant date fair value, RSUs forfeited
$ 30.08 
 
 
Weighted average grant date fair value, RSUs expected to vest
$ 32.36 
 
 
Employee Stock Option [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Expiration Period
7 years 
 
 
Market-Based Restricted Stock Units (OSUs) [Member]
 
 
 
Estimated Values And Weighted Average Assumptions [Abstract]
 
 
 
Volatility (percent)
23.00% 
23.00% 
27.00% 
Restricted Stock Units Activity [Roll Forward]
 
 
 
Number of RSUs outstanding, ending balance
9.2 
 
 
Market-Based Restricted Stock Units (OSUs) [Member] |
Minimum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Vesting range (percent)
0.00% 
 
 
Market-Based Restricted Stock Units (OSUs) [Member] |
Maximum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Vesting range (percent)
200.00% 
 
 
Stock Purchase Plan RIghts [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Compensation Cost Not yet Recognized
13,000,000 
 
 
Compensation Cost Not yet Recognized, Period for Recognition
0 years 2 months 
 
 
Stock Purchase Plan Shares Issued in Period
14.5 
16.5 
15.8 
Employee Purchases, Amount
432,000,000 
415,000,000 
421,000,000 
Estimated Values And Weighted Average Assumptions [Abstract]
 
 
 
Estimated values (in dollars per share)
$ 7.20 
$ 6.70 
$ 6.56 
Risk-free interest rate
1.00% 
0.50% 
0.10% 
Dividend yield
2.90% 
3.20% 
3.10% 
Volatility (percent)
19.00% 
22.00% 
25.00% 
Expected life (in years)
0 years 6 months 
0 years 6 months 
0 years 6 months 
2006 Equity Incentive Plan [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
33 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Number of Shares Authorized
786 
 
 
Number of Shares Available for Grant
215.0 
 
 
2006 Stock Purchase Plan [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Number of Shares Authorized
373 
 
 
Number of Shares Available for Grant
150.0 
 
 
Stock Purchase Plan, Purchase Price of Common Stock, Percent
85.00% 
 
 
Inventories [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
 
 
 
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount
$ 49,000,000 
$ 44,000,000 
$ 49,000,000 
Commitments (Details) (USD $)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
 
 
 
Operating Leases, Rent Expense
$ 264,000,000 
$ 282,000,000 
$ 253,000,000 
Operating Leases, Future Minimum Payments Due, Next Twelve Months
215,000,000 
 
 
Operating Leases, Future Minimum Payments, Due in Two Years
186,000,000 
 
 
Operating Leases, Future Minimum Payments, Due in Three Years
162,000,000 
 
 
Operating Leases, Future Minimum Payments, Due in Four Years
136,000,000 
 
 
Operating Leases, Future Minimum Payments, Due in Five Years
105,000,000 
 
 
Operating Leases, Future Minimum Payments, Due Thereafter
441,000,000 
 
 
Operating Leases, Future Minimum Payments Due
1,245,000,000 
 
 
Unrecorded Unconditional Purchase Obligation [Line Items]
 
 
 
Unrecorded Unconditional Purchase Obligation
2,700,000,000 
3,000,000,000 
 
Capital Addition Purchase Commitments [Member]
 
 
 
Unrecorded Unconditional Purchase Obligation [Line Items]
 
 
 
Unrecorded Unconditional Purchase Obligation
$ 12,100,000,000 
$ 7,500,000,000 
 
Contingencies (Details)
In Billions, except Per Share data, unless otherwise specified
1 Months Ended 12 Months Ended 1 Months Ended
May 31, 2009
EC Fine [Member]
USD ($)
May 31, 2009
EC Fine [Member]
EUR (€)
Dec. 30, 2017
Class Action [Domain]
Pending Litigation [Member]
lawsuit
Dec. 30, 2017
Securities Class Action [Domain]
Pending Litigation [Member]
lawsuit
Aug. 19, 2010
Mc Afee Inc [Member]
Mc Afee Shareholder Litigation [Member]
USD ($)
Jun. 30, 2012
Mc Afee Inc [Member]
Mc Afee Shareholder Litigation [Member]
Pending Litigation [Member]
USD ($)
Loss Contingencies [Line Items]
 
 
 
 
 
 
Loss Contingency, Damages Paid, Value
$ 1.4 
€ 1.1 
 
 
 
 
Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition
 
 
 
 
$ 48.00 
 
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages
 
 
 
 
 
$ 62.08 
Loss Contingency, New Claims Filed, Number
 
 
30 
 
 
Valuation and Qualifying Accounts (Detail) (Valuation allowance for deferred tax assets [Member], USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Valuation allowance for deferred tax assets [Member]
 
 
 
Valuation Allowances And Reserves, Disclosure [Roll Forward]
 
 
 
Valuation Allowances And Reserves, Beginning Balance
$ 953 
$ 701 
$ 595 
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts
237 
261 
190 
Valuation Allowances And Reserves, Net (Deductions) Recoveries
(19)
(9)
(84)
Valuation Allowances And Reserves, Ending Balance
$ 1,171 
$ 953 
$ 701